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Herein is described our work towards the total synthesis of the marine natural 
product (±)-chartelline C and the potent antibiotic (–)-platensimycin.  Part 1 relates the 
(±)-chartelline C project.  The first chapter reviews (±)-chartelline C’s isolation, 
biogeneity, and previously reported studies relevant to the area.  Chapter 2 tells of our 
contributions including the development of a convergent, regioselective assembly of an 
indole-imidazole compound en route to the natural product.  Chapter 3 includes the 
experimental details of this work and the characterization of previously unreported 
compounds.  Part 2 recounts the (–)-platensimycin research project.  Chapter 4 discusses 
the importance of the natural product and the relevant previous research reported.  
Chapter 5 describes our efforts in this area, culminating in the stereoselective synthesis of 
an intermediate closely related to a known compound, which was converted to the natural 
product.  Chapter 6 includes the experimental details of this work and the characterization 
of previously unreported compounds. 
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PART 1:  STUDIES TOWARD THE SYNTHESIS OF                            
(±)-CHARTELLINE C 
 2 
Chapter 1:  The Chartelline Alkaloids 
1.1. ISOLATION 
Marine organisms are a rich source of structurally complex and diverse natural 
products.  Alkaloids isolated from such marine organisms have been found to contain 
unprecedented molecular architectures and often possess compelling biological activity.1,2  
Bryozoans in particular, are invertebrate phyla that have served as a source of 
biologically active compounds.3  The difficulty of obtaining large quantities of these 
organisms for serious investigations has led to fewer studies relative to other sources of 
natural products.   
In 1985, Christophersen reported the isolation and characterization of chartelline 
A4 from the marine bryozoan Chartella papyracea belonging to the family Flustridae.  
This was followed in 1987 by the disclosure of chartellines B and C (Figure 1. 1).5  The 
three chartellines were collected during a diving expedition in the autumn of 1981, from 
Roscoff Marine Biological Station in the North Sea.  Organic extraction of the 
lyophilized material, followed by silica gel chromatography of the crude extract yielded 
0.07% of a compound whose structure was determined by NMR spectroscopy and 
confirmed by X-ray analysis to be that shown for chartelline A.  Due to the 
unprecedented and intriguingly complex structure of chartelline A, the remaining alkaloid 
extracts were further studied.  This resulted in the characterization of chartellines B and 
C, differing only in their halogenation patterns.   
Christophersen has also reported the isolation and characterization of 
chartellamides A and B from the same organism.6  The absolute stereochemistry was 
determined to be the same as in the chartellines based on the similarities of their CD 
 3 
curves.  The structurally related alkaloids, securamines A-D, were later isolated from 
Securiflustra securifrons, another member of the family Flustridae.7, 8    
 
Figure 1. 1:  Chartellines and Related Alkaloids 
Though they have been tested for anitmicrobial activity, neither chartelline A, nor 
the crude extracts of alkaloids, have been shown to possess any significant biological 
activity against both gram-positive and gram-negative bacteria or molds.  No significant 
biological activity has been reported for any of the chartellines, chartellamides, 
securamines, or securines.   
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1.2. STRUCTURE 
These alkaloids all consist of indole and imidazole subunits linked by an isoprene 
moiety. In the chartellines A-C (1 - 3), the subunits are linked in a 10-membered 
macrolactam ring with an unprecedented spiro-β-lactam ring at C-20 (chartelline 
numbering).  The X-ray structure of chartelline A4 reveals its unique structure; it adopts a 
cup-like conformation wherein the imidazole is orientated under the indole (Figure 1. 2).  
The configuration around C-20 was determined to be S (as shown) by Christophersen. 
 
Figure 1. 2:  3-D Representation of chartelline A 
Chartellamides A and B (4, 5) also contain a spiro-β-lactam ring but they differ in 
that they contain a trans-annular link between C-12 (the indole C-2) and C-8 (the 
imidazole C-5) creating a more compact polycyclic molecule (Figure 1. 3).   
Additionally, the polyhalogenation pattern is unlike that found in the chartellines.   
The securamines A-D (8 – 11) also are made up of indole and imidazole portions 
joined by an isoprene unit, though the macrolactam core is different.   Securamines 
contain a γ-lactam where the amide N is attached to the indole C-2.  While the 
 5 
chartellines contain a 10-membered macrolactam ring core, the securamines A (8) and B 
(9)–differing only in a bromine substituent–have a 9-membered macrolactam ring core.   
The securamines C (10) and D (11)–also differing only in bromine substitution–appear to 
be the product of indole N attack at imidazole C-5, giving rise to the compact polycyclic 
core. 
The securines A and B7 (6, 7) are comprised of a 12-membered macrolactam core, 
the largest among these alkaloids.  They were observed to form when securamines A and 
B were kept in DMSO solution.  
 
Figure 1. 3:  Related Alkaloids 
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1.3. BIOGENETIC RELATIONSHIP 
1.3.1.  Chartellines, Securamines, and Securines 
The chartellines, chartellamides, securamines and securines are all believed to be 
tryptophan, histamine, and isoprene derived natural products.  The aforementioned 
observation that the securamines open to form the securines when kept in DMSO gives 
credence to the hypothesis of a common biogeneity of these alkaloids (Scheme 1. 1).  
Furthermore, dissolution of the securines in CHCl3 gives rise to the reverse ring-closing 
process, returning the securamines.9 
Scheme 1. 1: Solvent dependent equilibrium between securamine and securine 
The securines have thus been suggested as a biogenetic precursor to the 
securamines and chartellines.  The common aza-2,4-cyclononadiene system can be 
converted from the simple macrolactam present in securine 7, into the skeleton of the 
securamines via protonation of the indole C-3 to give intermediate 12 (R = H) (Path A, 
Scheme 1. 2), followed by attack of the amide N onto the intermediate imine, thus 
delivering the γ-lactam containing securamines (9).10  Alternatively, an oxidant, such as a 
hypohalite,11 could undergo electrophilic attack at the indole C-3 to give an intermediate 
13 (R = “O”, an oxidant) (Path B, Scheme 1. 2).12, 13  In this case, the amide N would 
undergo attack at indole C-3 to displace the oxidant (likely via an extended iminium) 
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giving rise to the spiro-β-lactam found in the chartellines (1 – 3) and chartellamides (4 – 
5).  Loss of HCl installs the lower cis-olefin and gives the chartellines. 
 
 
Scheme 1. 2: Possible Biosynthetic Pathways via Securine  
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1.4. β-LACTAM FORMATION 
The idea that the unprecedented spiro-β-lactam in the chartellines and 
chartellamides is biosynthetically derived via enzymatic oxidation has its roots in the 
biosynthesis of the β-lactam antibiotics.  The penicillins 14 and cephalosporins 15 
(Figure 1. 4), stimulated great interest because of their importance as pharmaceuticals and 
because of their chemical structure.   
 
Figure 1. 4: Classes of β-Lactam Antiobitics 
The extensive research into their biosynthesis led to the conclusion that the 
“Arnstein tripeptide”  δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine 22 was the linear 
precursor to the antibiotics.  Two modes of β-lactam formation from linear 22 were 
proposed, both involving an enzymatic oxidation of an intermediate 23 (Scheme 1. 3).  
Path A entails oxidation α to the thiol, installing a leaving group (24).   Displacement by 
the amide N, forms the β-lactam and subsequent enzymatic transformations form the 
other ring, either providing penam or cepham antibiotics via 26.  Path B involves 
oxidizing the amide nitrogen to a hydroxamic acid-like intermediate 25.  In this case, an 
anion formed α to the thiol would attack the amide nitrogen, furnishing the β-lactam en 
route to the antibiotics.  Both paths have been demonstrated to be viable non-
enzymatically. 
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Scheme 1. 3:  Enzymatic Pathways for β-Lactam Synthesis 
 
1.4.1. Early examples of β-lactam synthesis 
The classical approach to β-lactam synthesis, developed by Sheehan in his 
groundbreaking synthesis of penicillin, was to use amide bond formation as the key 
disconnection.  The hypothetical biosynthetic pathways represented a different 
disconnection though.   
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The two main departures were investigated long before the chartellines were 
discovered.  Path B was demonstrated to be viable by Scott and co-workers14.  The 
synthesis of a hydroxamic acid derivative 17 was performed (from 16).  Oxidation of the 
ring sulfur to the sulfone installed a functional handle for a non-enzymatic anion 
formation.  In fact, treatment of the sulfone with potassium t-butoxide provided the β-
lactam derivative 18 in 50% yield.  While 18 was not a precursor to the penam or cepham 
antibiotics, it clearly established the capability of β-lactam synthesis via carbon to amide 
nucleophilic dispacement.   
Scheme 1. 4: Approaches to β-lactam Synthesis 
Path A, Scheme 1. 3 was utilized in work from Miller and co-workers15, 16 and 
would find application in the approach to chartelline synthesis (vide infra, 1.5.2. Isobe).  
Miller found that the use of a hydroxamic acid derivative 19 to generate an anion was 
necessary as the amide failed.  In the incidence of treating Cl-containing hydroxamic acid 
derivatives 20 with NaH, β-lactam formation was observed in 75–88% yields.  Once 
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again, while no clear mapping onto the penam or cepham antibiotics was evident, the 
route to β-lactam synthesis was shown to be feasible. 
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1.5.  STUDIES TOWARDS THE SYNTHESIS OF CHARTELLINES 
The chartellines were first disclosed in the 1980’s, yet the first published report of 
efforts towards their synthesis did not appear until 2001.17  Though there has been no 
reported biological activity, these alkaloids have spurred several research groups to 
undertake their syntheses due to their complex molecular architecture.   The focus of 
much of the published efforts has been on strategies for the synthesis of the spiro-β-
lactam.  There has been one total synthesis of chartelline C (3). 
 
1.5.1. Weinreb’s Studies Toward the Chartellines and Chartellamides 
Weinreb and co-workers were the first to report their efforts towards the synthesis 
of chartelline alkaloids.17  The strategy involved the early formation of oxindole-3-spiro-
β-lactam from an isatin derivative via [2+2]-cycloaddition.  The rest of the structure 
would be installed through nucleophilic attack at the oxindole carbonyl.  A model study 
tested the viability of a Staudinger ketene-imine cycloaddition to form the β-lactam.  In a 
system aimed at the total synthesis,18 the isatin derivative 27 was treated with an in situ 
generated ketene to yield the cycloadduct 28 in 74% from isatin.  Reduction of the 
aromatic nitro and reductive removal of the Cl provided an oxindole (Scheme 1. 5) with 
the spiro-β-lactam intact.  Installation of the three bromines around the indole ring and 
removal of the lactam protecting group furnished 29, which was ready for the proposed 
oxindole acetylene addition.   
Acetylenic imidazole fragment 31, derived in 10 steps and 7% overall yield from 
4-substituted imidazole 30, was treated with LiHMDS and then subjected to the oxindole 
29, resulting in efficient addition into the carbonyl to yield propargyl alcohol 32.  
 13 
However, propargyl alcohol 32 could not be converted to chartelline A.  Treatment of 32 
with acid resulted in the rearranged enone 33. 
 
Scheme 1. 5: Weinreb’s efforts towards the chartellines 
Weinreb’s work showed the feasibility of the Staudinger [2+2] cycloaddition to 
form the spiro-β-lactam 28 and demonstrated its stability by carrying it through the 
subsequent functionalizations and alkyne addition.  Additionally, this strategy has been 
applied in studies directed toward the total synthesis of chartellamides.19  However, while 
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the installation of the imidazole acetylene fragment via nucleophilic addition into an 
oxindole was successful, the advancement of this strategy towards the total synthesis of 
these alkalkoids has proved unsuccessful to date. 
   
1.5.2. Isobe’s Studies Toward the Chartellines 
Isobe and co-workers have disclosed several efforts towards the synthesis of the 
chartellines.20, 21  An intial disclosure into the synthesis of the β-lactam via peptide 
coupling,20 though successful in the model compounds, was never progressed towards 
chartelline C.  Their second strategy21 involved an intramolecular attack of the indole C-3 
at an electrophilic N-ONs amide (Ns = p-nitrobenzenesulfonyl).  This approach is 
obviously rooted in the work done by Scott14.  They have demonstrated the success of this 
method in the synthesis of several model indole-3-spiro-β-lactams (Scheme 1. 6).20  
Indole acetate 34 was converted to O-Ns hydroxamate 35 in 6 steps and 42% yield.  
Upon deprotonation of the indole N-H with LiHMDS, the N-ONs underwent nucleophilic 
attack to form the spiro-β-lactam 36 in 62% yield.  Isobe observed that the indole’s 6-Br 
had a large, negative impact on the efficiency of the reaction.21  In the absence of the Br, 
cyclization was facile at –78 °C and with the 6-Br present, the reaction was performed at 
room temperature with lesser success.   
Scheme 1. 6:  Isobe’s Approach to Spiro-β-lactam Synthesis 
N
H N
H
Me
N
Me
N
O
LiHMDS, THF
-78 °C - rt
Me
CO2Et
Br
O
N ONs
Br Br
62%
6 steps
42%
34 35 36
 15 
Central to this approach is the assumption that this method will be applicable to a 
more complex substrate containing both an indole and imidazole portion present in the 
natural product.  Towards that end, () a method for the synthesis of an appropriate N-ONs 
hydroxyenamide was sought.22  Isobe showed that the reaction of an imidazole containing 
oxime 38 with an indole-3-acetyl chloride 37 provided an N-(O-allyl) enamide 39.  While 
the O-allyl protecting group was removed easily on simpler substrates, the indole-
imidazole containing substrate was left unchanged.  Additionally, the process resulted in 
E-enamides exclusively, thereby questioning the relavancy of this approach towards a 
total synthesis of Z-olefin containing chartelline C. 
 
Scheme 1. 7:  Isobe’s hydroxyenamide formation 
 
1.5.3. Baran’s Total Synthesis of (±)-Chartelline C 
Baran and co-workers completed the total synthesis of chartelline C in 2006.23, 24  
The strategy employed therein is based on the supposition that the spiro-β-lactam could 
arise from a late-stage oxidative cyclization, similar to that proposed in the biosynthesis 
of these alkaloids (Scheme 1. 2).    
Initial studies on a model system, reported in 2005,23 established the viability of 
using a hypervalent bromine (NBS) oxidation on a securine-like macrolactam to instigate 
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Reagents and Conditions: a) CH2Cl2, 3Å MS, !; b) p-TsOH, CH3CN, 39%
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the β-lactam formation.  The synthesis of such a macrolactam and the application of the 
developed method to the real system was reported a year later.24 
The report commences with the Sonogashira coupling of 6-bromo-2-iodo-indole 
42 (derived from 6-bromoindole 40 in 6 steps and 44% yield) with imidazole acetylene 
43 (prepared from O-TBS serine methyl ester 41 in 4 steps and 50% yield).  The Pd 
catalyzed coupling occurs at the 2-iodo selectively, yielding alkyne 45 in 85% yield 
(Scheme 1. 9).  Reduction of the acetylene with Raney Ni to the cis-alkene–leaving the 
aromatic Br intact–preceded removal of the O-TBS and oxidation to the aldehyde.  The 
strategy for formation of the macrolactam was to perform an intramolecular Horner-
Wadsworth-Emmons (HWE) on the aldehyde.  To do this, the 3-indole acetate was 
hydrolyzed to the acid and coupled with phosphonate amine 44 to give the HWE 
precursor 46.  The cyclization provided an enamide in 56% yield, which upon sequential 
treatment with Br2 and N-bromoacetamide (NBA) gave the tribromo macrolactam 47. 
With a successful synthesis of a polyhalogenated macrolactam 47, the first such 
reported in this area, Baran examined the oxidative formation of the spiro-β-lactam.  In 
the initially reported model system, the ring contraction was found to proceed on an N-H 
indole macrolactam upon exposure to NBS.  Therefore, the N-Boc on the indole 47 was 
removed thermally (185 °C, neat) in the polyhalogenated system (Scheme 1. 9).  The 
intermediate N-H indole was taken up in acetonitrile and upon exposure to NBS at 
ambient temperature was converted to the β-lactam 50.  While several mechanistic 
pathways are possible and may likely be operable, the mechanism suggested by Baran is 
shown (Scheme 1. 9).  Bromination at C-20 (indole C-3) would form an intermediate 
imine 48.  The amide would then attack the imine at the indole C-2, contracting the 
macrolactam and providing a securamine-like pyrroloindoline.  Loss of the indole C-3 
bromine, forming the extended imine species 49, initiates a [1,5]-shift of the amide 
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converting the pyrrolindoline 49 into the β-lactam 50.  Upon workup of the reaction with 
aq. NaCl (brine), the enamide Br mildly exchanged for Cl, generating the chartelline-like 
51 in a remarkably facile and efficient 93% yield over the three steps.   
 
Scheme 1. 8: Baran’s synthesis of a securine-like macrolactam 
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Completion of the synthesis required only to remove the ester of the enamide.  
This was achieved by hydrolysis of the trimethylsilylethyl (TMSE) ester 51 to its acid 
and a thermal decarboxylation.  Heating of the intermediate acid to 200 °C in 
o-dichlorobenzene (DCB) for 5 min, cleanly decarboxylated to provide chartelline C (3).   
Thus, the first total synthesis of a chartelline alkaloid had been achieved in a 
straightforward and elegant fashion.  The work featured a remarkably facile, 
“biosynthetically inspired” strategy of securine-like macrolactam contraction to form the 
spiro-β-lactam in the chartellines. 
 
Scheme 1. 9:  The completion of Baran’s total synthesis of chartelline C 
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1.6. STUDIES TOWARDS THE SYNTHESIS OF SECURINE AND SECURAMINE 
The securines and securamines are biogenetically and structurally related to the 
chartellines, though there has been only one published report of synthetic effort towards 
these compounds.   
 
1.6.1. Wood’s Studies Toward the Synthesis of Securine A 
Wood and co-workers disclosed their work towards the synthesis of securine A,25 
culminating in the synthesis of a securine A carbon skeletal compound (Scheme 1. 10).  
The strategy entailed the rearrangement of a macrolactone to the macrolactam present in 
securines. 
The work commenced with the synthesis of imidazole 52 in 8 steps and 27% yield 
from ketone 51.  Coupling of the terminal acetylene to iodoarene 53 followed by a Pd(0) 
mediated indole formation gave the indole 54.  Protection of the alcohol as its silyl ether 
preceded functionalization of the vinyl species on the imidazole, which was best achieved 
via iodonium ion formation and opening with acetate.  Displacement of the primary 
iodide with azide gave macrolactone precursor  55.  Hydrolysis of the indole-3-acetate 
and the benzylic acetate was facile and gave way to a Yamaguchi lactonization to give 
macrolactone 56.  Reduction of the azide with tributyltin hydride and AIBN provided an 
intermediate amine that underwent an acyl transfer to the macrolactam 57 in 55% yield.  
Hydrogenolysis to cleave the imidazole N-benzyl to the N-H 58 went in 77% yield.  
Disappointingly, treatment of the diol 58 with tributylphosphine and carbon tetrachloride 
converted the northern alcohol to a Cl, while the lower hydroxyl was eliminated.  The 
hope was that the converse would occur, providing securine A 6.  The macrolactam 58 
exists as a mixture of olefin isomers.   
 20 
Scheme 1. 10: Wood’s Approach to the Securines 
While Wood’s strategy for macrolactam formation was successful, producing a 
securine-like 59 containing all of the carbons and nitrogens of the natural product, 
advancement to the enamide present in securine proved unfruitful. 
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1.7. CONCLUSIONS  
Chartelline A’s (1) isolation was reported in 1985 followed by chartellines B (2) 
and C (3) in 1987.  Their disclosure as isolates from the marine bryozoan Chartella 
papyracea described the structurally unprecedented molecules as displaying an unusual 
“boat-like” conformation and consisting of polyhalogenated indole, imidazole, and 
isoprene units joined in a macrolactam with a spiro-β-lactam at the indole C-3.  Though 
they were not found to exhibit any significant biological activity, these intriguing 
alkaloids have generated great interest in the synthetic community.   Weinreb, Isobe, and 
Baran worked towards the total synthesis of the chartellines, each demonstrating different 
strategies to the β-lactam formation.  Baran’s work culminated in the total synthesis of 
chartelline C.   
Additional alkaloids consisting of similar structural elements were later reported 
and are believed to be biogenetically related to the chartellines.  The chartellamides (4, 5) 
and securamines (8 – 11) are virtually constitutional isomers of the chartellines, varying 
in connectivities around the macrolactam and in halogenation patterns.  None of these 
have been shown to possess any biological activity.  The chartellamides have been the 
subject of study by Weinreb.  The securines (6, 7), which resulted from the securamines 
storage in DMSO, are simpler macrolactam stuctures than the other alkaloids discussed.  
Wood has reported work towards the synthesis of securines.  It was suggested by 
Christophersen that the securines may be biosynthetic precursors to both the chartellines 
and securamines. 
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Chapter 2:  Efforts Towards the Synthesis of Chartelline C 
2.1. SYNTHETIC STRATEGY 
Inspired by the hypothesis that the chartelline alkaloids are biogenetically related 
to the securines and securamines, our synthetic strategy was based on the supposition that 
the β-lactam could be accessible via oxidation of a suitable substrate.   The chartelline C 
(3) skeleton would be formed by a late-stage oxidative cyclization of a securine-like 
macrolactam (60) (Scheme 2. 1).  The macrolactam is seen arising from an 
intramolecular amide formation of an indole-imidazole substrate 61.  The indole-
imidazole substrate could arise from the convergent assembly of a 2-halo-indole 62 and 
an acetylenic imidazole 63.  An acetylene is seen as being advantageous due to the 
plethora of methods available for its reduction to a cis-olefin. 
Scheme 2. 1: Synthetic Strategy 
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 Central to this strategy is the ability to selectively halogenate the C-2 of indole in 
the presence of the 6-Br, a component of the natural product.  Additionally, the synthesis 
of a 2-H-4,5-substituted imidazole presents certain challenges that would need to be met.   
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2.2. INDOLE SYNTHESIS 
The first objective in our efforts towards the synthesis of chartelline C 3 is the 
achievement of a 6-bromo indole substrate with the ability to functionalize the 2 position 
selectively.  Also, the presence of an acid surrogate in the 3-position that would be 
amenable to macrolactamization was sought.  In consideration of methods to attach an 
acetylenic component at the indole C-2, the Sonogoshira cross-coupling1 of an aryl halide 
and terminal acetylene seemed a direct solution.  Therefore, a selective Sonogashira 
coupling of a 2-halo-6-bromo indole was initially investigated. 
 
2.2.1. First Generation Indole Synthesis 
While many methods for the synthesis of indoles have been developed, 2, 3  we 
desired a flexible route with respect to substitution at indole C-3.  Several routes were 
initially investigated4 with varied success, leading to the use of the Bischler-Möhlau 
synthesis to access a suitable substrate.   
The Bischler-Möhlau synthesis involves the intramolecular condensation of an 
α-anilino-ketone to form an indole (Scheme 2. 2).  An aniline 64 can be treated with an 
α-halo ketone 65, providing the Bischler-Möhlau precursor 66.  Upon heating of the α-
anilino ketone 66 with acid present, the electrophilic aromatic addition of the ketone to 
the arene followed by a dehydration/aromatization provides indole 67.  The R-groups on 
the α-ketone become the 2,3-substituents on the indole ring produced.  This strategy for 
the synthesis of an indole 68  seemed well-matched. 
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Scheme 2. 2: The Bischler-Möhlau Indole Synthesis 
In this case, 3-bromoaniline was the starting aniline 70.  The reductive amination 
of 3-bromoaniline 70 with benzaldehdye provided N-benzyl 71 in 98% yield (Scheme 2. 
3).  Treatment of aniline 71 with bromo-β-ketoester 72 (prepared from the β-ketoester) 
gave the Bischler-Möhlau substrate 73, which upon heating with a Lewis acid, 
dehydrated to a mixture of 4-bromoindole 74 and the desired 6-bromoindole 75.  After 
extensive experimentation, it was found that the best results were obtained when TiCl4 
was the Lewis acid.  A 6-bromo/4-bromo cyclized product ratio of 5:1 was obtained in a 
combined 78% yield.   Bromination at indole C-2 with NBS provided a 
2,6-dibromoindole 76 used to investigate the regioselectivity of Sonogashira couplings. 
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Scheme 2. 3: Bischler-Möhlau Synthesis of 6-Bromoindole 76 
Disappointingly, subjecting indole 76 to a standard set of conditions (Pd(II), CuI, 
Et3N) with triisopropylsilylacetylene 77 as the alkyne gave a mixture of 2-coupled (79), 
6-coupled (78), and 2,6-dicoupled products (80) (Scheme 2. 4). Although 2-iodo indoles 
were also investigated, selectivity in a Sonogashira coupling with a 2-halo-6-bromo-N-
benzyl indole could not be achieved.4 
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Scheme 2. 4: Unsuccessful regioselectivity 
Conversion of the N-benzyl indole 75 to an N-Boc indole was achieved in a three 
step process (Scheme 2. 5).  Removal of the benzyl group with AlCl3–hydrogenolysis 
methods gave indolines–followed by bromination of the intermediate indole and Boc 
protection, furnished N-Boc-2,6-dibromoindole 81.  The yield over the three steps was a 
modest 19%, however enough material for the desired investigative reactions was 
obtained. 
In the event, treatment of indole 81 with triisopropylacetylene 77 in the presence 
of Pd(PPh3)2Cl2, CuI, and NEt3 delivered only the 2-coupled product 83 in an 82% yield.4  
This result established the necessity of using an N-Boc protecting group on the indole for 
the purpose of obtaining regioselective functionalization of the indole C-2 through Pd 
cataylzed coupling.   
The origin of the regioselectivity is at present unclear.  Purely inductive effects 
could be responsible.  As the carbamate withdraws electron density from the indole ring, 
the proximal C2–Br bond is weakened relative to the distal C6–Br.  This possibly lowers 
the activation energy for Pd insertion at C-2, causing the increased rate of C-2 coupling.   
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While the weakening of the C–Br bond is a reasonable explanation–it agrees with the 
observations in the literature that aryl iodides are faster to couple than aryl bromides–it is 
not in agreement with the general observation that more electron rich aryl halides react 
faster when other factors are equalized.1  
Alternatively, the carbamate could act as a directing group by a pre-coordination 
to the Pd.  In this case, insertion of Pd into the adjacent C2–Br bond would be faster based 
on a steric argument; that the Pd, while coordinated to the carbamate O, cannot reach the 
farther C6–Br.  Both of these arguments are based on the assumption that Pd insertion is 
the rate determining step, an assumption still up for debate and one that seems substrate 
dependent.  At this point, the cause of the observed selectivity has not been 
unambiguously determined.  
 
Scheme 2. 5: A regioselective Sonogashira coupling 
In any case, this route to 2,6-dibromoindole-3-acetates would not have been 
amenable to obtaining sufficient quantities of indole 81.  A more direct route was desired.  
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2.2.2. Second Generation Indole Synthesis 
Smith and co-workers have previously demonstrated the regioselective 
dibromination of certain indoles via a SiO2 mediated bromination with NBS.5  The 
examples they showed did not include any with an acetate at C-3; rather a C-3 
acetonitrile example was deemed relevant precedence.  Clearly, introduction of the 
nitrogen had been previously planned on arising from the imidazole component of the 
convergent synthetic plan.  It seemed reasonable that considering the large number of 
known methods of converting nitriles6 to amides,7 esters, and acids8 that substitution of 
the acetate for an acetonitrile might be advantageous.   
Indole-3-acetontrile9, though commercially available, was accessed cheaply from 
indole-3-carboxaldehyde.10   Reduction of the aldehyde 84 followed by heating with an 
excess of NaCN produced the indole-3-acetonitrile 85 (Scheme 2. 6).  Indole 85, in 
accordance with Smith’s report, was found to regioselectively brominate at the 2 and 6 
positions upon treatment with NBS in the presence of SiO2 (rigorously dried).  While the 
bromination appeared to work well, the intermediate dibromo indole 86 could not be 
isolated in appreciable quantities.  Such indoles are known to be readily hydrolyzed to 
oxindoles11,12 and while no oxindole was observed either, in situ protection as its t-butyl 
carbamate allowed for 2,6-dibromo indole 87 to be isolated in 54% yield. 
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Scheme 2. 6: Synthesis of indole 87  
Normally, bromination of indoles occurs quickest at the 2 position (as in this case) 
and then at the 5-position, para to the nitrogen.  The exact cause of the shift in 
bromination pattern is unclear.  It is possible that the silica gel becomes covalently bound 
to the N, producing an ammonium species.  This would shut off the donating effect of the 
N, the reason for 5-bromination.  Now the alkyl substitution presents a tolyl-like arene, 
directing bromination to the observed 6-position. 
The bromination of an indole in the 2 and 6 positions clearly represents a direct 
route to the desired indole.  However, the regioselective cross-coupling had been found 
on the indole-3-acetate.  Gratifyingly, the Sonogashira reaction displayed the same level 
of control in the test reaction shown (Scheme 2. 7).  Indole 87 could be coupled with the 
propargyl acetate 88 giving only the 2-coupled product 89 in 42% yield.  This result was 
also important because the quaternary carbon in alkyne 88 was a mimic for the steric 
environment of our proposed substrate en route to chartellines. 
N
H
N
H
CN
N
H
CN
Br
Br
N
CN
Br
Br
Boc
NaBH4, NaCN, 
MeOH/Formamide, 100 °C
NBS, SiO2 
CH2Cl2, 25 °C
Boc2O, Et3N,
DMAP, CH2Cl2, 25 °C
CHO
54%
85%
84 85
86 87
 34 
Scheme 2. 7: Test Sonogashira coupling of indole 87 
A viable, two-step synthesis of indole 87 and its regioselective functionalization 
(to 89) had been established.  The synthesis of a suitable alkyne coupling partner was 
investigated. 
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2.3. IMIDAZOLE SYNTHESIS 
Imidazole is a very common structural motif in alkaloids13 and as such, there have 
been many methods developed for their syntheses14.  Our strategy for the synthesis of the 
imidazole acetylene envisioned as the coupling partner to indole 87 for the convergent 
synthesis of chartelline C 3 is discussed herein.  
 
2.3.1. An imidazole coupling partner 
The notion that a 1,2-diketone 90 could be efficiently converted to an imidazole 
91 was central to the employed strategy (Scheme 2. 8).  As the carbonyl carbons of the 
1,2-diketone 90 become the C-4 and C-5 of the imidazole  91, it seemed a straightforward 
starting point for investigation into synthesis of the 4,5-disubstituted imidazole 93.  The 
use of the 1,2-diketone disconnect for imidazole synthesis is usually successful on those 
dicarbonyls without α-protons; an advantage we have with one carbonyl.  Therefore, the 
synthesis of an α-gem-dimethyl 1,2-diketone 92 was the focus.  
Scheme 2. 8:  The conversion of 1,2-dicarbonyl compounds to imidazoles 
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The work commenced with the protection of 1,4-butanediol 94 as its mono-benzyl 
ether (Scheme 2. 9).  Oxidation of the primary alcohol to the aldehyde 95 was found to 
proceed best (83% yield over the two steps) with Dess-Martin periodinane15 (DMP) as an 
oxidant.  The Horner-Wadsworth-Emmons reaction of the aldehyde with 
triethylphosphonoacetate gave α,β-unsaturated ester 96 in 90% yield.   
To install the α-gem-methyls, a deconjugative alkylation of α,β-unsaturated ester 
96 was imagined.  During initial investigations into the deconjugative alkylation, it was 
observed that the addition of HMPA to the reaction had a great impact on its efficiency.  
The extended enolate was formed upon treatment of α,β-unsaturated ester 96 with 
LiHMDS at –78 °C, however in the absence of HMPA, quenching of the anion with MeI 
only produced modest yields of the desired product.  The presence of HMPA improved 
the conversions and yields to quantitative.   
 
Scheme 2. 9:  Synthesis of α,β-unsaturated ester 97 
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Under the optimized conditions, both alkylations could be carried out sequentially 
in a one-pot process (99% yield over the two alkylations).  The deconjugated olefin in the 
product was obtained as an inseparable mixture of E and Z isomers.  The olefin would 
serve as a functional handle for introduction of the 1,2-diketone while the α-gem-
dimethyl ester 97 would be converted to the terminal alkyne. 
Conversion of the ester to an alkyne was most successfully accomplished in a 
three-step process (Scheme 2. 10).  Reduction with LAH followed by oxidation of the 
crude alcohol with DMP provided separable aldehydes trans-99 and cis-99 in an 
approximately 1 : 7 ratio.  The homologation of the aldehydes was achieved with the 
Ohira16, 17 reagent (100).  Attempts at the utilization of the two-step Corey-Fuchs protocol 
for the conversion of aldehydes to alkynes were less successful.  Treatment of the 
aldehydes 99, carried out as a mixture of olefin isomers in MeOH with K2CO3, with the 
Ohira reagent 100 furnished the terminal alkyne 101 as a mixture of internal olefin 
isomers in 96% yield.  
Scheme 2. 10: Synthesis of diols trans-102 and cis-103 
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Dihydroxylation of the internal olefin yielded the diastereomeric diols trans-102 
and cis-103 in approximately a 1 : 7 ratio, suggesting that no isomerization occurred 
during the homologation or dihydroxylation.  When potassium osmate dihydrate was 
employed as the catalytic oxidant, as opposed to OsO4, the diols could be obtained in a 
quantitative yield (in all examples NMO was used as the stoichiometric oxidant). 
To prepare the 1,2-diketone, the direct precursor to an imidazole, oxidation of the 
diol was undertaken.  In this case, it was found to work most efficiently with SO3•pyr in 
DMSO to give an 83% yield of the α-dicarbonyl 104 as a bright yellow oil, diagnostic of 
this functional group (Scheme 2. 11).  With the diketone in hand, conversion to the 
imidazole18 was next.  To accomplish this, a nitrogen source, an aldehyde source and an 
acid were necessary.  After screening conditions, the use of NH4OAc, paraformaldehyde, 
and acetic acid (as solvent) were determined for use.  Heating of the α-dicarbonyl to 100 
°C in the presence of these reagents provided imidazole 105 in 74% yield.  It is worth 
noting that the reaction, even under these optimized conditions, behaved capriciously.  
While the yield of product was found to be inconsistent, the reaction always gave a 
separable mixture of the starting dione 104, which could be recycled, and the product 
imidazole 105. 
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Scheme 2. 11:  Synthesis of imidazole 106 
Protection of the imidazole 105 as its methoxymethyl (MOM) aminal, performed 
with MOMCl in benzene, provided imidazole 106 in 75% yield.  Thus, with a synthesis 
of an imidazole acetylene 106 accomplished, its ability to couple with the indole was 
investigated. 
 
 
2.3.2. Unsuccessful Coupling 
Application of the previously established conditions (vide supra) for the 
Sonogashira coupling1 of indole 87 were utilized in the coupling of imidazole 106.   
Disappointingly, no product 107 was observed (Scheme 2. 12).  At mild temperatures (20 
°C to 45 °C), as in the conditions used for simpler alkynes, no reaction occurred and the 
starting materials were returned (the indole 87 could be recovered quantitatively).  
Warming of the reaction only led to complex mixtures of products, with no evidence of 
the desired coupling product.  It appeared that temperatures nearing and above 100 °C led 
to decomposition of the indole, either through loss of the N-Boc or reduction of the 2-Br 
SO3.pyr, DMSO,
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to a 2-H.  Additionally, the use of different solvents, amine bases, or Pd sources 
[Pd2(dba)3, Pd(PPh3)4, Pd(OAc)2, and Pd/C] resulted in similar reaction failures.   
 
Scheme 2. 12: The attempted imidazole Sonogashira coupling 
The mechanism of the Sonogashira coupling is shown (Scheme 2. 13).  The 
possibly of a 2-H indole product being formed was encouraging.  It implied Pd insertion 
was occurring (A, Scheme 2. 13).  The ability of a generic Pd catalyst 108 to insert into 
87, forming intermediate 109 (not isolated) meant that the transmetalation of the Cu-
acetylide to Pd (B) was not taking place, as the ensuing reductive elimination (E) is 
generally considered fast.  The lack of transmetalation was surprising, in that it clearly 
was not an issue for simpler terminal acetylenes, including those with similar steric 
congestion adjacent to the alkyne.  This would limit the possibilities of problems to either 
the formation of the copper acetylide (C or D) or in its ability to transmetalate to Pd (B).    
NBr
Boc
Br
CN
N
MOM
N
BnO
NBr
Boc
NC
N
MOM
N
OBn
+
87 106 107
 41 
Scheme 2. 13: Mechanism of the attempted Sonogashira coupling of 106 and 87 
In order for the copper acetylide 110 to form, pre-coordination of the Cu(I) salt to 
the acetylene (111) must occur (C).  The ability of Cu (112) to coordinate 106 or the 
ensuing deprotonation of the alkyne H (D) to give 110 seemed the most likely causes. 
While there are many examples of Sonogashira coulings where the aryl halide is 
an imidazole, there are few examples where the acetylenic partner contains an imidazole. 
We reasoned that the existence of the imidazole N-3 might be shutting the reaction off as 
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this seemed the most obvious structural difference between those couplings discussed 
herein (vide supra, Scheme 1. 8) that worked and those that did not. Either the Cu(I) was 
bound by the N (113) and therefore not forming the copper acetylide–which forms via 
initial coordination of the alkyne to the CuI (114)–or the copper acetylide was bound by 
the N (dimerized) and therefore unable to transmetalate (Scheme 2. 14).  The formation 
of a imidazolium-copper species 113 may be invoked in either case.  This species would 
be expected to be higher in enegy than the normal copper acetylide and may decompose 
in an undetermined way.  Alternatively, the coordination and formation of an 
imidazolium 113 could increase the energy necessary for copper to insert into the alkyne 
C-H bond.   
The use of excess CuI, either in the presence of Pd or absence (Castro-Stephens 
type coupling19) did not meet success.  These results were made especially troubling by 
the eventual disclosure by Baran (vide supra) of a similar Sonogashira couplings23, 24 
success, reported a year after this approach was abandoned.  The conditions disclosed in 
Baran’s report were attempted with our substrates and yet we still had no success with an 
imidazole acetylene.  The conspicuous difference between their successful substrate 43 
and our attempted substrate 106 was the absence of a protecting group on the imidazole 
N.  The pathway that possibly led to the failure in our case, would not present such a 
hindrance in theirs.  The copper-imidazolium species could lose a proton forming 115, 
which is not charged and formation of the copper-acetylide should therefore be relatively 
unaffected.  Owing to these failures, it was decided to look into alternative coupling 
partners. 
 43 
Scheme 2. 14: Possible Problems in Copper Acetylide Formation  
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2.4. AN ALTERNATIVE IMIDAZOLE SOURCE 
2.4.1. First Generation Alternative Coupling Partner 
The hypothesis that the presence of a pyridine-like nitrogen was disabling the 
Sonogashira coupling from occurring led us to pursue an alternative strategy.  The 
options were to pursue an alternative coupling strategy that would be amenable to the 
imidazole acetylene 106 or pursue an alternative coupling partner that could utilize the 
already established coupling conditions.  The convergent assembly of an acetylenic 
imidazole precursor and the indole 87 seemed attractive. 
A protected diol was first examined as a substrate.  A mixture of diols trans-102 
and cis-103 were protected as their 1,2-acetonide 116 by stirring in acetone with catalytic 
p-TsOH in 95% yield (Scheme 2. 15).  The acetonide was chosen as a diol protecting 
group due to its ease of attachment and removal,20 and the supposed orthogonal 
relationship with the other protecting groups.  
 
Scheme 2. 15:  Protection of diols 102 and 103  
The key test was in the ability of acetonide 116  to undergo the Sonogashira 
coupling.  In fact, treatment of indole 87, in the presence of PdCl2(PPh3)2, CuI, in 
triethylamine, with acetonide acetylene 116 produced the desired coupling product 117 
(Scheme 2. 16).  By heating the reaction to 65 °C, a 93% yield of coupled product 117 
could be obtained.   
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Scheme 2. 16:  Acetonide 116 in the Sonogashira coupling 
With the successful coupling of indole 87 and acetonide 116, the objective was to 
advance the 1,2-acetonide in 117 to an imidazole as in 107.  Removal of the 1,2-
acetonide in 117 was achieved mildly by transketalization with MeOH and p-TsOH 
(Scheme 2. 17).  The deprotected diol 118 could be obtained near quantitatively (98%) 
via this route.  The direct coupling of diols 102 and 103 were successful, albeit in lower 
yields.  It was found to be more efficient to prepare the acetonide, couple it with the 
indole, and remove the acetonide (87% over three steps) than the direct coupling of the 
diols (42%).  These successful reactions furthered the assumption that the Sonogashira 
coupling was simply incompatible with our imdiazole acetylene and so this route was 
further explored.  
The coupled diol 118 was oxidized to the 1,2-dicarbonyl 119 using Dess-Martin 
periodinane (Scheme 2. 17).  Strangely, while the Dess-Martin reagent was used (vide 
supra) on the uncoupled substrates in lower yielding reactions, the SO3•pyr and DMSO 
conditions proved less effective in this case.  In any event, the α-dicarbonyl 119 was 
submitted to the imidazole forming conditions and was degraded by them.  However, 
lowering the temperature of the reaction from 100 °C to 65 °C produced an acceptable 
yield of 61% of the imidazole 120.  The decomposition of the dione 119 is believed to 
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arise from the loss of the N-Boc on the indole under the acidic conditions.  This should be 
facile, and the resultant unprotected indole might then decompose via a gramine-like 
intermediate (vide infra, Scheme 2. 31). 
 
Scheme 2. 17:  Advancement of acetonide 117 to indole 120 
With the desired indole imidazole compound 120 in hand, the reduction of the 
acetylene to a cis-olefin was examined (Scheme 2. 18).  Initial attempts, using in situ 
generated diimide, returned the starting acetylene unchanged.  Hydrogenations with 
Lindlar’s catalyst, Pd on BaSO4, and PtO2 failed to give the desired product.  
Hydrogenations with Pd/C or Raney Ni returned complex mixtures of products, probably 
resulting from hydrogenolysis of the benzyl ether and loss of the aromatic bromide.  
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Scheme 2. 18: The unsuccessful hydrogenation of acetylene 121 
In a desire to screen conditions for olefin formation without aromatic bromide 
loss, acetonide 122 was hydrogenated (Scheme 2. 19).  Still, the mild diimide reductions 
failed.   Screening of catalytic hydrogenations resulted in similar trends as observed in 
the imidazole series.  Lindlar’s catalyst, Pt/C, Rh/C and Pd on BaSO4 were apparently too 
mild as they returned the alkyne unchanged.  Raney Ni returned a mixture of olefinic 
compounds, but the aromatic bromide was clearly lost.  The use of Pd/C also gave 
olefinic products, though it appeared that the aromatic bromide and benzyl ether had been 
lost.  Fortunately, PtO2 (Adam’s catalyst) was found to deliver the cis-olefin 123.  
Unfortunately, the reaction was exceedingly slow, and was unable to be driven to 
completion cleanly.  After lengthy reaction times, an undesirable overreduction appeared.   
Cyclohexyl 124 was obtained as the major product when the starting material was 
completely consumed.   
While PtO2 is known to be resistant to hydrogenolytic removal of benzyl ethers, 
its use as an aromatic hydrogenation catalyst is known.  Further complicating matters, the 
alkyne and cis-olefin were inseparable, and the reaction could only be monitored by 1H 
NMR analysis of worked-up aliquots.  In fact, it seems the cyclohexyl product 124 was 
formed from the cis-olefin product 123 as no cyclohexyl alkyne species were ever 
observed.  The existence of 124, while separable from the mixture of starting alkyne 122 
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and olefin 123, presented a problem as the selective removal of the 
cyclohexylmethylenoxy ether would be extremely difficult.   
 
Scheme 2. 19: The hydrogenation and over-reduction products 
In any case, with cis-olefin 123 in hand, its advancement to imidazole 121 was 
explored (Scheme 2. 20).  Again, removal of the acetonide was facile, yielding 98% of 
the diol 124.  The diol was oxidized, using the Dess-Martin periodinane, for a 50% yield 
of dione 125.  The imidazole 121 could then be formed under the same conditions as 
before in a modest 20% yield.  
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Scheme 2. 20: Synthesis of indole-imidazole 121 
 
2.4.2. Second-generation coupling partner 
The use of a benzyl ether had become a hindrance to the synthesis of chartelline C 
3.  As such, an alternative was sought that would be easily removable, yet robust enough 
for the protocol established thus far.  With a high-yielding, scalable route to O-benzyl 
ether diols 102 and 103 established, and a moderate quantity in hand, the alternative 
protecting group investigation started here.   
Initially, removal of the benzyl ether from coupled acetonide 117 was considered.  
As the incompatibility of hydrogenolysis to the substrate had been established, lewis 
acids BCl3 and BBr3 were tried.  However, it appeared that acetonide deprotection 
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occurred quicker than benzyl ether cleavage.  Therefore, an alternative to the acetonide 
that might allow for benzyl ether cleavage after coupling to the indole was sought. 
Protection of the early diol intermediate 102 as its 1,2-carbonate 126 was carried 
out (Scheme 2. 21).   Treatment of diol 102 with triphosgene provided the carbonate 126 
in 87% yield.   
 
Scheme 2. 21:  Carbonate 126 synthesis 
The inherent substrate differences associated with the Sonogashira couplings of 
indole 87 gave us pause with respect to changing from acetonide 116 to carbonate 126.  
Gratifyingly, the carbonate had no effect on the coupling’s success, and was able to be 
performed at room temperature without addtional warming(Scheme 2. 22).  The reaction 
of indole 87 and carbonate 126 with PdCl2(PPh3)2 and CuI gave coupled alkyne 127 in 
51% yield.  With the coupled carbonate alkyne 127 in hand, it was worthwhile 
investigating the removal of the carbonate, as its orthogonal cleavability was essential to 
the approach.  This was achieved mildly with NaOH (aq.) in dioxane to provide diol 128, 
identical to that previously synthesized. 
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Scheme 2. 22: The coupling of carbonate 126 and indole 87 
 Removing the benzyl group while leaving the molecule otherwise intact, however, 
proved difficult.  Treatment of benzyl carbonate compound 127 with BCl3 (Scheme 2. 23) 
cleaved the benzyl group but also cleanly removed the N-Boc, in the process giving N-H 
indole 129 in 52% yield.  None of the desired alcohol, with the N-Boc intact, was 
observed.  Attempts to reinstall the N-H Boc on the indole returned the bis-Boc product 
130 in 41% yield.  It seems that exchange of the benzyl group would be best 
accomplished earlier in the synthesis.   
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Scheme 2. 23: Attempted benzyl ether cleavage 
The viability of a carbonate in the synthesis having been established, the problem 
of the benzyl ether could be addressed.  The choice of silyl ether as protecting group was 
chosen because they are inert to catalytic hydrogenation and are generally easy to remove 
upon treatment with fluoride.  Therefore, the benzyl ether in carbonate 126 was converted 
to the triisopropylsilyl ether carbonate 131 in a two-step process and 89% overall yield 
(Scheme 2. 24). 
 
Scheme 2. 24:  Carbonate 131 Synthesis 
The triisopropylsilyl carbonate 131 was now used in the coupling with indole 87 
producing alkyne 132 in 67% yield (Scheme 2. 25).  
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Scheme 2. 25:  Coupling of carbonate acetylene 131 and indole 87 
Having shown the capability of the TIPS-carbonate 131 to perform the 
Sonogashira coupling, the synthesis of 131 from 1,4-butanediol 94 was carried out. The 
work commenced with the protection of 1,4-butanediol 94 as its mono-silyl ether in 89% 
yield (Scheme 2. 26).  Oxidation of the primary alcohol to the aldehyde 133 was once 
again best 96% performed with the Dess-Martin periodinane15 (DMP) as an oxidant.  The 
Horner-Wadsworth-Emmons reaction of the aldehyde with the same phosphonate as 
before gave α,β-unsaturated ester 134 in 81% yield.  The deconjugative alkylation of 
α,β-unsaturated ester 134 was operated in a step-wise fashion without optimization to a 
one-pot process to provide the dialkylated 135 in 67% after the two reactions.    
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Scheme 2. 26: Synthesis of ester 135  
Conversion of the ester 135 to alkyne 138 was again accomplished in a three-step 
process (Scheme 2. 27).  Reduction with LAH followed by oxidation of the crude alcohol 
with DMP provided separable aldehydes trans-136 and cis-136 in an approximately 1 : 7 
ratio and 96% yield over the two steps.  The subsequent homologation of the aldehydes 
was achieved with the Ohira reagent 100, providing the alkyne 138 in 70% yield.  
Dihydroxylation of the internal olefin with potassium osmate dihydrate yielded the TIPS 
diols trans-139 and cis-140 in approximately 1 : 7 ratio.  Interestingly, the cis-140 is 
obtained as a white solid while the trans-139 exists at room temperature as a colorless oil.  
In any event, treatment of the diols with triphosgene provided the carbonate 131 
spectroscopically identical to that produced before.  
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Scheme 2. 27:  Carbonate diol synthesis 
With a more straightforward approach to the synthesis of alkyne 131 established, 
our attention returned to the coupled carbonate 132.  Hydrogenation of the alkyne 132 to 
the cis-olefin 141 proceeded well using the PtO2 protocol (89%) (Scheme 2. 28).  The 
carbonate was removed using NaOH (aq.) in dioxane and the crude diol 142 was oxidized 
using the Dess-Martin reagent for a 43% yield of dione 143 over two steps.  The dione 
143 could then be converted to the imidazole 144 as before.  The product obtained, 
imidazole 144, consisted of all the carbon’s present in the natural product, chartelline C 
(3).   
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Scheme 2. 28: Synthesis of imidazole 144 
With a compound composed of all of the carbons in the chartelline, securamine, 
and securine skeletons, the formation of a securine-like macrolactam was the next 
objective.  As the original synthetic strategy was to assemble the lactam bond via an 
intramolecular peptide coupling, necessitating an acid and amine, a re-evaluation was in 
order.  It seemed at the time, counter-productive to install a N by converting the silyl 
ether to an amine, while removing the nitrogen of the nitrile by hydrolyzing it to an acid.  
Therefore, an alternative macrolactamization strategy was envisaged. 
 
NaOH, Dioxane
NH4OAc, (CH2O)n
AcOH, 60 °C, O/N
H2, PtO2, EtOH
89%
50%
NBr
Boc
CN
O
O
OTIPS
O
132
N
Br
Boc
NC
O
O
OTIPS
141
O
Dess-Martin, 
NaHCO3, CH2Cl2
43%
over two stepsN
Br
Boc
NC
OH
OH
OTIPS
142
143 144
N
Br
Boc
NC
OTIPS
N
H
N
N
Br
Boc
NC
O
O
OTIPS
 57 
2.5. MACROLACTAMIZATION STRATEGIES 
2.5.1. Nitrile to amide hydration 
The indole-imidazole compound 144 was a starting point for investigation of 
macrolactamization strategies. The compound 144 includes an acetonitrile moeity and 
with a nitrogen already installed, it seemed counter-productive to attempt to remove that 
nitrogen only to replace the primary triisopropylsiloxy group with an amine to effect the 
peptide coupling.  In an effort to maintain a straightforward approach hydrolysis of the 
nitrile to an amide21 was examined.  
Two main options were available starting from nitrile 144.  The first, more direct 
route would be based on the methods developed by Fukuyama,22, 23 where the lactam 146 
and 147 is formed via the intramolecular Mitsunobu reaction of an N-Ns amide 145 
(Scheme 2. 29).  This would require the conversion of the nitrile 144 to an N-Ns amide 
148 and the unmasking of the primary alcohol.   
 
Scheme 2. 29:  Fukuyama’s macrolactamization and possible application 
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To achieve the proposed amide intermediate incompatible 148, hydration of the 
nitrile was examined.  Initially, the classical conditions using basic hydrogen peroxide 
were explored (Scheme 2. 30).  These experiments resulted only in intractable mixtures 
which clearly exhibited the loss of the N-Boc group and showed no evidence of amide 
formation as determined by IR and 1H NMR spectroscopic analysis of the crude isolates.   
Catalytic hydration of the nitrile using the homogeneous Pt catalyst 150 developed by 
Parkins24, 25 was equally unfruitful.  No reaction occurred at ambient temperature and as 
the reaction was warmed to reflux–the literature conditions call for refluxing in water–
decomposition of the starting material was observed.  Once again, loss of the N-Boc was 
implicated as the quickest reaction pathway accessible to starting material 144.   
 
Scheme 2. 30:  Failed nitrile hydration 
While no indole N-H compounds were ever isolated, the lack of the 9H singlet in 
1H NMR spectra of the crude reaction products was conspicuous.  The loss of the N-Boc 
was not completely unexpected in that N-Boc indoles are labile comparably to other N-
Boc amines.  From an N-H indole 152 intermediate, decomposition possibly goes through 
gramine-like pathways 153 (Scheme 2. 31).   
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Scheme 2. 31: Possible pathways to the decomposition of 144 
 
2.5.2. Nitrile to acid hydrolysis 
Considering the failure of nitrile to amide conversion route, the prospect of a 
successful acidic hydrolysis seemed less likely.  However, acidic hydrolysis was 
attempted and, not surprisingly, was met with similar failures.   
The nitrile 144 was subjected to a variety of Brönsted and Lewis acids in attempts 
to access either an acid, amide, or imidate.  Any non-nitrile product would have, at this 
point, been deemed a success and the macrolactam strategy would have been adjusted 
accordingly.  Unfortunately, all attempts at the acidic hydrolysis of the nitrile 144 were 
either too mild, returning starting material, or were too harsh, yielding intractable 
mixtures. 
After these results, the unpleasant conclusion that the nitrile was incompatible 
with our synthetic strategy was reached.  The assumption made early on, that the indole-
3-acetonitrile was amenable to our synthetic approach to the synthesis of chartelline C, 
had been proven false. 
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2.6. CONCLUSIONS 
Studies towards the total synthesis of the complex and unusual marine alkaloid 
chartelline C 3 were undertaken.  The hypothesis that the spiro-β-lactam present in the 
natural product could be assembled from a suitable macrolactam along a supposed 
biomimetic pathway guided our synthetic approach.  The proposed macrolactam was the 
intermediate of specific interest as its skeleton resembles that of the natural product 
securine, implicated in the biosynthesis of chartelline C 3. 
The macrolactam was attempted to be made via the convergent assembly of an 
indole and imidazole acetylene fragments.  A 2,6-dibromoindole 87 was coupled 
selectively to an acetylenic imidazole precursor 131 and was advanced to an indole-
imidazole compound 144 containing all of the carbons of the natural products securine 
and chartelline C 3 was accomplished.  The macrolactamization was investigated next 
However, it was while this work was progressing that the total synthesis of 
chartelline C was reported by Baran and co-workers.  In view of the inevitable similarity 
in the possible conversion of 144 into 60, and hence into chartelline C 3, to Baran’s work, 
it was decided to discontinue any further work in the area.26  
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Chapter 3: Experimental Section 
 
3.1 GENERAL METHODS.   
Melting points were taken on a Thomas-Hoover capillary tube apparatus and are 
uncorrected. Infrared spectra were recorded on a Nicolet FT-IR spectrophotometer neat 
unless otherwise indicated.  1H and 13C NMR spectra were recorded on a General Electric 
QE-300 spectrometer at 300 MHz and 75 MHz, respectively and are reported in ppm 
relative to tetramethylsilane.  All NMR spectra were taken with CDCl3 as solvent unless 
otherwise noted.   Mass spectra were obtained on a VG ZAB2E or a Finnigan TSQ70.  
TLC was performed on glass sheets precoated with silica gel (Silica Gel 60, F254, 
0.25mm Layer Thickness).  Column chromatographic separations were performed on 
silica gel (Silica gel 60, 230-400 mesh) under pressure.  Solvents and commercial 
reagents were purified in accordance with Perrin and Armarego or used without further 
purification. 
All moisture sensitive reactions were performed under an atmosphere of Ar, and 
glassware was pre-dried at 125 °C prior to use.  THF and ether were dried by distillation 
over Na/benzophenone, CH2Cl2, Et3N, CH3CN, and i-Pr2NH were dried by distillation 
from CaH2.  All other reagents or solvents were used as received without further 
purification unless otherwise stated. 
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3.2.  EXPERIMENTAL CONDITIONS AND CHARACTERIZATIONS 
 
Ethyl 4-bromo-3-oxo-butyrate (72): 
 
 
Bromine (5.1 mL, 0.1 mmol) was added slowly to a solution of ethyl-3-
oxobutanoate (12.7 mL, 0.1 mol) in chloroform (90 mL) over 1 hour.  The reaction was 
stirred at room temperature for 15 hours.  Nitrogen gas was then bubbled into the mixture 
for 2 hours to remove the excess hydrogen bromide.  Water (100 mL) was added to the 
reaction mixture, and the organic layer was separated, dried (Na2SO4) and concentrated in 
vacuo.  The sample was purified by flash-column chromatography (10% EtOAc in 
hexanes) to give bromide1,2 72 (16.59 g, 79 %) as a light-brown oil whose spectral data 
matched that previously reported: IR (thin film) 1712, 1636 cm-1; 1H NMR δ 1.30 (t, 2H), 
3.72 (s, 2H), 4.05 (s, 2H), 4.22 (q, 3H); 13C NMR δ  = 194.4, 166.4, 61.6, 45.8, 33.7, 13.8.  
 
Benzyl-(3-bromo-phenyl)-amine (71): 
 
4-Bromoaniline (6.4 mL, 58.1 mmol) and benzaldehyde (6.0 mL, 59.3 mmol) 
were dissolved in 1,2-dichloroethane (250 mL).  To this solution was added glacial acetic 
O
OEt
O
Br
N
H
Br
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acid (3.6 mL, 62.2 mmol) and sodium trisacetoxyborohydride (16.02 g, 75.6 mmol).  The 
mixture was stirred at room temperature for 18 hours, acidified with 1 N HCl (100 mL) 
and then neutralized with 4 M aq. NaOH (25 mL).  The aqueous layer was extracted with 
dichloromethane (4 x 50 mL).  The combined organic layers were washed with water 
(150 mL), brine (100 mL), dried (Na2SO4) and concentrated in vacuo to give benzyl 
aniline 71 (14.94 g, 98 %) as a yellow oil whose spectral data matched that previously 
reported.3 
 
Ethyl 4-(N-benzyl-N-(3-bromophenyl)amino)-3-oxobutanoate (73): 
 
 
Aniline 71 (9.94 g, 38.0 mmol), bromide 72 (2.66 g, 12.7 mmol) and 
tetrabutylammonium iodide (0.47 g, 1.27 mmol) were stirred at 40 oC for 18 hours.  The 
mixture was diluted with ether (100 mL) and washed with sat. aq. NaHCO3 (100 mL).  
The aqueous layer was extracted with ether (3 x 50 mL) and the combined organic 
extracts were washed with brine (100 mL), dried (Na2SO4) and concentrated in vacuo.  
The sample was purified by flash-column chromatography (10% EtOAc in hexanes) to 
give aniline 73 (3.64 g, 73 %) as a pale-tan solid: m.p. 73-75 oC; IR (neat) 1748, 1718 
cm-1;  1H NMR δ 7.2-7.4 (m, 5H), 7.02 (t, 1H), 6.81 (m, 2H) 6.59 (dd, 1H), 4.60 (s, 2H), 
4.25 (s, 2H), 4.20 (q, 3H), 3.42 (s, 2H),  1.25 (t, 3H); 13C NMR δ  200.6, 166.6, 149.4, 
137.1, 130.4, 128.6, 127.2, 126.6, 123.3, 120.5, 115.2, 111.0, 61.5, 60.0, 55.2, 46.1, 13.9. 
O
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Ethyl 2-(1-benzyl-6-bromo-1H-indol-3-yl)acetate (75) and ethyl 2-(1-benzyl-4-
bromo-1H-indol-3-yl)acetate (74): 
 
 
Titanium tetrachloride (0.74 mL, 6.73 mmol) was added to a solution of α-anilino 
ketone 73 (2.5 g, 6.41 mmol) in nitromethane (30 mL).  The mixture was heated at 100 
oC for 1 hour, cooled, diluted with ethyl acetate (100 mL) and washed with sat. aq. 
NaHCO3 (100 mL).  The aqueous layer was extracted with ethyl acetate (3 x 100 mL) and 
the combined organic layers were washed with brine (100 mL), dried (Na2SO4) and 
concentrated in vacuo.  The sample was purified by flash-column chromatography (20:1 
hexane/ ethyl acetate) to give a mixture of 6-bromo 75 and 4-bromo 74 cyclized products 
(1.85 g, 78 %; 5:1 6-bromo:4-bromo) as a pale-tan solid. 
 
Ethyl 2-(6-bromo-1H-indol-3-yl)acetate: 
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(1-Benzyl-6-bromo-1H-indol-3-yl)-acetic acid ethyl ester (0.056 g, 0.15 mmol) 
and aluminium trichloride (0.080 g, 0.60 mmol) were heated to 100 oC in anisole (2 mL) 
for 1 hour.  The mixture was cooled, diluted with ethyl acetate (25 mL) and washed with 
a solution of Rochelle’s salt (25 mL).  The aqueous layer was extracted with ethyl acetate 
(4 x 25 mL) and the combined organic layers washed with brine (50 mL), dried (Na2SO4) 
and concentrated in vacuo.  The sample was purified by flash-column chromatography 
(10:1 hexane/ ethyl acetate) to give the title compound (0.013 g, 31 %) as a pale-tan solid 
whose spectral data matched that previously reported.4 
 
tert-butyl 3-((ethoxycarbonyl)methyl)-2,6-dibromo-1H-indole-1-carboxylate (81): 
 
 
N-Bromosuccinimide (1.19 g, 6.67 mmol) was added to a solution of ethyl 2-(6-
bromo-1H-indol-3-yl)acetate (1.71 g, 6.06 mmol) in anhydrous carbon tetrachloride (15 
mL).  The reaction was stirred at room temperature for 2.5 hours then diluted with 
chloroform (100 mL).  The organic layer was washed with sat. aq. NaHCO3 (100 mL), 
water (100 mL), brine (100 mL), dried (MgSO4) and concentrated in vacuo to give 2,6-
dibromo-NH-indole as a dark-crimson oil.  A solution of this crude oil in acetonitrile (50 
mL) was added DMAP (0.148 g, 1.21 mmol) and Boc2O (3.04 g, 13.9 mmol).  The 
mixture was stirred at room temperature for 4.5 hours, diluted with ether (100 mL) and 
washed with water (100 mL).  The aqueous layer was extracted with diethyl ether (3 x 50 
O
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mL), the combined organic layers washed with brine (100 mL), dried (MgSO4) and 
concentrated in vacuo.  The crude mixture was purified by flash-column chromatography 
(SiO2; 30:1 hexane/diethyl ether) to yield the N-Boc indole 81 (1.68 g, 60% from 75) as a 
pale-yellow solid: m.p. 72-75 °C; IR (thin film) 2980, 1739, 1346, 1154 cm-1; 1H NMR δ 
8.29 (s, 1H), 7.32 (d, J = 1.5Hz, 2H), 4.13 (q, J = 7.4 Hz, 2H), 3.71 (s, 2H), 1.68 (s, 9H); 
13C NMR δ  169.5, 148.3, 136.7, 133.8, 127.2, 126.1, 119.2, 118.3, 118.2, 116.1, 85.5, 
61.0, 31.3, 27.9, 14.0; HRMS for C17H19NO4Br2 [MH+] m/z calc458.9681, found 
458.9685. 
 
(1H-Indol-3-yl)-acetonitrile (85): 
 
 
Sodium borohydride (0.023 g, 0.62 mmol) was added to a solution of indole-3-
carboxaldehyde 84 (0.068 g, 0.47 mmol) in methanol/formamide (1:1, 8 mL) at room 
temperature.  After stirring for 1h, sodium cyanide (0.237 g, 4.84 mmol) was added and 
the mixture heated at 100 oC for 4.5 hours.  The solution was cooled and poured into 
brine (100 mL).  The aqueous layer was extracted with chloroform/methanol (95:5; 4 x 
50 mL) and the combined organic layers dried (Na2SO4) and concentrated in vacuo.  The 
crude mixture was purified by flash-column chromatography (SiO2; CHCl3) to provide 
indole 85 (0.062 g, 85%) as a colorless oil whose spectral data matched that previously 
reported5: IR (thin film) 2249 cm-1;  1H NMR δ 8.38 (bs, 1H), 7.62 (d, J = 7.8 Hz,  1H), 
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7.41 (d, J = 8.2 Hz, 1H), 7.2-7.3 (m, 2H), 7.15 (s, 1H), 3.86 (s, 2H); 13C NMR δ 136.1, 
125.8, 122.9, 122.6, 120.0, 117.8, 111.6, 104.1, 14.1. 
 
tert-butyl 2,6-dibromo-3-(cyanomethyl)-1H-indole-1-carboxylate (87): 
 
 
N-Bromosuccinimide (2.49 g, 14.0 mmol) in dichloromethane (100 mL) was 
added dropwise to a solution of (1H-indol-3-yl)-acetonitrile 85 (1.09 g, 7.0 mmol) in 
dichloromethane (50 mL) containing oven-dried SiO2 (> 100 oC, 28 g) over 1 hour at 23 
°C.  The mixture was stirred for a further 0.5 hour, filtered, and concentrated in vacuo to 
give 2.2 g of a brown solid.  To this solid (3.06 g, 14.0 mmol) in dichloromethane (10 
mL), was added DMAP (0.086 g, 0.7 mmol),  Boc2O (3.34 g, 15.29 mmol) and 
triethylamine (1.07 mL, 7.7 mmol).  The mixture was stirred at room temperature for 1 
hour and then diluted with DCM (25 mL) and washed with sat. aq. NH4Cl (2 x 25 mL), 
brine (25 mL), and concentrated in vacuo.  The crude mixture was purified by flash-
column chromatography (SiO2, 10% EtOAc in hexanes) to provide the N-Boc indole 87 
(1.25 g, 43 %) as a white solid after recrystallisation from diethyl ether: m.p. 145-147 oC; 
IR (thin film) 2249, 1740 cm-1; 1H NMR δ 8.36 (s, 1H), 7.44 (dd, J = 7.4, 1.5 Hz, 2H), 
3.80 (s, 2H), 1.71 (s, 9H); 13C NMR δ  148.0, 136.7, 126.6, 125.7, 119.0, 118.6, 
115.7,111.6, 111.2, 86.2, 27.9, 14.5; HRMS for C15H15N2O2Br2 [MH+] m/z calc. 
412.9500, found 412.9504. 
 
N
N
Br
Br
Boc
 71 
 
 
 
tert-butyl 2-(3-acetoxy-3-methylbut-1-ynyl)-6-bromo-3-(cyanomethyl)-1H-indole-1-
carboxylate (89): 
 
A mixture of 2-methylbut-3-yn-2-yl acetate (88) (0.291 g, 2.31 mmol), indole 87 
(0.870 g, 2.10 mmol), and PdCl2(PPh3)2 (0.074g, 0.105 mmol) in triethylamine (25 mL, 
distilled over CaH2) was thoroughly degassed with Ar at 23 °C.  To this mixture was 
added a degassed suspension of CuI (0.060g, 0.311 mmol) in triethylamine (2mL).  The 
reaction was stirred 16h at 23 °C under an atmosphere of Ar.  The reaction was filtered 
over celite, washing with ether and the organic filtrate was concentrated in vacuo.  
Column chromatography (15% EtOAc in hexanes) of the crude residue gave the 2-
coupled product 89 as a pale yellow oil which produced a foam in vacuo (0.400 g, 42%): 
Rf = 0.34 (10% EtOAc in hexanes); IR (neat) 2986, 2937, 1738, 1243, 1146 cm-1; 1H 
NMR δ 8.39 (s, 1H), 7.43 (dd, J = 8.4, 1.7 Hz, 2H), 3.92 (s, 2H), 2.08 (s, 3H), 1.80 (s, 
6H), 1.69 (s, 9H); 13C NMR δ 169.5, 148.5, 136.1, 126.1, 125.8, 120.3, 119.5, 119.4, 
118.9, 117.4, 116.6, 101.5, 85.5, 74.5, 72.1, 28.7, 28.6, 28.1, 21.8, 13.5; HRMS for 
C22H24N2O4Br [MH+] m/z calc. 459.0919, found 459.0917. 
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4-Benzyloxy-1-butanol:   
 
To a solution of 1,4-butanediol 94 (30.0 mL, 0.340 mol) in dry THF (250 mL) at 
0 °C was added NaH (60% in mineral oil, 14.2 g, 0.36 mol) slowly.  The reaction was 
stirred for 30 min and benzyl bromide (42 mL, 0.36 mol) and tetrabutylammonium iodide 
(1.25 g, 3.40 mmol) were added.  The reaction was warmed to 23 °C and stirred an 
additional 4 h.  The mixture was quenched with 10% aq. NH4Cl (100 mL) and washed 
with water (100 mL).  The organic layer was separated and the aqueous layer extracted 
with EtOAc (2 x 150 mL).  The combined organic layer was washed with water (100 
mL), brine (100 mL), dried over Na2SO4, filtered and concentrated in vacuo.  Purification 
by column chromatography (gradient elution, 10% EtOAc/hexanes to 100% EtOAc) gave 
4-benzyloxy-1-butanol as a pure yellowish oil (52.9 g, 87%) whose spectral data was 
consistent with that previously reported.6 
 
4-Benzyloxy-1-butanal (95): 
 
 
To a solution of the Dess-Martin periodinane7 (14.7 g, 35.0 mmol) in dry CH2Cl2 
(140 mL), at room temperature, was added 4-benzyloxy-1-butanol (5.00 g, 27.8 mmol) as 
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a solution in CH2Cl2 (20 mL).  A slight exotherm ensued and the solution was stirred 30 
min then was diluted in ether (150 mL), poured into aq. NaOH (1M, 100 mL) and stirred 
until two clear layers were evident.  The organic layer was separated, washed with water 
(150 mL), brine (150 mL), dried over Na2SO4 and concentrated in vacuo to give aldehyde 
95 as a colorless oil (4.67 g, 95%) whose spectral data was consistent with that of 
previous reports.8 
 
Ethyl (2E)-6-(benzyloxy)hex-2-enoate (96): 
 
 
To a solution of triethylphosphonoacetate (1.70 mL, 8.42 mmol) in dry THF (25 
mL) at 0 °C was added NaH (60% in mineral oil, 340 mg, 8.42 mmol).  The mixture was 
stirred for 30 min at 0 °C after which the aldehyde 95 (1.0 g, 5.61 mmol) was added as a 
solution in THF (10 mL) and the reaction was stirred an additional 1.5 h.  After warming 
the reaction to 23 °C, and diluting with ether (50 mL), the solution was washed with 
water (50 mL) then brine (25 mL), and the organic layer was concentrated in vacuo.  
Purification of the yellow residue by column chromatography (5% EtOAc in hexanes) 
gave ester9 96 as a pure colorless oil (1.26 g, 90%): Rf = 0.29 (5% EtOAc/hexanes); IR 
(neat) 2980, 2938, 2857, 1717, 1654 cm-1; 1H NMR δ 7.30 (m, 5H), 6.97 (dt, J = 15, 6.9 
Hz, 1H), 5.83 (dd, J = 15, 1.5 Hz), 4.50 (s, 2H), 4.20 (q, J = 7.2 Hz, 2H), 3.50 (t, J = 6.3 
Hz, 2H), 2.32 (q, J = 7.2 Hz, 2H), 1.78 (m, 2H), 1.29 (t, J = 7.5 Hz, 3H); 13C NMR δ 
14.0, 28.0, 28.7, 59.9, 69.0, 72.7, 121.5, 127.3, 127.4, 128.2, 138.2, 148.3, 166.4; HRMS 
for C15H21O3 [MH+] m/z calc. 249.1491, found 249.1492. 
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Ethyl 6-(benzyloxy)2-methylhex-3-enoate: 
 
 
To a solution of 1,1,1,3,3,3-hexamethyldisilazane (distilled from CaH2, 2.20 mL, 
10.45 mmol) in dry THF (15 mL) at −78 °C was added n-BuLi (2.4M in hexanes, 4.4 
mL, 10.45 mmol) and hexamethylphosphoramide (distilled from CaH2, 1.82 mL, 10.45 
mmol).  The solution was stirred for 30 min at −78 °C.  The α,β-unsaturated ester 96 
(2.16g, 8.71 mmol) was then added as a solution in THF (10 mL) and the reaction was 
allowed to warm to room temperature over 30 min at which point the solution turned a 
dark yellow-orange, indicating formation of the anion.  Methyl iodide (distilled, 2.0 mL, 
32.1 mmol) was then added at −78 °C and the solution was stirred an additional 30 min.  
The reaction was quenched with 10% aq. NH4Cl (10 mL) and diluted in ether (25 mL).  
The organic layer was washed 10% aq NH4Cl (25 mL), water (25 mL), brine (25 mL),  
dried over Na2SO4, and concentrated.  The residue was taken up in ether, filtered over a 
silica plug, eluting with 10% EtOAc in hexanes.  Concentration of the filtrate in vacuo 
gave 2.28g (>99%) of the title compound as a yellowish oil which proved an to be an 
inseparable mixture of E/Z olefins: Rf = 0.35 (5% EtOAc/hexanes); IR (neat) 2977, 2934, 
2858, 1732 cm-1;  1H NMR δ 7.30 (m, 5H), 5.53 (m, 2H), 4.52 (s, 2H), 4.11 (q, J = 4.0 
Hz, 2H), 3.50 (m, 3H), 2.44 (q, J =  6.3 Hz, 1H), 1.78 (m, 2H), 1.29 (m, 8H); 13C NMR δ 
13.8, 17.8, 28.0, 38.1, 60.3, 69.5, 124.7, 127.3, 127.3, 127.5, 128.2, 138.2, 174.6.   
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Ethyl 6-(benzyloxy)2,2-dimethylhex-3-enoate (XXX): 
 
 
To a solution of 1,1,1,3,3,3-hexamethyl-disilazane (distilled from CaH2, 2.20 mL, 
10.45 mmol) in dry THF (15 mL) at −78 oC was added n-BuLi (2.4M in hexanes, 4.4 mL, 
10.45 mmol).  The solution was stirred for 30 min at 0 °C. Ethyl 6-(benzyloxy)2-
methylhex-3-enoate (2.28g, 8.67 mmol) was then added as a solution in THF (10 mL) 
and the reaction was allowed to warm to 23 °C over 30 min at which point the solution 
turned a dark yellow-orange, indicating formation of the anion.  Methyl iodide (distilled, 
2.0 mL, 32.1 mmol) was then added at 0 °C and the solution was stirred an additional 30 
min.  The reaction was quenched with 10% aq. NH4Cl (10 mL) and diluted in ether (25 
mL).  The organic layer was washed 10% aq. NH4Cl (25 mL), water (25 mL), brine (25 
mL),  dried over Na2SO4, and concentrated.  The residue was taken up in ether, filtered 
over a silica plug, eluting with 10% EtOAc in hexanes.  Concentration of the filtrate in 
vacuo gave 2.23g (93%) of gem-dimethyl ester 97 as a yellowish oil which proved to be 
an inseparable mixture of E/Z olefins: Rf = 0.38 (5% EtOAc/hexanes); IR (neat) 2977, 
2934, 2858, 1728 cm-1;  1H NMR δ 7.30 (m, 5H), 5.53 (m, 2H), 4.52 (s, 2H), 4.11 (q, J = 
7.2 Hz, 2H), 3.50 (t, J = 6.6 Hz 3H), 2.34 (m, 2H), 1.34 (s, 6H), 1.29 (t, J = 6.6 Hz, 3H); 
13C NMR δ 13.9, 24.9, 28.0, 32.8, 60.5, 69.2, 124.7, 127.3, 127.4, 128.1, 135.8, 136.2, 
177.2; HRMS for C17H24O3 [MH+] m/z calc. 277.180370, found 277.181510. 
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6-(benzyloxy)2,2-dimethylhex-3-enal (cis-99 and  trans-99): 
 
 
To a stirred solution of the ester 97 (2.20 g, 7.96 mmol) in dry ether (25 mL) at 
−78 °C was added slowly lithium aluminum hydride (s) until no more starting material 
was evident in the TLC.  The mixture was stirred an additional 10 min and warmed to 0 
°C.  The reaction was qenched dropwise with Na2SO4 (sat. aq.) and poured into 
potassium sodium tartrate (sat. aq., 25 mL).  Extraction with ether (2 x 25 mL) and 
concentration of the organics gave a colorless oil which was used without further 
purification.  To a solution of the Dess-Martin periodinane (4.05 g, 9.55 mmol) in dry 
CH2Cl2 (35 mL), at 23 °C, was added the intermediate alcohol (7.96 mmol) as a solution 
in CH2Cl2 (10 mL).  The solution was stirred 30 min and then poured into 1M aq. NaOH 
(25 mL) and stirred an additional 20 min.  The organic layer was separated, washed with 
water (10 mL), brine (10 mL), dried over Na2SO4 and concentrated in vacuo to give of 
aldehydes 99 (1.64 g, 89% from 97) as a yellowish oil whose 1H NMR indicated a 
mixture of isomeric aldehydes, 7:1 Z/E.  Purification by column chromatography (5% 
EtOAc in hexanes) readily separated the isomers for characterization purposes: cis- 99: Rf 
= 0.43 (5% EtOAc/hexanes); IR (neat) 2972, 2931, 2858, 1726 cm-1; 1H NMR δ 9.52 (s, 
1H), 7.30 (m, 5H), 5.56 (dt, J = 11.4, 7.5 Hz, 1H), 5.40 (dd, J = 13.5, 9.6, Hz, 1H),  4.50 
(s, 2H), 3.46 (t, J = 6.6 Hz, 2H), 2.27 (dq, J = 6.9, 1.2 Hz, 2H), 1.22 (s, 6H); 13C NMR δ 
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13.9, 22.5, 22.9, 33.1, 47.5, 69.4, 127.4, 127.5, 128.5, 133.1, 138.1, 202.0; HRMS for 
C15H19O2 [MH+] m/z calc. 231.138505, found 231.138972.  trans- 99: Rf = 0.40 (5% 
EtOAc/hexanes); IR (neat) 2973, 2933, 2859, 1727 cm-1;  1H NMR δ 9.35 (s, 1H), 7.30 
(m, 5H), 5.50 (m, 2H), 4.52 (s, 2H), 3.51 (t, J = 6.6 Hz, 2H), 2.39 (q, J = 6.6 Hz, 2H), 
1.21 (s, 6H); 13C NMR δ 13.9, 21.3, 23.0, 28.9, 47.5, 69.2, 72.7,  127.3, 127.4, 128.1, 
133.1, 138.2, 202.9; HRMS for C15H19O2 [MH+] m/z calc. 231.138505, found 
231.138195. 
 
({[5,5-dimethylhept-3-en-6-yn-1-yl]oxy}methyl)benzene (cis-101 and  trans-101): 
 
 
To a stirred solution of a mixture isomeric aldehydes 99 (390 mg, 1.68 mmol) in 
methanol (dried over MgSO4 prior to use, 15 mL) with K2CO3 (500 mg, 3.70 mmol) was 
added Ohira’s reagent10,11 (100) (390 mg, 2.02 mmol).  The reaction was stirred 
overnight.  The mixture was diluted in EtOAc (10 mL), washed with NaHCO3 (sat. aq., 
10 mL), water (10 mL), brine (10 mL), and dried over Na2SO4.  Concentration of the 
organic layer in vacuo gave alkyne 101 as a colorless oil (368 mg, 96%).  trans-101: Rf = 
0.67 (5% EtOAc/ hexanes); IR (neat) 3301, 2971, 2929, 2859 cm-1;  1H NMR δ 7.33 (m, 
5H), 5.76 (dt, J = 15.6, 6.6 Hz, 1H), 5.40 (d, J = 15.0 Hz, 1H),  4.53 (s, 2H), 3.52 (t, J = 
6.9 Hz, 2H), 2.37 (q, J = 6.9 Hz, 2H), 2.24 (s, 1H), 1.36 (s, 6H); 13C NMR δ 25.2, 28.2, 
31.0, 68.2, 69.5, 72.6, 108.7, 126.8, 127.3, 127.4, 128.1, 136.3; HRMS for C16H21O1 
[MH+] m/z calc. 229.159240, found 229.158868.  cis-101: Rf = 0.67 (5% EtOAc/ 
hexanes); IR (neat) 3301, 2971, 2929, 2859 cm-1;   1H NMR δ 7.33 (m, 5H), 5.40 (m, 1H), 
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4.54 (s, 2H), 3.55 (t, J = 6.9 Hz, 2H), 2.77 (q, J = 6. Hz, 2H), 1.22 (s, 6H); 13C NMR δ 
25.2, 28.2, 31.0, 68.2, 69.5, 72.6, 108.7, 126.8, 127.3, 127.4, 128.1, 136.3.; HRMS for 
C16H21O1 [MH+] m/z calc. 229.159240, found 229.158868. 
 
1-(benzyloxy)-5,5-dimethylhept-6-yne-3,4-diol (cis-103 and  trans-102): 
 
 
A solution of the olefin 101 (610 mg, 2.67 mmol) in wet acetone (10 mL) with 4-
methylmorpholine-N-oxide (345 mg, 2.94 mmol) and K2O4Os•2H2O (cat.) was stirred 
overnight.  The solution turned black as the osmate was added.  Additional 4-
methylmorpholine-N-oxide was added as needed until the reaction was complete by TLC 
monitoring (50% EtOAc in hexanes).  To this was added 1M aq. Na2S2O3 (5 mL) to 
quench the osmium, and the solution turned to a dark red color.  The aqueous mixture 
was extracted with CH2Cl2 (3 x 15 mL), dried over Na2SO4, and concentrated in vacuo.  
The diols 102 and 103 were collected in quantitative yield as a mixture of diastereomers 
(700 mg, 100%) and carried on without purification.  Purification by column 
chromatography (30% EtOAc in hexanes) was performed for characterization purposes: 
trans-102:  Rf = 0.86 (1:1 EtOAc/ hexanes); IR (neat) 3446, 3297, 2930, 2869 cm-1; 1H 
NMR δ 7.33 (m, 5H), 4.55 (s, 2H), 4.02 (m, 1H), 3.75 (m, 2H), 3.37 (d, J = 6.0 Hz, 1H), 
2.25 (s, 1H), 2.10 (m, 2H), 1.34 (s, 3H), 1.31 (s, 3H); 13C NMR δ 24.8, 26.5, 35.1, 35.9, 
68.3, 69.2, 70.4, 73.4, 78.4, 90.1, 127.8, 127.8, 128.5, 137.8; HRMS for C16H21O3 [M-H] 
m/z calc. 261.149070, found 261.148940.  cis-103:   Rf = 0.66 (1:1 EtOAc/ hexanes); IR 
(neat) 3420, 3295, 2971, 2929, 2870 cm-1; 1H NMR δ 7.33 (m, 5H), 4.54 (s, 2H), 4.28 
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(dd, J = 8.7, 3.6 Hz, 1H), 3.72 (m, 2H), 3.14 (d, J = 8.1 Hz, 1H), 2.21 (s, 1H), 2.10 (m, 
1H), 1.75 (m, 1H), 1.27 (s, 6H); 13C NMR δ 26.1, 26.2, 31.7, 34.8, 68.1, 70.9, 71.9, 73.2, 
79.0, 89.5, 127.5, 127.6, 128.3, 137.5; HRMS for C16H23O3 [MH+] m/z calc. 263.164720, 
found 263.163444. 
 
1-(benzyloxy)-5,5-dimethyl-hept-6-yne-3,4-dione (104): 
 
 
To a solution of the diasteromeric diols (102 & 103) (700 mg, 2.67 mmol) in dry 
CH2Cl2 (15 mL) with triethylamine (2.23 mL, 16.0 mmol) was added a solution of 
SO3•pyridine complex (2.55g, 16.0 mmol) in dimethylsulfoxide (3.0 mL).  The reaction 
was stirred 2 h and then concentrated in vacuo to give a crude brown oil.  Extraction of 
the residue with ether (3 x 15 mL) was followed by washing of the organic layer with 
water (10 mL), sat. aq. CuSO4 (10 mL), brine (10 mL) and drying over Na2SO4.  
Concentration of the organic layer in vacuo gave dione 104 (570 mg, 83%) as a yellow 
oil: Rf = 0.10 (5% EtOAc/hexanes); IR (neat) 2983, 2872, 1756, 1715 cm-1; 1H NMR δ 
7.32 (m, 5H), 4.52 (s, 2H), 3.80 (t, J = 6.0 Hz, 2H), 3.04 (t, J = 6.3 Hz, 2H), 2.33 (s, 1H), 
1.51 (s, 6H); 13C NMR δ 13.9, 22.4, 25.8, 39.0, 40.3, 64.1, 72.4, 73.0, 84.9, 127.5, 128.2, 
128.2, 137.6, 198.7, 199.1.  HRMS for C16H19O3 [MH+] m/z calc. 259.133420, found 
259.133500. 
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4-(2-[benzyloxy]ethyl)-5-(2-methylbut-3-yn-2-yl)-1H-imidazole (105): 
 
 
The α-dicarbonyl 104 (84 mg, 0.325 mmol) was dissolved in acetic acid (2 mL).  
Ammonium acetate (excess) and paraformaldehyde (25 mg, 0.833 mmol) were added.  
The reaction was heated to 100 °C and stirred for 2 h then cooled to 23 °C.  The reaction 
was slowly poured into sat. aq. NaHCO3 (10 mL) at 0 °C.  The aqueous layer was 
extracted with ether (3 x 15 mL), dried over Na2SO4 and concentrated in vacuo overnight 
to provide imidazole 105 (84 mg, 96%) as a brown oil: Rf = 0.10 (5% MeOH/CH2Cl2); IR 
(neat) 3271, 2978, 2929, 1722, 1694 cm-1; 1H NMR δ 7.32 (m, 5H), 4.57 (s, 2H), 3.79 (t, 
J = 6.0 Hz, 2H), 3.25 (t, J = 6.0 Hz, 2H), 2.31 (s, 1H), 1.69 (s, 6H); 13C NMR δ 25.5, 
29.4, 30.5, 30.6, 69.2, 69.2, 73.0, 89.8, 127.5, 127.6, 128.2, 128.3, 131.8, 137.7; HRMS 
for C17H21N2O1 [MH+] m/z calc. 269.16538, found 269.163015. 
 
5-(2-[benzyloxy]ethyl)-1-methoxymethyl-4-(2-methylbut-3-yn-2-yl)-imidazole (106): 
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To a stirred solution of the imidazole 105 (84 mg, 0.31 mmol) in benzene (5 mL) 
was added chloromethyl methyl ether (50 μL, 0.62 mmol) and triethylamine (86 μL, 0.62 
mmol).  The reaction was stirred overnight and diluted in EtOAc (20 mL), washed with 
water (15 mL), brine (15 mL), dried over Na2SO4 and concentrated in vacuo.  Purification 
by column chromatography (2% MeOH in CH2Cl2) furnished imidazole 106 (73 mg, 75% 
yield) as a brown oil: Rf = 0.85 (5% MeOH/CH2Cl2); IR (neat) 2928, 2851, 1719 cm-1;  1H 
NMR δ 7.51 (s, 1H), 7.32 (m, 5H), 5.23 (s, 2H), 4.49 (s, 2H), 3.70 (t, J = 6.9 Hz, 2H), 
3.28 (t, J = 6.9 Hz, 2H), 3.23 (s, 3H), 2.21 (s, 1H), 1.62 (s, 6H); 13C NMR δ 23.8, 29.5, 
30.7, 30.9, 55.5, 68.9, 69.7, 72.8, 90.3, 127.3, 127.5, 128.2, 128.3, 135.5, 138.0; HRMS 
for C19H25N2O2 [MH+] m/z calc. 313.191603 found 313.190623. 
 
4-[2-(benzyloxy)ethyl]-2,2-dimethyl-5-(2-methylbut-3-yn-2-yl)-1,3-dioxolane (116): 
 
 
To a solution of  diols 102 & 103 (1.430 g, 5.45 mmol) in dry acetone (250 mL) 
at room temperature was added catalytic p-TsOH (200 mg). After stirring for 2h, the 
reaction was quenched with NaHCO3 (s) and concentrated in vacuo.  The residue was 
dissolved in CH2Cl2 (10 mL) and filtered over a silica plug eluting with 20% EtOAc in 
hexanes.  The collected organics were combined and concentrated to give a clear, 
brownish oil of acetonide 116 as an otherwise pure mixture of diastereomers (1.557 g, 
95%): Rf = 0.46 (20% EtOAc/ hexanes); IR (neat) 2929, 2870 cm-1; 1H NMR δ 7.33 (m, 
O
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5H), 4.54 (s, 2H), 4.34 (m, 1H), 4.14 (m, 1H), 3.84 (d, J = 6.0 Hz, 1H), 3.63 (m, 2H), 
3.62 (m, 2H),  2.25 (m, 2H), 2.20 (m, 2H), 1.50 (s, 3H), 1.42 (s, 3H), 1.36 (s, 3H), 1.34 
(s, 6H), 1.29 (s, 6H), 1.26 (s, 3H); 13C NMR δ 24.8, 26.5, 26.7, 27.6, 30.5, 32.3, 35.1, 
35.9, 68.3, 69.2, 70.4, 73.4, 78.4, 90.1, 107.2, 127.8, 127.8, 128.5, 137.8; HRMS for 
C19H27O3 [MH+] m/z calc. 303.1960, found 303.1963. 
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tert-Butyl 2-(3-{5-[2-(benzyloxy)ethyl]-2,2-dimethyl-1,3-dioxolan-4-yl}-3-methylbut-
1-yn-1-yl)-6-bromo-3-(cyanomethyl)-indole-1-carboxylate (cis-117): 
 
 
A mixture of cis-acetonide alkyne cis-116 (0.686g, 2.27 mmol), indole 87 
(0.857g, 2.07 mmol), and PdCl2(PPh3)2 (0.073g, 0.104 mmol) in triethylamine (25 mL, 
distilled over CaH2) was thoroughly degassed with Ar at room temperature.  To this 
mixture was added a degassed suspension of CuI (0.060g, 0.311 mmol) in triethylamine 
(2mL).  The mixture was heated to 60 °C and stirred overnight under an atmosphere of 
Ar.  The reaction was allowed to cool to room temperature and filtered over celite, 
washing with ether and the organic filtrate was concentrated in vacuo.  Column 
chromatography (10% EtOAc/hexanes) on the crude residue gave the 2-coupled product 
cis-117 as a red oil which produced a foam in vacuo (1.26g, 96%): Rf = 0.26 (10% 
EtOAc/ hexanes); IR (neat) 2981, 2934, 1739 cm-1; 1H NMR δ 8.32 (s, 1H), 7.43 (d, J = 
2.0 Hz, 2H), 7.33 (m, 5H), 4.50 (s, 2H), 4.45 (m, 1H), 3.95 (d, J = 6.0 Hz, 1H), 3.83 (s, 
2H), 3.68 (m, 2H), 2.21 (m, 1H), 1.69 (s, 9H), 1.53 (s, 3H), 1.49 (s, 3H), 1.42 (s, 3H), 
1.39 (s, 3H); 13C NMR δ 148.4, 138.3, 135.6, 128.1, 127.5, 127.5, 127.4, 127.3, 126.5, 
125.8, 120.5, 119.1, 118.8, 115.5, 107.5, 106.1, 85.5, 85.1, 83.2, 74.9, 72.9, 67.4, 33.9, 
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30.8, 28.0, 26.9,  25.6, 14.0, 14.0, 13.8; HRMS for C34H40N2O5Br [MH+] m/z calc. 
635.2121, found 635.2112.  
tert-Butyl 2-(3-{5-[2-(benzyloxy)ethyl]-2,2-dimethyl-1,3-dioxolan-4-yl}-3-methylbut-
1-yn-1-yl)-6-bromo-3-(cyanomethyl)-indole-1-carboxylate (117): 
 
 
A mixture of cis and trans acetonide alkynes 116 (0.665g, 2.20 mmol), indole 87 
(0.828 g, 2.00 mmol), and PdCl2(PPh3)2 (0.070g, 0.10 mmol) in triethylamine (25 mL, 
distilled over CaH2) was thoroughly degassed with Ar at room temperature.  To this 
mixture was added a degassed suspension of CuI (0.057 g, 0.3  mmol) in triethylamine 
(2mL).  The mixture was stirred 16h at 50 °C under an atmosphere of Ar.  After cooling 
to 23 °C, the reaction was filtered over celite, washing with ether, and the organic filtrate 
was concentrated in vacuo.  Column chromatography (10% EtOAc/hexanes) on the crude 
residue gave the 2-coupled products cis-117 and trans-117 as red oil which produced 
foams in vacuo (1.13 g, 89%): cis-117:  characaterized as above. trans-117: Rf = 0.20 
(10% EtOAc/ hexanes); IR (neat) 2981, 2934, 1739 cm-1; 1H NMR δ 8.32 (s, 1H), 7.43 
(d, J = 2.0 Hz, 2H), 7.33 (m, 5H), 4.50 (s, 2H), 4.28 (dt, J = 7.6, 2.2 Hz, 1H), 3.72 (m, 
4H), 2.10 (m, 1H), 1.91 (m, 1H), 1.68 (s, 9H), 1.44 (s, 3H), 1.43 (s, 3H), 1.42 (s, 3H), 
1.39 (s, 3H); 13C NMR δ 148.4, 138.2, 135.7, 128.1, 127.4, 127.4, 126.5, 125.7, 119.7, 
119.1, 118.7, 116.3, 115.7, 108.7, 106.1, 86.5, 85.2, 84.7, 72.9, 67.2, 35.9, 35.3, 28.1, 
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27.9, 27.4, 27.2, 27.1, 25.8, 25.0, 13.5; HRMS for C34H40N2O5Br [MH+] m/z calc. 
635.2121, found 635.2112. 
 
tert-butyl 2-[7-(benzyloxy)-4,5-dihydroxy-3,3-dimethylhept-1-yn-1-yl]-6-bromo-3-
cyanomethyl-indole-1-carboxylate (118): 
 
 
To a stirred solution of the acetonide 117 (1.086 g, 1.71 mmol) in methanol/H2O 
(60 mL, 5:1) was added p-TsOH (1.0 g).  The solution was stirred overnight.  The 
reaction was quenched with sat. aq. K2CO3 (25 mL) and extracted with EtOAc (3 x 50 
mL).  The combined organics were dried over Na2SO4 (s) and concentrated in vacuo.  
Column chromatography (1:1 EtOAc:hexanes) of the crude residue yielded the diol 118 
as an orange oil (0.911 g, 89%): cis-118 Rf = 0.60 (50% EtOAc/hexanes); IR (neat) 3440, 
3268, 2979, 2932, 1739 cm-1; 1H NMR δ 8.20 (s, 1H), 7.43 (dd, J = 2.0 Hz, 2H), 7.33 (m, 
5H), 4.54 (s, 2H), 4.06 (m, 1H), 3.83 (s 2H),  3.78 (m, 2H), 3.50 (t,  J = 6.2 Hz, 1H), 3.45 
(d, J = 5.6 Hz, 1H), 3.27 (d, J = 6.2 Hz, 1H), 2.21 (m, 1H), 2.00 (m, 1H), 1.70 (s, 9H), 
1.50 (s, 3H), 1.45 (s, 3H); 13C NMR δ 13.5, 13.6, 24.9, 26.6, 28.0, 32.5, 37.1, 68.5, 72.6, 
73.2, 79.8, 85.8, 107.5, 113.6, 115.0, 116.2, 118.9, 119.7, 125.9, 126.7, 127.5, 127.6, 
128.2, 128.3,  135.3, 137.6, 148.7; HRMS for C31H35N2O5Br [MH+] m/z calc. 594.1729, 
found 594.1738. 
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tert-butyl 2-[7-(benzyloxy)-3,3-dimethyl-4,5-dioxohept-1-yn-1-yl]-6-bromo-3-(cyano-
methyl)indole-1-carboxylate (119): 
 
 
To a stirred solution of the diol 118 (76 mg, 0.128 mmol), in CH2Cl2 (10 mL) was 
added the Dess-Martin reagent (120 mg, 0.282 mmol).  The mixture was stirred 
overnight.  The mixture was concentrated and the crude residue was purified by column 
chromatography (20% EtOAc/hexanes) to give the pure dione 119 as a bright yellow oil 
(68 mg, 90%): Rf = 0.60 (50% EtOAc/hexanes); IR (neat) 2979, 2928, 2869, 1738, 1732, 
1716 cm-1; 1H NMR δ 8.33 (s, 1H), 7.44 (bs, 2H), 7.27 (m, 5H), 4.54 (s, 2H), 3.82 (t,  J = 
6.0 Hz, 2H), 3.79 (s, 2H),  3.10 (t, J = 6.0 Hz, 2H), 1.68 (s, 9H), 1.65 (bs, 6H), 13C NMR 
δ 13.4, 25.8, 28.0, 38.6, 41.5, 64.3, 73.0, 74.4, 85.3, 116.3, 116.6, 118.8, 119.1, 119.2, 
119.3, 120.0, 125.7, 126.7, 126.7, 127.4, 128.1, 135.7, 137.5, 148.3, 197.3, 197.9; HRMS 
for C31H31N2O5Br [MH+] m/z calc. 591.1429, found 591.1438. 
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tert-butyl 2-(3-{5-[2-(benzyloxy)ethyl]-1H-imidazol-4-yl}-3-methyl-but-1-ynyl)-6-
bromo-3-cyanomethyl-indole-1-carboxylate (120): 
 
 
To a stirred solution of dione 119 (57 mg, 0.096 mmol) in acetic acid (2 mL) was 
added NH4OAc (40 mg, 0.52 mmol) and  paraformaldehyde (3 mg, 0.096 mmol).  The 
solution was heated to 65 °C and stirred 4h.  The reaction was allowed to cool to room 
temperature, at which time the solution was slowly added to a suspension of K2CO3 (s) in 
EtOAc.  The mixture was then filtered and the organics concentrated to give a crude 
orange oil which was determined to be a mixture of starting dione 119 and desired 
imidazole 120.  Purification by column chromatography (4% MeOH in CH2Cl2) gave 
pure imidazole 120 as a red oil (31 mg, 54%): Rf = 0.40 (4% MeOH in CH2Cl2); IR (neat) 
3276, 2981, 2916, 1739, 1733, 1558 cm-1; 1H NMR δ 8.13 (s, 1H), 7.62 (s, 1H), 7.36 (bs, 
2H), 7.19 (m, 5H), 4.41 (s, 2H), 3.71 (s, 2H), 3.65 (t,  J = 6.0 Hz, 2H), 3.03 (t, J = 6.0 Hz, 
2H), 1.65 (s, 6H), 1.56 (s, 9H), 13C NMR δ 13.6, 26.6, 27.9, 28.0, 30.0, 30.1, 32.3, 69.6, 
71.2, 73.0, 85.9, 107.7, 115.3, 116.1, 118.9, 119.2, 119.3, 119.9, 120.2, 126.7, 126.8, 
127.5, 127.9, 128.2, 131.7, 131.8, 135.5, 137.8, 148.8. HRMS for C32H34N4O3Br [MH+] 
m/z calc. 601.1814, found 601.1805. 
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tert-butyl 2-[(1Z)-3-{5-[2-(benzyloxy)ethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl}-3-
methylbut-1-en-1-yl]-6-bromo-3-(cyanomethyl)-indole-1-carboxylate (123): 
 
 
and 
tert-butyl 6-bromo-3-(cyanomethyl)-2-[(1Z)-3-{5-[2-(cyclohexylmethoxy)ethyl)-2,2-
dimethyl-[1,3]dioxolan-4-yl}-3-methylbut-1-en-1-yl]- indole-1-carboxylate (124): 
 
 
To a stirred solution of the alkyne 122 (106 mg, 0.167 mmol) in ethanol (5 mL) 
saturated with H2 (g) was added PtO2 (4 mg, 0.019 mmol).  The heterogeneous mixture 
was stirred overnight under an atmosphere of H2.  The mixture was filtered over celite 
and concentrated in vacuo.  Column chromatography (20% EtOAc/hexanes) gave 
recovered alkyne 122 (66 mg), the desired cis-olefin 123 as a yellow oil (26 mg), and the 
over reduced cylohexyl species 124 (8 mg) as a yellow oil. cis-olefin 123: Rf = 0.26 (10% 
EtOAc/hexanes); IR (neat) 2980, 2928, 2852, 1739, 1733, 1370, 1351, 1144, 1122 cm-1; 
1H NMR (some resonances doubled due to carbamate resonance) δ 8.38 (s, 0.5H), 8.32 
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(s, 0.5H), 7.48 (dd, J = 8.1, 5.2 Hz, 1H), 7.43 (dd, J = 8.1, 5.2 Hz, 1H), 7.35 (m, 5H), 
6.33 (d, J = 12.6 Hz, 0.5H), 6.31 (d, J = 12.6 Hz, 0.5H), 6.21 (d, J = 12.6 Hz, 0.5H), 6.11 
(d, J = 12.6 Hz, 0.5H),  4.54 (m, 1H), 4.50 (m, 1H), 4.25 (m, 1H), 3.58 – 3.82 (m, 4H), 
1.88 (m, 2H), 1.65 (s, 4.5H), 1.64 (s, 4.5H), 1.47 (d, J = 7.5 Hz, 3H), 1.34 (d, J = 2.6 Hz, 
3H), 1.03 (s, 3H), 0.89 (d, J = 10.3 Hz, 3H); 13C NMR (some resonances doubled due to 
carbamate resonance) δ 149.6, 142.6, 142.4, 138.3, 135.8, 134.8, 134.4, 128.1, 128.1, 
128.0, 127.4, 127.4, 127.3, 126.4, 126.3, 126.1, 126.1, 119.2, 119.1, 118.8, 118.7, 118.4, 
118.3, 117.9, 117.3, 108.0, 107.0, 85.5, 84.9, 84.3, 72.9, 67.4, 67.2, 39.0, 38.7, 34.4, 31.9, 
31.6, 31.4, 28.1, 28.0, 27.9, 27.8, 26.5, 25.6, 25.0, 23.9, 22.4, 13.9, 13.9; HRMS for 
C34H41N2O5Br [MH+] m/z calc. 636.2199, found 635.2201; 124: Rf = 0.42 (10% 
EtOAc/hexanes); IR (neat) 2980, 2928, 2852, 1739, 1733, 1144, 1122 cm-1; 1H NMR 
(some resonances doubled due to carbamate resonance) δ 8.38 (s, 0.5H), 8.32 (s, 0.5H), 
7.50 (dd, J = 8.3, 8.1 Hz, 1H), 7.42 (dd, J = 8.3, 8.1 Hz, 1H), 6.30 (d, J = 12.6 Hz, 0.5H), 
6.29 (d, J = 12.6 Hz, 0.5H), 6.21 (d, J = 12.6 Hz, 0.5H), 6.12 (d, J = 12.6 Hz, 0.5H), 4.20 
(m, 1H), 3.70 – 3.80 (m, 3H), 3.5 – 3.57 (m, 2H), 3.21 – 3.25 (m, 2H), 1.10 – 1.85 (m, 
11H), 1.67 (s, 4.5H), 1.65 (s, 4.5H), 1.48 (d, J = 5.6 Hz, 3H), 1.34 (d, J = 2.0 Hz, 3H), 
1.03 (d, J = 4.0 Hz, 3H), 0.86 (d, J = 13.3 Hz, 3H); 13C NMR (some resonances doubled 
due to carbamate resonance) δ 149.0, 142.7, 141.4, 134.8, 134.4, 126.4, 126.3, 126.2, 
126.1, 119.2, 119.1, 118.8, 118.7, 117.8, 117.2, 116.8, 116.7, 108.0, 107.0, 85.5, 84.9, 
74.9, 74.9, 67.9, 67.6, 39.0, 38.7, 37.8, 37.8, 37.7, 31.8, 31.5, 29.9, 29.8,  28.1, 28.1, 28.0, 
27.9, 27.8, 27.8, 27.7, 26.5, 25.3, 25.8, 25.7, 25.6, 25.6, 25.5, 13.9, 13.9; HRMS for 
C34H46N2O5Br [MH+] m/z calc. 641.9199, found 641.9201. 
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tert-butyl 2-[(1Z)-7-(benzyloxy)-4,5-dihydroxy-3,3-dimethylhept-1-en-1-yl]-6-bromo-
3-(cyanomethyl)-indole-1-carboxylate (124): 
 
 
A solution of acetonide 123 (250 mg, 1.56 mmol) in MeOH (15 mL) with 
p-toluenesulfonic acid (500 mg) was stirred at 23 °C for 4h.  The solution was diluted in 
EtOAc (25 mL), washed with sat. aq. NaHCO3 (20 mL), water (20 mL), brine (20 mL) 
and concentrated.  The crude oil was purified by column chromatography (SiO2, gradient 
elution, 30% EtOAc in hexanes to 60% EtOAc in hexanes) to yield diol 124 as a 
colorless oil (210 mg, 89%): Rf = 0.26 (10% EtOAc/hexanes); IR (neat) 3440, 2980, 
2928, 1733 cm-1; 1H NMR (some resonances doubled due to carbamate resonance) δ 8.27 
(s, 0.5H), 8.26 (s, 0.5H), 7.49 (dd, J = 8.1, 5.2 Hz, 1H), 7.43 (dd, J = 8.1, 5.2 Hz, 1H), 
7.35 (m, 5H), 6.28 (d, J = 12.6 Hz, 0.5H), 6.26 (d, J = 12.6 Hz, 0.5H), 6.06 (d, J = 12.6 
Hz, 0.5H), 6.04 (d, J = 12.6 Hz, 0.5H),  4.54 (s, 1H), 4.52 (s, 1H), 3.65 – 3.82 (m, 5H), 
3.29 (m, 1H), 1.91 – 2.05 (m, 3H), 1.67 (s, 4.5H), 1.65 (s, 4.5H), 1.60 (m, 1H), 1.26 (s, 
3H), 0.86 (d, J = 5.1 Hz, 3H); 13C NMR (some resonances doubled due to carbamate 
resonance) δ 149.7, 149.4, 144.1, 143.0, 137.4, 137.3, 135.7, 135.6, 135.2, 135.0, 128.3, 
127.6, 127.6, 126.5, 126.3, 126.1, 125.9, 119.2, 119.0, 118.8, 118.3, 118.2, 118.0, 117.0, 
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116.9, 116.7, 115.9, 108.1, 108.1, 85.5, 85.1, 81.1, 80.4, 73.2, 72.5, 71.0, 69.1, 67.6, 41.6, 
41.5, 32.9, 32.1, 29.5, 28.1, 28.0, 24.7, 24.4, 23.5, 23.4, 21.5, 13.7, 13.6; HRMS for 
C31H38N2O5Br [MH+] m/z calc. 597.1964, found 597.1970. 
 
tert-butyl 2-[(1Z)-7-(benzyloxy)-3,3-dimethyl-4,5-dioxohept-1-en-1-yl]-6-bromo-3-
(cyanomethyl)-indole-1-carboxylate (125): 
 
 
A solution of diol 124 (170 mg, 0.285 mmol) in CH2Cl2 (20 mL) was treated with 
Dess-Martin periodinane (270 mg, 0.627 mmol) and stirred at 23 °C for 16h.  The solvent 
was removed and the residue purified via flash column chromatography (SiO2, gradient 
elution, 10%, 20%, 30% EtOAc in hexanes) providing dione 125 as a bright yellow oil 
(81 mg, 48%): Rf = 0.26 (30% EtOAc/hexanes); IR (neat) 2980, 2928, 2869, 1739, 1732, 
1716 cm-1; 1H NMR δ 8.38 (s, 1H), 7.44 (bs, 2H), 7.28 (m, 5H), 6.36 (d, J = 11.9 Hz, 
1H), 6.02 (d, J = 11.9 Hz, 1H), 4.42 (s, 2H), 3.82 (t,  J = 5.9 Hz, 2H), 3.47 (s, 2H),  2.71 
(t, J = 5.9 Hz, 2H), 1.68 (s, 9H), 1.27 (bs, 6H), 1.16 (bs, 3H); HRMS for C31H33N2O5Br 
[MH+] m/z calc. 593.1639, found 593.1638. 
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tert-butyl 2-[(1Z)-3-{5-[2-(benzyloxy)ethyl]-1H-imidazol-4-yl}-3-methylbut-1-en-1-
yl}-6-bromo-3-cyanomethyl-indole-1-carboxylate (121): 
 
 
To a stirred solution of dione 125 (90 mg, 0.152 mmol) in acetic acid (8 mL) was 
added NH4OAc (40 mg, 0.52 mmol) and paraformaldehyde (30 mg, 0.96 mmol).  The 
solution was heated to 65 °C and stirred 3h.  The reaction was allowed to cool to room 
temperature, at which time the solution was slowly added to a suspension of K2CO3 (s) in 
EtOAc.  The mixture was then filtered and the organics concentrated to give a crude 
orange oil which was determined to be a mixture of starting dione and desired imidazole.  
Purification by column chromatography (4% MeOH in CH2Cl2) gave the pure imidazole 
121as a red oil (18 mg, 20%): Rf = 0.36 (4% MeOH in CH2Cl2); IR (neat) 3276, 2981, 
2916, 1739, 1733, 1558 cm-1; 1H NMR δ 8.29 (s, 1H), 7.43 (s, 1H), 7.39 (bs, 2H), 7.33 
(m, 5H), 6.57 (d, J = 16.4 Hz, 1H), 6.08 (d, J = 16.2 Hz, 1H), 4.49 (s, 2H), 3.76 (s, 2H), 
3.60 (t,  J = 5.8 Hz, 2H), 3.00 (t, J = 5.8 Hz, 2H), 1.66 (s, 9H), 1.35 (s, 3H), 1.26 (s, 3H); 
HRMS for C32H36N4O3Br [MH+] m/z calc. 603.1814, found 603.1805. 
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4-[2-(Benzyloxy)ethyl)-5-(2-methylbut-3-yn-2-yl)-[1,3]-dioxolan-2-one (126): 
 
 
To a stirred solution of the diol 103 (300 mg, 1.14 mmol) in CH2Cl2 (10 mL) with 
pyridine (1 mL) was added triphosgene (413 mg, 1.39 mmol) at 0 °C.  The mixture was 
allowed to slowly warm to room temperature 3h.  After cooling back down to 0 °C, the 
reaction was quenched with 10% aq. NH4Cl (10 mL).  The organic layer was separated 
and the aqueous layer was washed with CH2Cl2 (2 x 10 mL).  The combined organics 
were washed with 10% aq. NH4Cl (20 mL) and brine (10mL) and concentrated in vacuo.  
Purification by column chromatography (20% EtOAc in hexanes) gave the carbonate 126 
as a yellow oil (300 mg, 92%): Rf = 0.40 (20% EtOAc in hexanes); IR (neat) 3284, 2977, 
2937, 2871, 1805, 1799, 1367, 1173 cm-1; 1H NMR δ 7.35 (m, 5H), 5.04 (m, 1H), 4.53 (s, 
2H), 4.39 (d, J = 7.4 Hz, 1H), 3.68 (m, 2H), 2.38 (m, 2H), 2.26 (s, 1H), 1.39 (s, 3H), 1.35 
(s, 3H), 13C NMR δ 25.8, 26.6, 32.7, 65.8, 72.5, 72.7, 77.2, 83.5, 85.5, 127.4, 127.5, 
127.5, 128.2, 137.8, 153.9; HRMS for C17H21O4 [MH+] m/z calc. 289.1440, found 
289.1440. 
 
 
 
 
 
O
O
O
O
 94 
 
tert-butyl 2-{3-[(4R,5R)-5-[2-(benzyloxy)ethyl]-2-oxo-1,3-dioxolan-4-yl]-3-methylbut-
1-yn-1-yl}-6-bromo-3-(cyanomethyl)-1H-indole-1-carboxylate (127): 
 
 
A mixture of alkyne 126 (0.317 g, 1.10 mmol), indole 87 (0.414 g, 1.0 mmol), 
and PdCl2(PPh3)2 (0.035 g, 0.05 mmol) in triethylamine (10 mL) distilled over CaH2) was 
thoroughly degassed with Ar at room temperature.  To this mixture was added a degassed 
suspension of CuI (0.029 g, 0.15 mmol) in triethylamine (2mL).  The reaction was then 
heated to 65 °C and stirred overnight under an atmosphere of Ar.  The reaction was 
allowed to cool to room temperature and filtered over celite, washing with ether.  The 
organic filtrate was concentrated in vacuo.  Column chromatography (30% EtOAc in 
hexanes) on the crude residue gave the 2-coupled product 127 as a red oil which 
produced a foam in vacuo (0.316 g, 51%): Rf = 0.24 (30% EtOAc in hexanes); IR (neat) 
2974, 2929, 1801, 1738, 1732, 1455, 1370, 1148 cm-1; 1H NMR δ 8.23 (s, 1H), 7.44 (d, J 
= 2.0 Hz, 2H), 7.30 (m, 5H), 5.13 (q, J = 7.0 Hz, 1H), 4.55 (d, J = 7.3 Hz, 1H), 4.50 (d, J 
= 2.5 Hz, 2H), 3.75 (d, J = 3.1 Hz, 1H), 3.70 (m, 2H), 2.46 (dd, J = 8.3, 6.5 Hz, 2H), 1.69 
(s, 9H), 1.56 (s, 3H), 1.52 (s, 3H); 13C NMR δ 153.9, 148.2, 137.7, 135.5, 128.2, 127.5, 
126.6, 125.7, 120.0, 119.5, 119.2, 118.9, 116.2, 102.6, 85.5, 83.6, 83.3, 74.2, 73.2, 65.9, 
45.9, 34.3, 29.7, 29.5, 27.9, 26.6, 26.0, 13.4; HRMS for C27H26N2O4Br [MH+] m/z calc. 
521.1076, found 521.1073. 
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tert-butyl 2-[(1Z)-3-[(4S,5R)-5-[2-(benzyloxy)ethyl]-2-oxo-1,3-dioxolan-4-yl]-3-
methylbut-1-en-1-yl]-6-bromo-3-(cyanomethyl)-1H-indole-1-carboxylate: 
 
 
To a stirred solution of the alkyne 127 (0.084 g, 0.135 mmol) in ethanol (10 mL) 
saturated with H2 (g) was added PtO2 (0.005 g, 0.019 mmol).  The heterogeneous mixture 
was stirred overnight under an atmosphere of H2.  The mixture was filtered over celite 
and concentrated in vacuo.  Column chromatography (30% EtOAc in hexanes) gave the 
title compound as a yellow oil (0.040 g, 48%):  IR (neat) 2916, 1801, 1739, 1733, 1455, 
1142 cm-1; 1H NMR (some resonances doubled due to carbamate resonance) δ 8.31 (s, 
0.5H), 8.25 (s, 0.5H), 7.46 (dd, J = 8.3, 2.5 Hz, 2H), 7.30 (m, 5H), 6.46 (d, J = 12.6 Hz, 
1H), 6.08 (d, J = 12.6 Hz, 0.5H), 5.92 (d, J = 12.6 Hz, 0.5H), 4.90 – 5.00 (m, 1H), 4.50 
(m, 2H), 4.41 (d, J = 5.1 Hz, 0.5H), 4.38 (d, J = 4.9 Hz, 0.5H), 3.70 (s, 1H), 1.98 – 2.22 
(m, 2H), 1.66 (s, 4.5H), 1.58 (s, 4.5H), 1.15 (s, 1.5H), 1.05 (s, 1.5H), 0.99 (s, 1.5H), 0.93 
(s, 1.5H); HRMS for C27H28N2O4Br [MH+] m/z calc. 523.1232, found 523.1232. 
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2-(6-bromo-2-{3-[(4S,5R)-5-(2-hydroxyethyl)-2-oxo-1,3-dioxolan-4-yl]-3-methylbut-
1-yn-1-yl}-1H-indol-3-yl)acetonitrile (129): 
 
 
To a stirred solution of the benzyl carbonate 127 (175 mg, 0.282 mmol) in CH2Cl2 
(10 mL) at 0 °C was added BCl3 (1 mL, 1.0 M soln in DCM), dropwise.  After 30 min., 
NEt3 (2 mL) was added and the reaction was quenched with MeOH (10mL).  The mixture 
was concentrated and the crude residue purified by column chromatography (SiO2, 
gradient elution, 50% then 100% EtOAc in hexanes) gave the product of benzyl and Boc 
cleavage 129 (63 mg, 52%) as a yellow oil which decomposed on standing: Rf = 0.24 
(50% EtOAc/hexanes); IR (neat) 3446, 2928, 1801 cm-1; 1H NMR δ 9.00 (s, 1H), 7.45 (d, 
J = 7.4 Hz, 2H), 7.28 (s, 1H), 5.07 (ddd, J = 7.2, 6.8, 3.7 Hz, 1H), 4.52 (d, J = 7.3 Hz, 
1H), 3.95 (m, 1H), 3.81 (m, 1H), 3.81 (s, 2H), 2.40 (m, 2H), 1.52 (s, 3H), 1.48 (s, 3H); 
HRMS for C20H19N2O4Br [MH+] m/z calc. 432.0508, found 432.0516.  
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tert-butyl 6-bromo-2-{3-[(4S,5R)-5-(2-{[(tert-butoxy)carbonyl]oxy}ethyl)-2-oxo-1,3-
dioxolan-4-yl]-3-methylbut-1-yn-1-yl}-3-(cyanomethyl)-1H-indole-1-carboxylate 
(130): 
 
To a stirred solution of N-H indole 129 (60 mg, 0.140 mmol) in CH2Cl2 (3 mL) 
with DMAP (19 mg, 0.154 mmol) was added t-butyloxycarbonate anhydride (34 mg, 
0.154 mmol) dropwise and the reaction was stirred 2h.  The reaction was quenched by the 
addition of 10% aq. NH4Cl (5 mL).  The mixture was extracted with EtOAc (2 x 10 mL) 
and the combined organic extracts were washed with 10% aq. NH4Cl (10 mL), brine (10 
mL) and concentrated in vacuo.  Column chromatography (SiO2, 30% EtOAc in hexanes) 
gave bis-t-butyloxycarbonate 130 (36 mg, 41%) as a yellow oil: Rf = 0.36 (30% 
EtOAc/hexanes); IR (neat) 2928, 2986, 1801, 1748, 1739 cm-1; 1H NMR δ 8.23 (s, 1H), 
7.62 (d, J = 6.0 Hz, 1H), 7.45 (d, J = 6.0 Hz, 1H), 5.04 (dd, J = 7.2, 3.1 Hz, 1H), 4.98 (d, 
J = 7.3 Hz, 1H), 4.58 (t, J = 7.6 Hz, 1H), 4.32 (m, 1H), 4.20 (m, 1H), 2.58 (m, 1H), 1.72 
(s, 9H), 1.56 (bs, 6H), 1.45 (s, 9H); 13C NMR δ 170.2, 162.2, 152.9, 135.5, 126.8, 124.7, 
120.2, 119., 118.9, 114.4, 102.8, 85.8, 84.9, 83.4, 83.3, 62.9, 60.2, 52.0, 35.9, 34.2, 30.5, 
29.5, 28.5, 28.4, 27.9, 27.5, 26.9, 25.8, 20.8, 18.9, 13.9; HRMS for C30H36N2O8Br [MH+] 
m/z calc. 631.1655, found 631.1664.  
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4-(2-Methylbut-3-yn-2-yl)-5-(2-{[tris(propan-2-yl)silyl]oxy}ethyl)-[1,3]dioxolan-2-
one (trans-131 & cis-131): 
 
 
To a solution of the benzyl ether 126 (3.63g, 12.6 mmol) in CH2Cl2 (30 mL) at 0 
°C was added 1M BCl3 in CH2Cl2 (16 mL).  The mixture was stirred 2h at which time 
methanol (10 mL) was added slowly at 0 °C to quench the reaction.  Concentration of the 
solution in vacuo revealed the crude, brown oil which, by 1H NMR indicated complete 
removal of the benzyl ether.  The crude oil was taken on without further purification.  To 
a stirred solution of the crude alcohol in N,N-dimethylformamide (35 mL) was added 
imidazole (2.0 g) and triisopropylsilylchloride (2.91 g,15.1 mmol).  The heterogeneous 
mixture was stirred for 3h at reflux, overnight at room temperature, and then an 
additional 3h at reflux.  The mixture was diluted in t-butylmethylether (100 mL) and 
washed with 10% aq. NH4Cl (3 x 50 mL) and brine (30 mL) and then concentrated in 
vacuo.  Purification of the crude oil via column chromatography (10% EtOAc in hexanes) 
followed by Kugelrohr distillation of the resultant oil gave the desired carbonates trans-
131 and cis-131 as an orange foam (4.19 g, 94%): Rf = 0.80, 0.80 (10% EtOAc in 
hexanes); IR (neat) 3309, 3263, 2942, 2941, 2868, 1809, 1801 cm-1; cis- 131: white 
powder, mp = 86.5 – 89.0 °C; 1H NMR δ 5.08 (m, 1H), 4.43 (d, J = 7.4 Hz, 1H), 3.88 (m, 
2H), 2.26 (s, 1H), 2.24 (m, 2H), 1.39 (s, 3H), 1.36 (s, 3H), 1.06 (s, 21H); 13C NMR δ 
154.1, 85.3, 83.5, 72.2, 58.7, 32.3, 26.7, 25.5, 17.7, 17.4, 11.9, 11.6; HRMS for 
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C19H35O4Si [MH+] m/z calc. 355.2305, found 355.2302. trans- 131: colorless oil; 1H 
NMR δ 4.95 (q, J = 5.2 Hz, 1H), 4.15 (d, J = 5.2 Hz, 1H), 3.89 (t, J = 5.8 Hz, 2H), 2.20 
(s, 1H), 1.94 (q, J = 5.9 Hz, 2H), 1.32 (s, 3H), 1.27 (s, 3H), 1.06 (s, 21H); 13C NMR δ 
153.3, 93.5, 85.9, 71.6, 58.4, 46.5, 38.6, 30.7, 24.9, 23.6, 17.9, 11.8; HRMS for 
C19H35O4Si [MH+] m/z calc. 355.2305, found 355.2302.  
 
4-{[tris(propan-2-yl)silyl]oxy}butan-1-ol: 
 
 
To a stirred solution of 1,4-butanediol 94 (53.17g, 590mmol) and imidazole 
(8.03g, 118 mmol) in THF (200 mL) at 0 °C was added triisopropylsilyl chloride (22.75 
g, 118 mmol).  Upon addition, the solution was warmed to 25 °C and stirred for 6 hours.  
The reaction was washed with ethyl acetate (4 x 200 mL) and the combined organics 
were dried over Na2SO4, filtered, and concentrated in vacuo.  The crude oil was purifed 
by flash column chromatography (SiO2, 5% EtOAc in hexanes) to provide the title 
compound as a colorless oil (26 g, 89%) whose spectral data matched those previously 
reported12:  Rf  = 0.89 (5% EtOAc in hexanes); IR (neat) 3344, 2941, 2866, 2726, 1464 
cm-1; 1H NMR δ 3.78 (t, J = 5.7 Hz, 2H), 3.67 (s, 2H), 1.69 (m, 4H), 1.08 (m, 21H); 13C 
NMR δ 63.5, 62.6, 30.1, 30.0, 17.9, 11.8; HRMS for C13H31O2Si [MH+] m/z calc. 
247.2093, found 247.2096. 
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4-{[tris(propan-2-yl)silyl]oxy}butan-1-al (133): 
 
 
To a solution of the Dess-Martin periodinane (11.5 g, 27.3 mmol) in dry CH2Cl2 
(160 mL) was added 4-{[tris(propan-2-yl)silyl]oxy}butan-1-ol (5.37 g, 21.84 mmol) in 
CH2Cl2 (40 mL).  The solution was stirred 30 min, and then the mixture was diluted in 
diethyl ether (150 mL).  A 1:1 mixture of saturated sodium thiosulfate and saturated 
sodium bicarbonate (100 mL) was added and the resulting solution was stirred both 
layers became clear.  The organic layer was separated, washed with H2O (200 mL), brine 
(200 mL), dried over Na2SO4, and then concentrated in vacuo.  Purification by column 
chromatography (SiO2, 5% EtOAc in hexanes) gave the aldehyde 133 as a colorless oil 
(5.06 g, 95%) whose spectral data matched those previously reported13: Rf = 0.53 (5% 
EtOAC in hexanes); IR (neat) 2943, 2892, 2867, 2716, 1729, 1464 cm-1;  1H NMR δ 9.81 
(s, 1H), 3.74 (t, J = 5.9 Hz, 2H), 2.55 (t, J = 7.0 Hz, 2H), 1.89 (m, 2H), 1.06 (m, 21H); 
13C NMR δ 202.2, 62.2, 40.6, 25.5, 17.8, 11.7;   HRMS for C13H29O2Si [MH+] m/z calc. 
245.1937, found 245.1939. 
 
Ethyl (2E)-6-{[tris(propan-2-yl)silyl]oxy}hex-2-enoate (134): 
 
O
O
TIPS
 101 
To a solution of triethylphosphonoacetate (8.05 mL, 40.0 mmol) in dry THF (125 
mL) at 0 °C was added NaH (1.6 g, 40.0 mmol, 60% dispersion in mineral oil) 
portionwise.  The suspension was stirred for 30 min, and then aldehyde 133 was added as 
a solution in dry THF (50 mL).  The reaction was warmed to 23 °C and stirred 1.5h.  The 
resulting solution was diluted in ether (250 mL), washed with H2O (250 mL), brine (150 
mL), and concentrated in vacuo.  Purification by column chromatography (SiO2, 2% 
EtOAc/hexanes) of the yellow residue gave ester 134 as a colorless oil (6.73g, 81%):  Rf = 
0.45 (5% EtOAc/hexanes); IR (neat) 2943, 2866, 1724, 1653, 1465, 1109 cm-1; 1H NMR 
δ 7.0 (dt, J = 15.9 Hz, 7.2 Hz, 1H), 5.81 (d, J = 17.6 Hz, 1H), 4.20 (q, J = 7.2 Hz, 2H), 
3.71 (t, J = 6.2 Hz, 2H), 2.30 (q, J = 6.6 Hz, 2H), 1.70 (m, 2H), 1.29 (t, J = 7.3 Hz, 2H), 
1.06 (m, 21H); 13C NMR δ 149.1, 121.4, 95.3, 62.4, 60.1, 31.3, 28.7, 18.0, 14.2, 11.9; 
HRMS for C17H35O3Si [MH+] m/z calc. 315.2355, found 315.2358. 
 
Ethyl 2-methyl-6-{[tris(propan-2-yl)silyl]oxy}hex-3-enoate: 
 
 
To a solution of 1,1,1,3,3,3- hexamethyldisilazane (distilled from CaH2, 5.4 mL, 
25.68 mmol) in dry THF (40 mL) at –78 °C was added n-BuLi (10.85 mL, 25.68 mmol, 
2.4 M solution in hexanes) and hexamethylphosphoramide (distilled from CaH2, 4.5 mL, 
25.68 mmol).  The resulting solution was stirred 30 min. at –78 °C, and the 
α,β-unsaturated ester 134 (6.73 g, 21.4 mmol) was added as a solution in THF (20 mL).  
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The solution was warmed to 23 °C over 30 min.  After 30 min of stirring, the solution 
was recooled to –78 °C and iodomethane (distilled, 4.94 mL, 79.2 mmol) was added and 
the solution stirred 30 min.  The reaction was quenched by the addition of sat. aq. NH4Cl 
(30 mL) and diluted in ether (75 mL).  The organic layer was washed sat. aq. NH4Cl (75 
mL), water (75 mL), and brine (75 mL), dried (Na2SO4), and concentrated.  Purification 
by column chromatography (5% EtOAc/hexanes) gave ethyl 2-methyl-6-{[tris(propan-2-
yl)silyl]oxy}hex-3-enoate as a colorless oil which proved to be an inseperable mixture of 
the E/Z olefins (6.4 g, 91%): Rf = 0.31 (5% EtOAc/hexanes); IR (neat) 2943, 2889, 2867, 
2722, 1738, 1464, 1177, 1105 cm-1; 1H NMR δ 5.52 (m, 4H), 4.11 (q, J = 7.2 Hz, 4H), 
3.68 (m, 4H), 3.43 (m, 2H), 2.34 (m, 4H), 1.22 (m, 12H), 1.07(s, 42H); 13C NMR δ 
174.9, 174.9, 127.9, 62.8, 60.4, 38.3, 31.4, 25.8, 17.9, 14.1, 11.9; HRMS for C18H37O3Si 
[MH+] m/z calc. 329.2512, found 329.2519. 
 
Ethyl 2,2-dimethyl-6-{[tris(propan-2-yl)silyl]oxy}hex-3-enoate (135): 
 
 
To a solution of 1,1,1,3,3,3-hexamethyldisilazane (distilled from CaH2, 8.1 mL, 
38.35 mmol) in dry THF (60 mL) at –78 °C was added n-BuLi (16.28 mL, 38.35 mmol).  
The solution was stirred for 30 min at 0 °C, and then ethyl 2-methyl-6-{[tris(propan-2-
yl)silyl]oxy}hex-3-enoate (10.5 g, 31.96 mmol) was added as a solution in THF (30 mL).  
The reaction was stirred for 30 min at 23 °C, cooled to 0 °C, methyl iodide (distilled, 7.5 
mL, 118.25 mmol) was added and stirred an additional 30 min.  The reaction was 
quenched with sat. aq. NH4Cl (50 mL) and diluted in ether (100 mL).  The organic layer 
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was washed with sat. aq. NH4Cl (100 mL), water (100 mL), brine (100 mL), dried 
(Na2SO4) and concentrated in vacuo.  Purification by column chromatography (5% 
EtOAc/hexanes) gave the gem-dimethyl ester 135 as a colorless oil which proved to be an 
inseparable mixture of E/Z olefins (8.10g, 74%). Rf = 0.31 (5% EtOAc/hexanes); IR 
(neat) 2956, 2929, 2857, 1732, 1256, 1020, 836, 775 cm-1; 1H NMR δ 5.52 (m, 4H), 4.11 
(q, J = 7.2 Hz, 4H), 3.68 (m, 4H), 3.43 (m, 2H), 2.34 (m, 4H), 1.22 (m, 12H), 1.07(s, 
42H); 13C NMR δ 174.9, 174.9, 136.2, 130.3, 127.9, 125.3, 63.3, 63.2, 63.0, 62.8, 60.4, 
38.3, 36.3, 31.4, 31.3, 29.6, 29.5, 25.8, 25.0, 18.0, 17.9, 17.8, 14.1, 14.0, 12.3, 11.9; 
HRMS for C19H40O3Si [MH+] m/z calc. 343.2512, found 343.2519. 
 
(3Z)-2,2-dimethyl-6-{[tris(propan-2-yl)silyl]oxy}hex-3-enal (Z-137) and (3E)-2,2-
dimethyl-6-{[tris(propan-2-yl)silyl]oxy}hex-3-enal (E-136): 
 
 
To a stirred solution of ester 135 (8.0 g, 23.35 mmol) in dry ether (250 mL) at –78 
°C was slowly added lithium aluminum hydride (s), portionwise until no starting material 
was evident by TLC.  The mixture was stirred an additional 10 min and warmed to 0 °C.  
The reaction was quenched by the dropwise addition of sat. aq. Na2SO4 and then poured 
into sat. aq. potassium sodium tartrate (100 mL).  The suspension was extracted with 
ether (2 x 100 mL) and the organic phase filtered over celite to remove any remaining 
aluminum.  The washings were concentrated to give a colorless oil which was used 
without further purification.  To a solution of the Dess-Martin periodinane (12.0 g, 28.0 
mmol) in dry CH2Cl2 (100 mL) was added the intermediate alcohol as a solution in dry 
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DCM (30 mL).  The solution was stirred 30 min, diluted in ether (100 mL), and then 
poured into a 1:1 sat. aq. sodium thiosulfate/sat. aq sodium bicarbonate solution (100 
mL).  The solution was stirred until both phases were clear.  The organic layer was 
separated, washed with brine (150 mL), dried (Na2SO4) and concentrated in vacuo.  
Purification by column chromatography (5% EtOAc/hexanes) gave aldehydes cis- 137 
and trans- 136 as a colorless oil (6.7 g, 96% from 135) which proved to be a mixture of 
alkene isomeric aldehydes.  cis- 137: Rf = 0.42 (5% EtOAc/hexanes); IR (neat) 2959, 
2943, 2892, 2866, 1727, 1464, 1106, 883 cm-1; 1H NMR δ 9.50 (s, 1H), 5.59 (dt, J = 11.4, 
7.4 Hz, 1H), 5.39 (dt, J = 11.4 Hz, 1.5 Hz, 1H), 3.66 (t, J = 6.4 Hz, 2H), 2.16 (dq, J = 6.0, 
1.5 Hz, 2H), 1.20 (s, 6H), 1.04 (s, 21H); 13C NMR δ 203.8, 132.8,131.2, 63.3, 62.7, 47.6, 
32.2, 23.2, 17.9, 11.9; trans- 136:  Rf = 0.40 (5% EtOAc/hexanes);  IR (neat) 2959, 2943, 
2892, 2866, 2704, 1728, 1464, 1107, 883 cm-1; 1H NMR δ 9.35 (s, 1H), 5.60 (m, 1H), 
5.40, (m, 1H), 3.68 (m, 2H), 2.29 (m, 2H), 1.17 (s, 6H), 1.04 (s, 21H); 13C NMR δ 202.5, 
133.0, 129.1, 62.9, 62.7, 48.4, 36.6, 21.4, 17.9, 11.9; HRMS for C17H35O2Si [MH+] m/z 
calc. 299.2406, found 299.2404. 
 
{[5,5-dimethylhept-3-en-6-yn-1-yl]oxy}tris(propan-2-yl)silane (138) 
 
 
To a stirred solution of aldehydes cis- 137 and trans- 136 (4.44 g, 15.33 mmol) in 
methanol (dried over MgSO4 before use, 150 mL) with K2CO3 (4.56 g, 33.73 mmol) was 
added Ohira’s reagent (100) (3.55g, 18.4 mmol) and the suspension stirred overnight.  
The mixture was diluted in EtOAc (100 mL), washed with sat. aq. NaHCO3 (100 mL), 
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water (100mL), brine (100 mL), and concentrated.  Purification by column 
chromatography (SiO2, hexanes) gave alkyne 138 as a colorless oil (3.1g, 70%). 138: Rf = 
0.24 (hexanes); IR (neat) 3311, 3010, 2942, 2866, 2725, 1464, 1106, 883 cm-1; 1H NMR 
δ 5.74 (m, 2H), 5.39 (m, 2H), 3.75 (m, 2H), 3.75 (t, J= 6.6 Hz, 2H), 2.67 (q, J= 6.4 Hz, 
2H), 2.27 (q, J= 6.5 Hz, 2H), 2.23 (s, 1H), 2.18 (s, 1H), 1.38 (s, 6H), 1.30 (s, 6H), 1.07 (s, 
42H); 13C NMR δ 137.5, 136.1, 128.4, 124.4, 91.1, 90.0, 69.2, 68.3, 63.2, 63.0, 35.9, 
33.2, 31.7, 31.3, 30.7, 29.8, 18.0, 12.0, 11.9; HRMS for C18H35OSi [MH+] m/z calc.  
 
5,5-dimethyl-1-{[tris(propan-2-yl)silyl]oxy}hept-6-yne-3,4-diol (139 & 140): 
 
 
A solution of the olefin 138 (2.1 g, 7.12 mmol) in wet acetone (30 mL) with 4-
methylmorpholine-N-oxide (3.34 g, 28.5 mmol) and K2O4Os•2H2O (cat.) was stirred 
overnight.  The solution turned black as the K2O4Os•2H2O was added.  Additional 4-
methylmorpholine-N-oxide was added as needed until the reaction was complete by TLC 
(1:1 EtOAc:hexanes).  To this was added aq. Na2S2O3 (1M, 5 mL) to quench the osmate, 
and the solution turned to a dark red color.  The aqueous mixture was extracted with 
CH2Cl2 (3 x 15 mL), dried over Na2SO4, and concentrated in vacuo.  The diols 139 and 
140 were collected in quantitative yield as a mixture of diastereomers (2.34 g, 100%) and 
carried on without purification.  Purification by column chromatography (30% EtOAc in 
hexanes) was performed for characterization purposes only: cis-140:  Rf = 0.64(1:1 
EtOAc/ hexanes); IR (neat) 3420, 2943, 2866, 1101 cm-1; 1H NMR δ 4.32 (dd, J = 8.7, 
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3.6 Hz, 1H), 4.16 (dd, J = 8.9, 3.7 Hz, 1H), 3.69 (m, 2H), 2.18 (s, 1H), 2.02 (m, 2H), 1.27 
(s, 3H), 1.25 (s, 3H), 1.07 (s, 21H); 13C NMR δ 80.2, 78.4, 70.0, 60.1, 37.6, 33.8, 26.6, 
23.4, 20.1, 17.8, 11.7; HRMS for C18H37O3Si [MH+] m/z calc. 329.2512, found 329.2520. 
trans-139:   Rf = 0.49 (1:1 EtOAc/ hexanes); IR (neat) 3420, 2943, 2866, 1464, 1104 cm-1; 
1H NMR δ 4.04 (m, 1H), 3.98 (m, 1H), 3.78 (m, 2H), 2.19 (s, 1H), 1.87 (m, 2H), 1.31 (s, 
3H), 1.30 (s, 3H), 1.07 (s, 21H); 13C NMR δ 84.1, 76.6, 61.4, 60.8, 37.9, 24.4, 21.3, 17.9, 
16.9, 11.8, 11.8; HRMS for C18H37O3Si [MH+] m/z calc. 329.2512, found 329.2520. 
 
4-(2-Methylbut-3-yn-2-yl)-5-(2-{[tris(propan-2-yl)silyl]oxy}ethyl)-[1,3]dioxolan-
2-one  (cis-131) and 4-(2-Methylbut-3-yn-2-yl)-5-(2-{[tris(propan-2-
yl)silyl]oxy}ethyl)-[1,3]dioxolan-2-one (trans-131): 
 
To a stirred solution of the diols 139 and 140 (2.34 g, 7.12 mmol) in CH2Cl2 (40 
mL) with pyridine (3 mL) was added triphosgene (2.65 g, 8.92 mmol) at 0 °C.  The 
mixture was allowed to slowly warm to room temperature 3h.  After cooling back down 
to 0 °C, the reaction was quenched with 10% aq. NH4Cl (50 mL).  The organic layer was 
separated and the aqueous layer was washed with CH2Cl2 (2 x 50 mL).  The combined 
organics were washed with 10% aq. NH4Cl (50 mL) and brine (30mL) and concentrated 
in vacuo.  Purification by column chromatography (10% EtOAc in hexanes) gave a 
mixture of the desired carbonate diastereomers 131, otherwise pure, as a yellow oil (2.17 
g, 86%): characterized as before. 
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tert-butyl 6-bromo-3-(cyanomethyl)-2-{3-methyl-3-[-2-oxo-5-(2-{[tris(propan-2-
yl)silyl]oxy}ethyl)-1,3-dioxolan-4-yl]but-1-yn-1-yl}-1H-indole-1-carboxylate (132): 
 
 
 
A mixture of cis-acetonide alkyne 131 (0.900 g, 2.54 mmol), indole 87 (0.956 g, 
2.31 mmol), and PdCl2(PPh3)2 (0.081 g, 0.115 mmol) in triethylamine (25 mL) distilled 
over CaH2) was thoroughly degassed with Ar at room temperature.  To this mixture was 
added a degassed suspension of CuI (0.066 g, 0.345 mmol) in triethylamine (2mL).  The 
reaction was then stirred overnight at 23 °C under an atmosphere of Ar.  The reaction was 
filtered over celite, washing with ether, and organic filtrate was concentrated in vacuo.  
Column chromatography (10% EtOAc/hexanes) on the crude residue gave the 2-coupled 
product 132 as an orange oil which produced a foam in vacuo (1.06 g, 67%): Rf = 0.18 
(20% EtOAc/ hexanes); IR (neat) 2942, 2865, 1806, 1746, 1354, 1145 cm-1; 1H NMR δ 
8.24 (s, 1H), 7.45 (dd, J = 8.1, 4.0 Hz, 2H), 5.16 (dd, J = 7.3, 3.0 Hz, 1H), 4.55 (d, J = 7.3 
Hz, 1H), 3.91 (m, 2H), 3.82 (bs, 2H), 2.35 (m, 2H), 1.70 (s, 9H), 1.59 (s, 3H), 1.52 (s, 
3H), 1.02 (m, 21H); 13C NMR δ 154.0, 148.2, 135.5, 126.6, 125.6, 120.6, 119.2, 118.8, 
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116.2, 113.6, 102.8, 85.4, 83.8, 74.2, 58.8, 34.6, 32.5, 27.9, 27.8, 26.6, 26.0, 17.7, 17.7, 
13.4, 11.6; HRMS for C34H46N2O6BrSi [MH+] m/z calc. 685.2309, found 685.2315. 
 
tert-butyl 6-bromo-3-(cyanomethyl)-2-{3-methyl-3-[-2-oxo-5-(2-{[tris(propan-2-
yl)silyl]oxy}ethyl)-1,3-dioxolan-4-yl]but-1-yn-1-yl}-1H-indole-1-carboxylate 
(trans-132): 
 
 
A mixture of cis- and trans- acetonide alkynes 131 (0.390 g, 1.10 mmol), indole 
87 (0.414 g, 1.0 mmol), and PdCl2(PPh3)2 (0.035 g, 0.05 mmol) in triethylamine/THF 
(1:1, 15 mL) distilled over CaH2) was thoroughly degassed with Ar at room temperature.  
To this mixture was added a degassed suspension of CuI (0.029 g, 0.15 mmol) in 
triethylamine (2mL).  The reaction was then stirred overnight at 23 °C under an 
atmosphere of Ar.  The reaction was filtered over celite, washing with ether, and organic 
filtrate was concentrated in vacuo.  Column chromatography (10% EtOAc/hexanes) on 
the crude residue gave the 2-coupled products 132 as an orange oil which produced a 
foam in vacuo (0.280 g, 41%): cis-132: characterized as above.  trans-132: Rf = 0.26 
(10% EtOAc/ hexanes); IR (neat) 2942, 2865, 1801, 1739 cm-1; 1H NMR δ 8.38 (s, 1H), 
7.44 (m, 2H), 5.09 (dd, J = 4.9, 3.0 Hz, 1H), 4.42 (d, J = 4.9 Hz, 1H), 3.75 (d, J = 3.1 Hz, 
1H), 3.70 – 3.99 (m, 2H), 2.80 (s, 2H), 2.20 (m, 2H), 1.69 (s, 9H), 1.42 (s, 3H), 1.38 (s, 
3H), 1.02 (m, 21H); 13C NMR δ 185.4, 154.0, 148.2, 136.9, 126.8, 125.9, 123.2, 118.8, 
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118.7, 115.9, 111.9, 111.4, 83.4, 83.6, 80.3, 68.5, 58.9, 33.7, 32.6, 29.7, 28.1, 26.6, 25.8, 
17.9, 14.6, 12.2, 12.0, 11.8; HRMS for C34H46N2O6BrSi [MH+] m/z calc. 685.2309, found 
685.2315. 
tert-butyl 6-bromo-3-(cyanomethyl)-2-[(1Z)-3-methyl-3-[2-oxo-5-(2-{[tris(propan-2-
yl)silyl]oxy}ethyl)-1,3-dioxolan-4-yl]but-1-en-1-yl]-1H-indole-1-carboxylate (141): 
 
 
A solution of alkyne 132 (0.265 g, 0.385 mmol) in ethanol (20 mL) was saturated 
with hydrogen gas and then was treated with PtO2 (35 mg).  The heterogeneous mixture 
was stirred 18h under an atmosphere of H2.  The mixture was filtered over celite and 
concentrated in vacuo.  Column chromatography (20% EtOAc/hexanes) yielded the 
desired cis-olefin 141 as a yellow foam (0.158 g, 60%): Rf = 0.36 (10% EtOAc/hexanes); 
IR (neat) 2942, 2865, 1805, 1739, 1457, 1349, 1122 cm-1; 1H NMR (some resonances 
doubled due to carbamate resonance) δ 8.33 (s, 0.5H), 8.27 (s, 0.5H), 7.48 (dd, J = 8.1, 
5.2 Hz, 1H), 7.46 (dd, J = 8.1, 5.2 Hz, 1H), 6.46 (d, J = 12.6 Hz, 1H), 6.09 (d, J = 12.6 
Hz, 0.5H), 5.95 (d, J = 12.6 Hz, 0.5H), 5.19 (d, J = 7.3 Hz, 1H), 5.01 (m, 1H), 4.43 (d, J 
= 7.2 Hz, 0.5H), 4.38 (d, J = 7.2 Hz, 0.5H), 3.87 (m, 2H), 3.71 (bs, 2H), 1.92 – 2.17 (m, 
2H), 1.67 (s, 4.5H), 1.66 (s, 4.5H), 1.58 (s, 3H), 1.51 (s, 3H), 1.06 (m, 21H); 13C NMR 
(some resonances doubled due to carbamate resonance) δ 154.1, 154.0, 149.0, 148.9, 
139.4, 138.2, 135.8, 135.7, 133.7, 133.3, 128.1, 126.4, 126.2, 124.9, 121.9, 120.1, 119.8, 
119.3, 119.2, 118.9, 118.8, 116.4, 116.3, 108.3, 108.2, 86.2, 82.2, 85.3, 85.1, 58.6, 58.5, 
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42.5, 39.8, 39.3, 33.2, 33.2, 33.0, 32.9, 32.3, 27.9, 27.9, 27.8, 25.7, 23.8, 22.9, 19.7, 17.7, 
17.5, 13.9, 13.8, 11.6, 11.5; HRMS for C34H50N2O6SiBr [MH+] m/z calc. 689.2622, found 
689.2626.  
tert-butyl 6-bromo-3-(cyanomethyl)-2-[(1Z)-4,5-dihydroxy-3,3-dimethyl-7-
{[tris(propan-2-yl)silyl]oxy}hept-1-en-1-yl]-1H-indole-1-carboxylate (142): 
 
 
A solution of carbonate 141 (590 mg, 0.858 mmol) in 1,4-dioxane (15 mL) was 
treated with 10% aq. NaOH (5 mL) was stirred at 23 °C for 4h.  The solution was diluted 
in ether (25 mL), washed with water (20 mL), brine (20 mL) and concentrated.  The 
crude oil was purified by column chromatography (SiO2, gradient elution, 30% EtOAc in 
hexanes to 60% EtOAc in hexanes) to yield diol 142 as a colorless oil (453 mg, 80%): Rf 
= 0.26 (10% EtOAc/hexanes); IR (neat) 3446, 2918, 2866, 1739, 1733, 1094 cm-1; 1H 
NMR (some resonances doubled due to carbamate resonance) δ 8.27 (s, 0.5H), 8.26 (s, 
0.5H), 7.48 (dd, J = 8.1, 5.2 Hz, 1H), 7.42 (dd, J = 8.1, 5.2 Hz, 1H), 6.28 (d, J = 12.6 Hz, 
0.5H), 6.26 (d, J = 12.6 Hz, 0.5H), 6.10 (d, J = 12.6 Hz, 0.5H), 6.06 (d, J = 12.6 Hz, 
0.5H), 3.67 – 4.09 (m, 4H), 3.76 (d, J = 10.6 Hz, 1H), 3.74 (d, J = 8.6 Hz, 1H), 3.33 (dd, 
J = 7.6, 5.9 Hz, 1H), 1.84 – 1.96 (m, 3H), 1.71 (s, 4.5H), 1.68 (s, 4.5H), 1.08 (s, 21H), 
1.03 (s, 1.5H), 1.02 (s, 1.5H), 0.87 (s, 3H); 13C NMR (some resonances doubled due to 
carbamate resonance) δ 144.2, 142.9, 135.6, 135.2, 126.5, 126.2, 126.2, 119.1, 118.8, 
118.3, 118.2, 116.8, 116.7, 116.1, 108.1, 85.0, 81.2, 80.2, 73.2, 71.7, 63.2, 61.4, 41.5, 
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41.2, 34.9, 33.6, 27.9, 27.9, 24.8, 24.6, 23.3, 21.7, 17.7, 13.7, 13.6, 11.5, 11.4; HRMS for 
C33H52N2O5SiBr [MH+] m/z calc. 663.2829, found 663.2826. 
 
tert-butyl 6-bromo-3-(cyanomethyl)-2-[(1Z)-3,3-dimethyl-4,5-dioxo-7-{[tris(propan-
2-yl)silyl]oxy}hept-1-en-1-yl]-1H-indole-1-carboxylate (143): 
 
 
A solution of diol 142 (153 mg, 0.231 mmol) in DCM (10 mL) was treated with 
Dess-Martin periodinane (216 mg, 0.51 mmol) and stirred at 23 °C for 16h.  The solvent 
was removed and the residue purified via flash column chromatography (SiO2,  10% 
EtOAc in hexanes) providing dione 143 as a bright yellow oil (90 mg, 59%): Rf = 0.75 
(30% EtOAc/hexanes); IR (neat) 2928, 2866, 1738, 1732, 1716, 1456, 1295, 1143, 1123 
cm-1; 1H NMR δ 8.34 (s, 1H), 7.44 (dd, J = 8.3, 1.5 Hz, 2H), 6.61 (d, J = 16.4 Hz, 1H), 
6.16 (d, J = 16.6 Hz, 1H), 4.03 (t, J = 6.0 Hz, 2H), 3.87 (s, 2H), 2.98 (t,  J = 6.0 Hz, 2H), 
1.67 (s, 9H), 1.57 (bs, 3H), 1.43 (bs, 3H), 1.02 (m, 21H); 13C NMR δ 200.0, 197.4, 139.5, 
139.2, 136.0, 133.5, 126.5, 125.9, 120.5, 119.3, 118.9, 118.8, 118.7, 108.6, 58.0, 47.7, 
40.8, 28.0, 27.8, 25.3, 23.9, 17.6, 13.6, 11.6; HRMS for C33H48N2O5BrSi [MH+] m/z calc. 
659.2516, found 659.2515. 
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tert-butyl 6-bromo-3-(cyanomethyl)-2-[(1Z)-3-methyl-3-[4-(2-{[tris(propan-2-
yl)silyl]oxy}ethyl)-1H-imidazol-5-yl]but-1-en-1-yl]-1H-indole-1-carboxylate (144): 
 
 
To a stirred solution of dione 143 (140 mg, 0.222 mmol) in acetic acid (14 mL) 
was added NH4OAc (420 mg, 5.20 mmol) and paraformaldehyde (58 mg, 1.90 mmol).  
The solution was heated to 60 °C and stirred 3h.  The reaction was allowed to cool to 
room temperature, at which time the solution was slowly diluted in ether (20 mL) and 
poured slowly into sat. aq. NaHCO3 (20 mL).  The organic layer was separated and the 
aqueous layer extracted with ether (2 x 10 mL).  The combined organics were washed 
with brine (10 mL) and concentrated to give a crude orange oil which was determined to 
be a mixture of starting dione and desired imidazole.  Purification by column 
chromatography (4% MeOH in CH2Cl2) gave pure imidazole 144 as a red oil (39 mg, 
26% overall yield): Rf = 0.36 (4% MeOH in CH2Cl2); IR (neat) 3446, 2916, 1733, 1653, 
1558 cm-1; 1H NMR δ 8.30 (s, 1H), 7.53 (s, 1H), 7.42 (bs, 2H), 6.57 (d, J = 16.3 Hz, 1H), 
6.09 (d, J = 16.3 Hz, 1H), 3.80 (s, 2H), 3.95 (t,  J = 5.5 Hz, 2H), 2.96 (t, J = 5.5 Hz, 2H), 
1.66 (s, 9H), 1.62 (bs, H), 1.05 (m, 21H); 13C NMR δ 148.6, 137.4, 135.1, 131.2, 128.0, 
127.8, 126.4, 126.2, 121.2, 120.6, 120.4, 119.2, 118.5, 108.2, 85.8, 35.6, 30.5, 27.9, 27.8, 
OTIPS
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26.6, 26.0, 17.7, 17.6, 13.4, 11.4; HRMS for C34H49N4O3BrSi [MH+] m/z calc. 671.2726, 
found 671.2730. 
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PART 2: EFFORTS TOWARD THE TOTAL SYNTHESIS OF            
(–)-PLATENSIMYCIN 
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Chapter 4:  Platensimycin 
4.1. PLATENSIYMYCIN IS A FABF INHIBITOR WITH POTENT ANTIBIOTIC PROPERTIES 
The discovery of antibacterial agents and their utility in man’s defense against 
infection could be considered the most important medical advance of the 20th century and 
and beyond.1  However, the advances made in the battle against bacteria have slowed as 
novel targets for antibiotic activity have eluded scientists.2  The need for new antibiotics 
and anitbacterial targets is a longstanding and constant problem.  The emergence of 
bacterial resistance to existing treatments means that bacterial infection will forever be a 
threat to human life and health.3  
 
4.1.1. Isolation and Characterization 
The search for novel therapeutic agents often, and most successfully, has been 
rooted in natural products isolation, characterization, and assay.4  Merck scientists 
assayed the natural product extracts from a strain of Streptomyces platensis, collected 
from a soil sample in South Africa.  The extracts, along with 250,000 other nautral 
product extracts, were screened in both target-based whole-cell and biochemical assays 
leading to the identification of a compound with potent antibiotic properties, which was 
structurally determined to be (–)-platensimycin 160 (Figure 4. 1).5 
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Figure 4. 1: Platensimycin 
Platensimycin was isolated from the fermentation broth of Streptomyces platensis 
in ~2 – 4 mg/L.  Based on the spectral data gathered, its structure was assigned as 
consisting of a 3-aminobenzoic acid and a pentacyclic ketolide joined through an amide 
linkage.  The structure was further confirmed by the X-ray analysis of 6′-
bromoplatensimycin.6,7 
 
4.1.2. Biological Activity 
Platensimycin has been shown to exhibit both in vitro and in vivo activity against 
Gram-positive bacteria including methicillin resistant Staphyloccocus aureus (MRSA) 
and vancomycin resistant bacteria, two drug-resistant bacteria afflicting hospitals.  The in 
vitro anitbacterial activity of platensimycin against various strains of S. aureus (MIC, 0.5 
µg/mL) was greater than that of linezolid, a currently used MRSA antibiotic, and with no 
observable toxicity.   
The target of platensimycin was determined to be FabF, an essential component 
of bacteria fatty acid biosynthesis.  It is believed that the antibiotic’s activity arises from 
the inhibition of FabF.  Single-enzyme binding assays demonstrated not only that it is a 
potent inhibitor of FabF (IC50 = 48 nM for S. aureus and 160 nM for E. coli.), but that it 
is selective in its binding (IC50 = 67 µM for FabH).  By crippling the bacteria’s ability to 
make fatty acids, it prevents formation of the fatty cell membranes the bacteria needs to 
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grow.8,9  While other inhibitors of fatty acid biosynthesis are known, none are clinically 
used today.  Platensimycin clearly represents a new class of antibiotics.10,11  Its novel 
mechanism of action represents the first novel target for antibiotics research since the 
early 1960’s.   
Still, platensimycin is not ready for clinical use.  Though in vivo activity has been 
established in a mouse model (a 104 – 105 fold decrease of infection over a 24 hour 
period), continuous delivery was necessary to maintain efficacy.  This is an indication of 
a poor pharmacokinetic profile for platensimycin, an issue that would need to be 
addressed before clinical development.   
Structurally, platensimycin’s activity is believed to be derived from the anilide 
portion of the molecule.  During initial investigations into platensimycin’s mechanism of 
action, a structure of it bound to a mutant FabF enzyme was obtained.  The X-ray 
revealed that the benzoic acid ring is oriented in the active site of the enzyme, while the 
ketolide is partially exposed to solvent at the mouth of the binding pocket.  Additionally, 
the benzoic acid carboxylate engages in a strong interaction with active site histidine 
residues.  These observations are circumstantial evidence that point to the benzoic acid 
being responsible for biological activity.  These conclusions were corroborated in later 
studies on related compounds (vide infra). 
 
4.1.3. Biosynthesis 
The biosynthetic origin of platensimycin has been examined through feeding 
studies of labeled precursors.12  The isotopic incorporations were determined through 
comparisons of the 13C NMR spectra of the labeled products to that of the natural 
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substance (Scheme 4. 1).  The likely biosynthetic pathways were deduced based on the 
results.   
Scheme 4. 1:  Stable isotope incorporation studies on platensimycin 
Feeding the S. platensis culture in successive experiments with sodium 
[1-13C]acetate (161) and sodium [2-13C]acetate showed enrichment in only the aromatic 
anilide portion of the molecule in a tail-tail coupling (red,Scheme 4. 1), indicative of 
TCA cycle (tricarboxylic acid, aka Krebs or citric acid cycle) participation.  When the 
culture was fed with sodium [2-13C]pyruvate (162) and sodium [3-13C]pyruvate (blue and 
green, Scheme 4. 1), an isotopic enrichment pattern was observed throughout the natural 
product, indicating that platensimycin is biosynthetically derived from pyruvate.  
Furthermore, as glycerol is biosynthetically converted to pyruvate, the culture was also 
fed with [2-13C]glycerol (163), confirming the earlier conclusions.  These results are 
consistent with a non-mevalonate terpenoid pathway13,14 invoked for the biosynthesis of 
the structurally related ent-kaurene class of natural products. 
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Interest into the biosynthesis of platensimycin and the possible discovery of 
bioactive congeners led to the isolation of homoplatensimide 169.15  The clear mapping 
of the homoplatensic acid skeleton onto that of the ent-kaurenes is further evidence of 
their biogenetic relationship.  The non-mevalonate terpenoid pathway believed to be 
operative, converts isopentenyl diphosphate 164 and dimethylallyl diphosphate 165 into 
geranylgeranyl diphosphate 166 which, in turn is cyclized to the skeletons of 
homoplatensic precursor 167 and ent-kaurene 168.  Extensive oxidation of the platensic 
carbon backbone provides homoplatensic acid 170 and homoplatensimide 169.  
Oxidative cleavage of the α,β-unsaturated acid forms the platensic acid structure 171 
which couples with the anilide to form the active agent. 
 
Scheme 4. 2:  Biosynthesis of platensimycin via homoplatensimide 169 
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4.1.4. Biological Activity Revisited 
The isolation of homoplatensimide 169, homoplatensic acid 170, and platensic 
acid 171 was used not only for biosynthetic studies but in biological assays as well 
(Scheme 4. 2).15  The congeners isolated from the fermentation broth, as well as a variety 
of compounds thus synthetically derived, were assayed. None possessed the 3-
aminobenzoic acid moiety present in the natural product and none were found to be 
active.  Therefore, the benzoic acid was deduced to be responsible for and necessary for 
FabF inhibition.16  This conclusion has been corroborated in synthetic analog work by 
Nicolaou where variations on the ketolide portion such as removing the oxygen 
(carbaplatensimycin)17 and attaching a simpler hydrophobic group 
(adamantaplatensimycin),18 all with the anilide portion present, led to compounds with 
significant in vitro activity, albeit slightly weaker than that of platensimycin.  
Furthermore, the discovery of platencin19,20 172 (Figure 4. 2) as a potent antibiotic whose 
structural similarities to platensimycin 160 include an identical anilide portion and a 
similar hydrophobic ketolide lacking the ethereal oxygen, corroborated that conclusion.  
Thus, the biological activity of platensimycin 160 can be confidently attributed to the 
aminobenzoic acid moiety. 
 
Figure 4. 2: Platencin and Platensimycin 
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4.2. SYNTHESES OF PLATENSIMYCIN 
The discovery of platensimycin 160 as a potent antibiotic with a novel mode of 
action was provocative for scientists interested in new antibiotics.  Combined with the 
compact, deceptively complex, and synthetically intriguing tetracyclic enone acid core, 
the result was numerous synthetic groups working to synthesize the natural product.  
Platensimycin’s disclosure in 2006 set off a large number of research groups work 
resulting in the first total synthesis of platensimycin by Nicolaou later in 2006.  This 
work was followed by several formal syntheses, most of which were recently reviewed.21  
Some of the approaches to the synthesis of platensimycin will be discussed herein.  
 
4.2.1. Nicolaou’s First Total Synthesis of (±)-Platensimycin 
Nicolaou’s total synthesis of platensimycin was reported roughly five months 
after the initial publication in Nature.  The strategy utilized by Nicolaou and co-workers 
involved a late stage combination of the anilide and ketolide portions.22  The synthesis of 
a protected version of aniline 175 for coupling to the tetracyclic acid 171 was believed to 
be necessary at the time.  Their approach to the ketolide synthesis involved the 
intramolecular reductive addition of an aldehyde to a dienone, the product of which was 
advanced to the ether.   
The synthesis of the aniline portion began from 2,5-dihydroxynitrobenzene 173 
with the protection of the phenolic OH’s as their methoxymethyl ethers (Scheme 4. 3).  
Hydrogenation of the nitro group and protection of the resultant aniline as its t-butyl 
carbamate gave aniline 174 in 81% over three steps.  Directed ortho lithiation of aniline 
174 was followed by quenching with methyl cyanoformate to install the carboxylate.  
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Pyrolysis of the intermediate N-Boc aniline provided the protected aniline 175a in 45% 
over two steps.  The aniline 175a was now ready for coupling to the enone acid 171.  
 
 
Scheme 4. 3: Nicolaou’s synthesis of the platensimycin aniline 
The synthesis of the ketolide portion of platensimycin, began with the conversion 
of vinylogous ester 176 to the γ-disubstitued enone 179 (Scheme 4. 4).  The sequential 
alkylation of ketone 176 with allylic bromide 177 and propargyl bromide 178 followed 
by the reduction and hydrolysis of the vinylogous ester provided enone 179 in 75% yield 
over four steps; the TBS protecting group was reinstalled after the hydrolysis step.  
Cycloisomerization of the enyne 179 using a ruthenium catalyst developed by Trost, 
formed the spriocyclopentane ring with concomitant isomerization the olefin to an 
intermediate silyl enol ether.  Oxidation of the enone to the dienone using the Saegusa 
protocol [Pd(OAc)2 catalyzed oxidation of a silyl enol ether] preceded hydrolysis of the 
silyl enol ether which gave the key aldehyde 180.   
When aldehyde 180 was treated with SmI2, the aldehyde was reduced to an anion 
radical which intramolecularly attacked the symmetric dienone, forming the tricyclic 
compound 182.  The reaction produced a 2 : 1 mixture of alcohol epimers 181 and 182, 
of which, only the axial 182 is useful in this work.  The ether was formed when axial 
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alcohol 182 was subjected to TFA, forming the tertiary cation which was trapped by the 
alcohol.  This tetracyclic enone 183 lacked only the methyl and propionyl side chains of 
platensic acid.   
Scheme 4. 4:  Nicolaou’s first approach to platensic acid 
Enone 183 would prove to be the key intermediate in most subsequent formal 
syntheses.  In fact, enone 183 was further elaborated to the natural product through 
sequential installation of the methyl group, and then allyl group providing 184 as a single 
isomer (Scheme 4. 5).  It was found that this order of alkylations was necessary to 
achieve the desired stereochemistry, namely the angular methyl.   
The allyl moiety in 184 was converted to acid 171 in a three step sequence.  
Exchange of the vinyl for a vinyl boronate via cross-metathesis with boronate 186 using 
Grubb’s second generation catalyst 185 followed by oxidation with trimethylamine N-
oxide gave an intermediate aldehyde, which was further oxidized to the acid using 
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sodium hypochlorite.  Platensic acid 171 was obtained in 5 steps and 53% yield from the 
enone 183.  Acid 171 was coupled to aniline 175a using HATU in 85% yield.  The 
protecting groups were removed and the ester hydrolyzed providing the natural product in 
racemic form.   
Nicolaou and co-workers would produce several different synthetic approaches to 
platensimycin resulting in several formal syntheses, all intercepting the enone 183.23,24  
This first route was soon thereafter adapted to be asymmetric.25  While this first total 
synthesis of platensimycin was completed quickly, the indirect route to aniline synthesis, 
the mixture of alcohols produced by the key reductive cyclization, and the awkward 
installation of the propanoate side chain left room for improvement in this area. 
 
Scheme 4. 5:  The completion of Nicolaou’s first total synthesis of platensimycin 
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4.2.2.  Nicolaou’s Synthesis of (–)-Platensimycin 
The first total synthesis of platensimycin was racemic, however it was quickly (5 
months later) followed by an asymmetric version also by Nicolaou.25  While two 
approaches to the ketolide portion were disclosed in this report, only one will be 
discussed further.  The first was an enantioselective synthesis of aldehyde 180 and while 
this constituted a formal enantioselective route to platensimycin, the issue of a lack of 
stereoselectivity in the subsequent aldehyde cyclization remained.  The other route used a 
similar strategy as in the racemic synthesis, involving an enantioselective 
cycloisomerization to set the stereochemistry.  
The dienone 179 was made in a similar fashion as before (vide supra, Scheme 4. 
4).  However, in this case, the alkyne had to be carboxylated to methyl ynoate 187, for 
the enantiodetermining cycloisomerization step (Scheme 4. 6).  In this case, a rhodium 
catalyst was used for the cyclization, using an (S)-BINAP ligand to influence the 
stereochemical outcome.  Enantioenriched enoate aldehyde 188 was obtained in 91% 
yield and greater than 95% e.e.  The enoate, though necessary for the rhodium 
cycloisomerization, was subsequently excised in a 5 step route to give aldehyde 189, the 
reductive cyclization precursor. This substrate 189 differs from that reported in the 
racemic synthesis (180) in the location of the olefin; it is exo to the cyclopentane ring 
above.  This minor change led to a major impact as the only epimer obtained (39% yield) 
was the desired axial alcohol 190.  No explanation was offered as to the fortuitous results.  
Cyclization of the ether behaved as before to give enantioenriched enone 183, 
constituting a formal synthesis.  The enantioselectivity notwithstanding, the synthesis 
suffers from low yielding key steps and a demonstrable substrate effect for 
stereoselectivity, both hindrances to analog syntheses and scale-up. 
 128 
 
Scheme 4. 6 : Nicolaou’s asymmetric approach to (–)-platensimycin 
 
4.2.3. Snider’s Formal Synthesis of (±)-Platensimycin 
Nicolaou’s intermediate 183 was the subject of a formal synthesis by Snider and 
co-workers reported less than a month following the disclosure of Nicolaou’s asymmetric 
route.26  Snider’s approach is unique from Nicolaou’s work in that the enone was installed 
at a late stage.   
The work began with a four-step conversion of 5-methoxytetralone 191 to enones 
192 as mixtures of cis and trans decalins, which were separated and equilibrated to a 6 : 4 
ratio (Scheme 4. 7).  The desired cis-decalin 192 was then reductively cyclized to tricycle 
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193 by treatment with tributyltin hydride and AIBN.  The dione 193 was reduced with 
L-Selectride to the diol 194.  It was found that Ca was stereoselectively reduced to give 
the axial alcohol, while Cb was obtained as a 1 : 1 mixture of axial to equatorial alcohols.  
The alcohol at Ca in diol 194 was cyclized to the ether in the same manner as in 
Nicolaou’s report.  The remaining alcohol Cb was eliminated to the olefin 195 under a 
variety of conditions.  The axial 194 was treated with triflic anhydride and then 
isopropanol to furnish the alkene 195, while equatorial 194 had to be eliminated via the 
triflate in a step-wise fashion.  With alkene 195 in hand, its allylic oxidation was 
examined and found to be best accomplished in a two-step process.  The allylic oxidation 
with SeO2 preceded MnO2 oxidation of the allylic alcohol to enone 193, intercepting 
Nicolaou’s intermediate.   
 
Scheme 4. 7: Snider’s formal synthesis 
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While Snider’s route was substantially shorter than Nicolaou’s, the lack of 
stereoselectivity and the resultant iterations required for different substrates to access 
enone 183 are not ideal. 
 
4.2.4. Yamamoto’s Formal Synthesis of (–)-Platensimycin 
 The enone 183 was also the subject of exploration by Yamamoto and co-workers 
who devised a unique enantioselective route.  The approach by Yamamoto and co-
workers involved an enantioselective Diels-Alder to set the stereochemistry early, and 
used a late stage Robinson annulation to form the cyclohexenone ring.27 
 The synthesis started with the enantioselective Diels-Alder cycloaddition between 
cyclopentadiene 197 and methyl acrylate 198 (Scheme 4. 8) catalyzed by the chiral 
oxazaborolidine 199 and the Brönsted acid 200.  The adduct 201 was obtained in 92% 
yield as a single diastereomer and 99% e.e.  The ester was cleaved to a ketone by 
quenching of the enolate with nitrosobenzene and oxidative decarboxylation.  The ketone 
was treated with basic hydrogen peroxide for a Baeyer-Villiger oxidation with 
rearrangement to give lactone 202 in 50% yield for the two steps.  The lactone was 
opened via SN2' addition of the vinyl cuprate with subsequent lactonization of the 
rearranged olefin to yield 203.  The lactone carbonyl was homologated in four steps to an 
α,β-unsaturated ketone and the vinyl group cleaved to an aldehyde providing key 
intermediate 204.  Upon treatment of the aldehyde 204 with proline in DMF, the 
Robinson annulation proceeded to give diastereomeric cyclohexenones  183 and 205 in a 
5 : 1 ratio, respectively.  The enone 183 intersects both Snider’s and Nicolaou’s 
intermediate and constitutes an enantioselective formal synthesis.  The brevity and 
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elegance of the synthesis notwithstanding, the lack of diastereoselectivity in the final step 
translates to a non-stereoselective synthesis of enone 183 and platensimycin 160. 
 
Scheme 4. 8: Yamamoto’s enantioselective formal synthesis 
 
4.3.5. Mulzer’s Formal Synthesis of (±)-Platensimycin 
Mulzer and Tiefenbacher reported their protecting group free formal synthesis of 
platensimycin in 2007.28  The similarity between the platensic acid core and the ent-
kaurene structure was observed by Mulzer.  Utilizing methods developed by Mander 
towards the synthesis of kaurene-type diterpenoids,29 Mulzer took an intermediate 
disclosed by Mander and converted it to enone 183. 
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HNTf2, 1,2-DCE, 70 °C, 81% (2 steps); e) DIBALH, PhMe, -78 °C, then Et2AlCN, BF3•OEt2,
43%; f) DIBALH/n-BuLi, -78 °C; g) NaH, CH3COCH2P(O)(OEt)2, THF, 0 °C, 65% (2 steps); h)
NaIO4, RuCl3, MeCN/H2O, 59%; i) L-Proline, DMF, 5d, then 2N aq. NaOH, 0 °C, 95%, 5 : 1.
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The tetralone 206 was converted, as per Mander, into dienone 207 in 5 steps and 
54% yield (Scheme 4. 9).  The advancement of dienone 207 to enone 183 is where 
Mulzer diverges.  The methyl Grignard addition attacked from the outside face of the 
ketone, which gave the tertiary alcohol.  Bromination γ to the dienone carbonyl gave 
bromide 208 which was closed to the ether under basic conditions.  Ether 209 was 
isolated in 80% yield.  Reduction of the dienone 209 to enone 183 was problematic. It 
was found to be unselective, as the best results were found using Crabtree’s Ir catalyst 
which produced the over-reduced 210 and 211 as a 1.3 : 1 ratio of diastereomers.  
Oxidation of the cyclohexanone 211 was accomplished with hypervalent iodine providing 
enone 183 in a short formal synthesis.  The lack of stereoselectivity in the hydrogenation 
again leaves this work short of a selective synthesis. 
 
Scheme 4. 9:  Mulzer’s formal synthesis  
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75%; c) NaOMe, THF, 0 °C, 80% ; d) cat. [Ir(cod)Py(PCy3)]PF6, H2 (1 bar), CH2Cl2, 78% brsm, 
210/211 = 1 : 1.3; e) HIO3·DMSO, DMSO, cyclohexene, 50 °C, 60%
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4.3.6. Corey’s Formal Synthesis of (–)-Platensimycin 
Corey’s approach to the formal synthesis of platensimycin was unique among the 
approaches discussed thus far.  Though it intersected with Mulzer’s dienone 209, Corey’s 
and Lalic’s approach was different, utilizing an alkylative dienone formation.30 
Napthol 212 was oxidized, with subsequent in situ ketal formation, to enone 213 
in 80% yield (Scheme 4. 10).  The enantioselective conjugate addition of propenyl-2-
trifluoroborate to enone 213 was accomplished in 96% and 94% e.e.  The ketone was 
then reduced to the alcohol, which was protected as its MEM ether.  The ketal was 
removed, and the ketone reduced down to the methylene in a two step process.  After 
phenolic demethylation, the phenol 214 was protected as its trisopropylsilyl ether, which 
was obtained in eight steps from ketone 213.  Treatment of the olefin in 214 with 
bromine led to intramolecular opening of the intermediate bromonium ion to form ether 
215.  Desilylative alkylation of the phenol gave dienone 209, which coincided with 
Mulzer’s intermediate.  However, Corey improved on Mulzer’s work, increasing the  
diastereoselection of enone hydrogenation.  Using a Rh catalyst,  with DIOP ligands,  
enone 209 was reduced giving the cyclohexenone 210 of the desired stereochemistry in 
72% yield—the hydrogenation was unspecific and the unwanted diastereomer 211 was 
isolated as well.  The enone was reinstalled providing Nicolaou’s intermediate 183 and a 
formal synthesis was completed.  This synthesis, though unique and enantioselective, 
suffers from the unstereoselective reduction of a dienenone.   
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Scheme 4. 10: Corey’s formal synthesis 
 
4.3.7.  Giannis’ Synthesis of the Platensimcyin Aniline 
The synthesis of the platensimycin aniline 175a by Nicolaou, as discussed above, 
was indirect and as such was supplanted by a more direct route.  Giannis disclosed the 
synthesis of the platensimycin aniline, both the protected aniline 175a (used by Nicolaou) 
and the unprotected aniline 175.31 
The commercially available methyl 2,4-dihydroxybenzoic acid 216 was nitrated 
with HNO3 and acetic anhydride/acetic acid (Scheme 4. 11) to yield a 1 : 1 mixture of 3-
nitro 217 and 5-nitro 218 products in a combined 56% yield (29% of the desired 3-nitro 
XXX).  Hydrogenation of 3-nitrobenzoic acid 217 provided the platensimycin aniline 175 
in 97% yield.  This two-step route, though not selective, is direct and convenient. 
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Reagents and Conditions: a) PhI(O2CCF3)2, Ethylene glycol, MeCN, 0 °C, 80%; b) propenyl-2-
trifluoroborate, (S)-BINAP, [Rh(cod)2]BF4, PhMe, H2O, Et3N, 96%, 94% ee; c) NaBH4, MeOH; 
d) MEMCl, DIEA, DCM; e) TsOH, Acetone, 0 °C; f) DIBALH, DCM, 0 °C; g) Et3SiH, TFAA, 
DCM, -20 °C, 79% (five steps); h) PhSH, Cs2CO3, DMF, 170 °C, 99%; i) TIPSCl, imid, DCM; j) 
Br2, DCM, -78 °C, 84%; k) TBAF, THF, 130 °C, 88%; l) [Rh(cod)2]BF4, (R,R)-DIOP, H2 (600 
psi), DCM, 72%; m) TMSOTf, Me3N, DCM; n) IBX, MPO, DMSO, 80% (two steps).
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Scheme 4. 11:  Giannis’ synthesis of the platensimycin aniline 
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Reagents and Conditions: a) HNO3, Ac2O, AcOH, 56%, 1:1 ratio; b) H2, Pd/C, EtOAc, 97%.
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4.3. CONCLUSION  
Platensimycin (160) is a potent, broad spectrum antibiotic whose structural 
complexity and compelling antibiotic activity has generated great interest in the scientific 
community.  It is a potent and selective inhibitor of FabF which is important for fatty acid 
biosynthesis and bacterial growth.  The biological activity has been shown to be derived 
from the 3-aminobenzoic acid moiety.  Though both in vitro and in vivo activity have 
been demonstrated, a poor pharmacokinetic profile has limited the potential for clinical 
development and spurred the exploration of analogs. 
While many approaches to the synthesis of platensimycin have been reported 
(including several not discussed here32, 33, 34), the achievement of a stereospecific route has 
thus far eluded researchers.  The biologically important nature of the target, as well as the 
draw of a stereoselective synthesis, compelled us to pursue a total synthesis of  
(-)-platensimycin.  Our efforts toward that goal will be presented. 
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Chapter 5:  Efforts Towards the Total Synthesis of Platensimycin 
5.1. INTRODUCTION 
Platensimycin, a natural product isolated by Merck scientists from a strain of 
Streptomyces platensis,  has recently been discovered to possess potent antibiotic activity 
against Gram-positive bacteria, including MRSA.  While in vivo efficacy has been 
established, a poor pharmacokinetic profile has been implicated and an analogue for 
clinical development is desirable.  Though much research into its total synthesis has been 
reported, resulting in one total synthesis and numerous formal syntheses, no synthetic 
approach disclosed thus far has been diastereoselective, leaving room for improvement.  
Our efforts towards a stereoselective total synthesis of platensimycin will be discussed 
herein. 
 
5.1.1. Synthetic Approach 
The common disconnection at the amide linkage will be used in this work as well, 
as it has clearly been established to be a viable route.  The aniline 175 and ketolide 171 
compounds are the targeted intermediates.  The aniline was seen coming from 2,4-
dihydroxybenzoate 216.  The enone acid 171, the more structurally complex target of the 
two, was seen arising from sequential phenolate cyclizations of 221 to furnish an enone 
220 similar to that of Mulzer’s.  
The key to our proposed stereoselective approach to acid 171 is the ability to use 
one stereocenter (C12, red) set early, to dictate the stereochemical outcome of later steps 
wherein the polycyclic ether core could be obtained as a single stereoisomer.  The 
majority of the previously reported formal syntheses relied on late stage hydrogenations 
to define the stereochemistry of the cyclohexenone core, resulting in mixtures of isomers 
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and no stereospecificity.  To improve on this, it was thought that the core might be best 
accessed if the proper oxidation state were maintained throughout, eliminating the need 
for hydrogenation or other reductions.  Therefore, the ketolide 171 would be the result of 
sequential deconjugative alkylations, methyl then propionyl to install the side chains, on 
dienone 220 followed by hydroboration/oxidation of the deconjugated double bond 
(Scheme 5. 1).  The installed alcohol would then be closed to the ether.  
The use of phenolate cyclizations to construct the tricyclic enone 220 was 
envisioned.  Therefore, a phenol of the type 221 was viewed as a starting point for such 
investigations.  The attractive feature of this approach was the belief that the 
stereochemistry of dienone 220 and subsequent compounds would be controlled by the 
methine (C-12, platensimycin numbering, highlighted in red) of phenol 221. 
 
Scheme 5. 1:  Synthetic approach to platensimycin XXX  
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5.1.2. Background on the Anionic Phenolate Cyclization1 
The discovery that some phenols with para-substituents containing a leaving 
group could be cyclized on carbon via the participation of the neighboring phenoxide ion 
by Winstein and Baird2 inspired numerous research groups to further investigate this 
powerful reaction.  In their seminal report, Winstein and Baird discovered that phenol 
223 with a 4-bromobenzenesulfonate (Bs) butanol side chain would cyclize to the 
dienone 224 under the influence of t-BuOK in t-BuOH (Scheme 5. 2).  That dienones like 
224 would be important intermediates for the synthesis of many natural products, 
including platensimycin (vide supra) was soon realized.  The utility of phenoxide ion’s in 
the intramolecular displacement of leaving groups for ring formation would soon become 
a productive area of research.1   
The similarities between platensimycin and the kaurene class of natural products 
has been established based on their proposed biosynthesis and structure.  So the synthesis 
of kaurene by Masamune is relevant to this discussion.  In a series of papers describing 
this work, Masamune expanded the scope of the phenolate cyclization first reported by 
Winstein and Baird.  The tetrahydronapthol tosylate 225 was cyclized under the same 
conditions reported by Winstein to provide the dienone 226 in 90%.  The bicyclo-[3.2.1] 
system is a motif that we hope to target in a synthesis of platensimycin.  The account by 
Masamune of the cyclization chemistry of the protected bromohdyrin 227, and its 
conversion to kaurene, was also relevant.  A mixture bromohydrin isomers was subjected 
to the cyclization conditions and it was observed that only one isomeric product was 
obtained; the product dienone with the “exo” tetrahydropyranyl ether 228.  The utility of 
this cyclization to intall the desired oxygen would be tested in this work (vide infra), 
albeit on a tertiary ether.   
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Scheme 5. 2:  Development of the phenolate cyclization for the synthesis of dienones 
While Masamune (1961) had demonstrated the utility of the phenolate cyclization 
of tetrahydronaphthols to dienones, the utility of the phenolate cyclization for the 
synthesis of tetrahydronaphthols had not yet been explored.  Murphy and co-workers 
reported a series of papers (1975) exploring various aspects of the reaction.  As our 
approach to platensimycin relied on the ability to access a tetrahdronaphtol, this was of 
interest.   
Murphy was the first to demonstrate that phenols of the type 229 could undergo 
ring formation through intramolecular displacement without competing intermolecular 
ether formation.3  The phenolic tosylate 229 was cyclized to tetrahydronapthols 230 and 
231 in a 3 : 1 ratio (Scheme 5. 3).  This so-called Ar2–6 reaction1 has been extended to a 
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large variety of substrates.  The analogous Ar2–5, Murphy showed, fails.  However, the 
ratio of ortho : para products showed some dependence on the reaction conditions.4  The 
use of different metal counter-ions gave varying ratios of products, with the ortho 230 
always predominating.  While different solvents were also investigated, t-BuOH was 
found to be superior; no solvolysis was observed. 
 
Scheme 5. 3 : Ar2–6 synthesis of tetrahydronaphtols 
In the end, the utility of the phenolate cyclization in the synthesis of dienones and 
tetrahydronaphthols is evident.  Its application to the stereoselective synthesis of 
platensimycin will be explored. 
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5.2. RESULTS AND DISCUSSION 
5.2.1. Synthesis of the Platensimycin Aniline 
Nicolaou’s initial total synthesis5 addressed the synthesis of an aniline for 
platensimycin.  However, their solution was lengthy (6 steps, including OH deprotection) 
and included protection of the phenols for the peptide coupling.  These two aspects 
warranted improvement.  Our attempts at an improved aniline synthesis were thus 
initiated.  This work, though not published, had been completed before Giannis’ 
disclosure of an improved aniline synthesis.6  
The nitration of methyl 2,4-dihydroxybenzoate (216), the commercially available 
starting material, was examined first.  It was found that under the standard nitration 
protocol, HNO3 in H2SO4, the 5-nitro product 218 was obtained in 68% yield with trace 
amounts of the desired 3-nitro 217 evident (Scheme 5. 4).  The penchant of aryl 216 for 
“para” nitration was expected on the grounds that the 3-position was ortho disubstituted 
and therefore, more hindered.  Giannis found that with the addition of acetic anhydride to 
a nitration protocol, a 1 : 1 mixture of 5-nitro and 3-nitro products could be obtained.   
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Scheme 5. 4: Synthesis of the platensimycin aniline 233 
The notion to use a removable blocking group to direct nitration was explored.  
As the nitrobenzene was to be reduced to an aniline in a subsequent step via 
hydrogenation, a blocking group removable by hydrogenolysis for the more reactive 5-
position was sought.  Bromination of benzoate 216 followed by nitration provided the 3-
nitro aryl 232 in 61% yield over the two steps.  The bromine was then removed in the 
subsequent hydrogenation step, providing aniline 233 as its hydrobromide salt.7   
With a direct and efficient route to the aniline, our attention turned to the aniline’s 
coupling ability.  The assumption that the phenols needed to be protected through the 
peptide coupling was challenged.  A simple test coupling with a propionic acid 234  was 
carried out (Scheme 5. 5).  The β-aryl acid 234 was coupled to aniline 233 using the DCC 
coupling conditions, to afford the amide 235 in 46% yield.   Therefore, phenol protection 
was deemed unnecessary.8   
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Scheme 5. 5 : Amide coupling of aniline 233 
 
NH3Br
OH
OH
CO2Me
H
N
OH
OH
CO2Me
O
OMe
DCC, Et3N, CH2Cl2
46%
233 235
OMe
CO2H
234
 149 
5.3.  STUDIES TOWARD THE SYNTHESIS OF ENONE ACID OF (–)-PLATENSIMYCIN 
With a synthesis of the aniline completed, the synthesis of the enone acid 171 was 
undertaken.  The first synthetic target was a phenol of the type 221 with a 3-alkyl 
substituent suitable for advancement to the dienone 220 (Scheme 5. 1).  The 
spirocyclodienone 220 has been a common structural motif of intermediates used in the 
synthesis of kaurene natural products, and their synthesis via anionic phenolate 
cyclizations is an established synthetic approach. 
 
5.3.1.  First Generation:  The Desmethyl Series 
The first targeted intermediate, phenol 221 (the phenolate cyclization substrate) 
was seen arising from an alkylation of a phenethyl halide, wherein the nucleophilic 
carbon (C-12) could be set via enantioselective alkylation.  The synthesis of a phenethyl 
electrophile began with the protection of commercially available phenol 236 as its 
triisopropylsilyl ether 237 (Scheme 5. 6).  The ester was reduced using LAH, providing 
the phenethyl alcohol 238, ready for conversion to a leaving group.  The phenethyl 
alcohol was converted to its bromide 239 (PBr3, 20%), tosylate 240 (TsCl, pyr, 34%), and 
mesylate 241 (MsCl, Et3N, 98%) for investigation into their alkylation potentials.   
 150 
 
Scheme 5. 6:  The synthesis of phenethyl alkylating agents 
Initial investigations were aimed towards a racemic synthesis, thereby testing the 
credibility of the proposed approach.  Ethyl 3,3-dimethylacrylate 242 was chosen as an 
appropriate nucleophile, including a functional handle for epoxide formation en route to 
phenol 221.  In the event (Scheme 5. 7), the extended enolate of acrylate 242, formed 
upon exposure to LDA, was treated with the tosylate 240.  The alkylation product 243 
could be obtained, albeit in a disappointing 27% yield.  The bromide behaved worse than 
the tosylate in this reaction, giving primarily a styrene, the product of bromide 
elimination.  The first attempt at the tosylate alkylation, using a roughly 1 : 1 ratio of 
nucleophile to electrophile gave only 8% of the desired product.  Additives such as 
HMPA and DMPU did not improve the yields.  Extending the time of the reaction gave 
reconjugated acrylate, suggestive that the enolate would rather equilibrate with alkylated 
product 243 than alkylate with the remaining electrophile.  Thus, it was concluded that 
the enolate of acrylate 242 was not reactive enough for the desired transformation.  
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However, the availability of product 243 allowed for further study.  Reduction of the 
ester to the homoallylic alcohol was accomplished with DIBALH in ether to give alcohol 
244 in 66% yield.   
 
Scheme 5. 7:  The alkylation of phenethyl tosylate 244 
With the success of a racemic alkylation, the investigation of an enantioselective 
alkylation was begun.  The known pseudoephedrine amide 245,9 a chiral auxiliary analog 
of ester 242, was envisaged as an appropriate nucleophile.  There was hope that an 
enantioselective synthesis could be carried on from the start.  While the dianion of 
pseudoephedrine amide 245, prepared using the standard protocol,10 had been alkylated 
before, only one phenethyl iodide had been used.11  The common problem of phenethyl 
alkylation, namely elimination to the styrene, manifested itself in this case.12  The 
alkylation of amide 245 with tosylate 240 produced a mixture of pseudoephedrine 
containing products which could not be separated (Scheme 5. 8).  The majority of the 
tosylate was eliminated.  The mixture appeared to contain the desired product 246, amide 
starting material 244 and the deconjugated pseudoephedrine amide.  The mixture was 
carried forward, with the reduction to the homoallylic alcohol 244, corresponding to 
(S)-244.  As such, the reduction using the known conditions,13 produced the alcohol 
OTs
TIPSO
O
EtO
TIPSO
O
OEt
LDA, THF
–78 °C
27%
TIPSO
OH
DIBALH, Et2O
66%
240 242 243
244
 152 
(S)-244, now readily purified and characterized as before.  A meager 21% yield over the 
two steps was recovered.  Using a chiral HPLC trace and through comparison with the 
racemic alcohol 244, the enriched alcohol was determined to be of 25% e.e.  While 
further experiments aimed at the optimization of this approach were performed, the 
enantioselective approach was temporarily discontinued. 
 
Scheme 5. 8:  The pseudoephedrine amide 245 alkylation of tosylate 240 
To achieve an efficient synthesis of platensimycin using this route, clearly 
improvement into the alkylation of these phenethyl electrophiles was necessary. The 
reason for the poor yields was believed to be the inertness of the enolate to alkylation, 
and so a more reactive enolate was desired.   
The ethyl acrylate 242, though commercially available, was economically best 
accessed in large quantities through the esterification of 3,3-dimethylacrylic acid with 
EtOH and sulfuric acid, and distillation of the crude mixture. The 3,3-dimethyl acrylic 
acid 247 starting material was thought to be a rational alternative to the ester via 
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alkylation of its dianion.  The use of these dianions in synthesis had been demonstrated,14 
and thus was explored in this case. 
In the event, acid 247 was treated with LDA (2.2 eq) and upon warming of the 
reaction mixture from –78 °C to room temperature, an off-white precipitate formed, 
indicating the formation of the dianion (Scheme 5. 9).  Quenching of the re-cooled (–78 
°C) dianion with mesylate 241 provided alkylated acid 248 in 54% yield on the first 
experiment, doubling the best yield obtained through the ester alkylation.  Using an 
excess of the acid, gave a scalable and reproducible procedure for accessing carboxylates 
248.  The acid was reduced using LAH, providing homoallylic alcohol 244 in 
quantitative yield.  It was found that the use of ether was superior to THF and toluene, 
which produced substandard yields of this reduction.  The use of ether gave the desired 
alcohol cleanly and quantitatively.  With improved access to alcohol 244 its utility in the 
synthesis of platensimycin was examined.   
 
Scheme 5. 9: An improved synthesis of homoallylic alcohol 244 
The strategy envisioned was to use successive phenolate alkylations to form 
dienone 220, wherein both the alkylations would be performed in a one-pot process on 
the doubly activated substrate 221.  To examine this strategy, homoallylic alcohol 244 
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would need to be converted to epoxide 251.  The two possibilities were to a) convert the 
alcohol to a leaving group and then epoxidize the olefin, or b) do it in the reverse order.  
Both were attempted. 
Epoxidation of homoallylic alcohol 244 was accomplished with m-CPBA to give 
an inconsequential mixture of diastereomeric epoxides 249 in a 1 : 1 ratio (Scheme 5. 
10).  However, the alcohol of 249 proved difficult to convert to a leaving group.  
Attempts aimed at converting it to a mesylate or tosylate met with decomposition of the 
starting epoxide.  The reaction mixtures clearly indicated the loss of the epoxide, either 
due to opening by the Cl– produced in the reaction or by the HCl produced, through its 
triethylammonium salt.  In any case, mesylate 251 was not accessed via the epoxide 249.   
 
Scheme 5. 10:  The failed attempts to synthesize epoxide 251 
While the alcohol 244 could easily be sulfonylated to 250 using MsCl, clean 
epoxidation of the olefin in 250 was unable to be achieved, even though epoxide 250 was 
believed to be present in the crude reaction mixtures.  All purification attempts led to 
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decomposition with no discernible products.  Some trace amounts of epoxide 251 of 
reasonable purity were obtained, but it decomposed on standing.  It was believed that a 
stepwise route to dienone formation would be necessary. 
 
5.3.2. Phenolate cyclizations 
A slight adjustment to the synthetic approach was made, wherein the two 
phenolate alkylations would arise through a step-wise route.  The synthesis of 
tetrahydronaphthol 253 from phenol 252 would precede functionalization of the exo-
propenyl group and cyclization to the dienone 220 (Scheme 5. 11).  
  
Scheme 5. 11:  An adjusted synthetic approach to dienone 220 
With access to mesylate 250 established, its cyclization into the 
tetrahydronapthol, based on the work of Murphy,3 was tested.  It was thought that 
removal of the silyl ether and cyclization could be accomplished in one transformation. 
However, the ratio of ortho : para cyclized products that would result was unknown as a 
different mechanism might be operable.  The notion that desilylation of the phenol and 
alkylation of the resultant phenolate anion in the para position might be achieved 
selectively, was explored.  Should the reaction behave in a concerted fashion, with 
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concomitant desilylation and Ar2–6 alkylation, the triisopropylsilyl ether might have a 
steric directing effect.   
Aprotic conditions were thought to be necessary to avoid protonation of the 
phenolate, so silyl ether mesylate 250 was treated with CsF in DMF.  This resulted in a 
single product forming, though different products resulted depending on the temperature 
at which the experiment was performed (Scheme 5. 12).  At room temperature, CsF 
cleanly and quantitatively removed the silyl ether providing phenol 254 with no 
cyclization observed.  At higher temperatures (150 °C reflux), fluoride behaved as an 
exceptional base, eliminating the mesylate to the diene 255 cleanly and with complete 
conversion. All attempts to affect the Ar2–6 cyclization from silyl 250 directly led to 
either phenolic mesylate 254 or diene 255.  Nonetheless, the desilylated phenol 254 could 
still be cyclized using the established phenolate cyclization conditions, but a one-pot 
process was not likely to be achieved. 
 
Scheme 5. 12: The attempted one-pot desilylation and phenolate cyclization 
Though cyclizations of phenols of the type 254 have been used in synthesis for 
many years, the reaction has been shown to exhibit substrate dependence.  While the 
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literature reports suggested the desired cyclization would provide an undesired result 
(predominately ortho cyclization), it was prudent to test this compound.   
The cyclization of phenol 254 was first instigated with t-BuOK in t-BuOH at 
reflux, the standard conditions, which give a mixture of three products with complete 
conversion (Scheme 5. 13).  The products were determined to be the ortho-phenol 256 
and para-phenol 253 (both from the SN2, Ar2–6, cyclization), and the diene 255 from the 
competing E2 pathway.  The desired para-phenol 253 was inseparable from the diene 
255, but the 1H NMR integrations revealed that the ortho-phenol 256 was the major 
product in a ratio of 6 : 2 : 1 (ortho : para : E2) with a combined yield of 96%.  However, 
this translates to a meager 20% yield of the desired product.  After extensive 
experimentation (Table 5. 1), the best ratio was obtained through the use of Cs2CO3 in 
t-BuOH.  The products were obtained in 2 : 1 (o : p) ratio with trace amounts of the E2 
product diene 255.  The use of strong bases such as potassium hydride and potassium 
hexamethyldisilazide produced only elimination, while weaker bases such as potassium 
hydroxide and potassium carbonate gave decomposition or recovered starting material.  
These results suggest that the effect of the counter-ion is felt in the transition state, 
directing the carbon-carbon bond formation selectively to the ortho position.  Ultimately, 
no conditions could be found wherein the para product was formed selectively.  
Unfortunately, this was a problem that needed to be solved, should a stereoselective 
synthesis of platensimycin be completed.   
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Scheme 5. 13: The cyclization of phenol 254 
The use of both products, ortho 256 and para 253, in exploratory studies is 
discussed next, while a solution to selective cyclization will be presented later. 
 Conditions Results o : p : E2 
(yield) 
Notes 
1 t-BuOK, t-BuOH, 83 °C 6 : 2 : 1 (96%) Classical conditions 
2 t-BuONa, t-BuOH, 83 °C 8 : 2 : 1 (67%) Tighter counter-ion 
leads to more ortho 
product 
3 t-BuOK, t-BuOH,  
18-crown-6, 83 °C 
0 : 0 : 1 (45%) No counter-ion, 
increased basicity 
gave only E2 
4 KH, THF 0 :  0  : 1 (68%) Strong base gives E2 
5 KHMDS, THF 0 :  0  : 1  Strong base gives E2 
6 KOH, H2O, 100 °C Trace amounts Mostly decomposition 
7 Cs2CO3, t-BuOH, 83 °C 2 : 1 : trace (45%) Very slow, but best 
ratio 
8 Cs2CO3, THF, 65 °C Trace amounts Slower, lot of decomp.  
9 K2CO3, t-BuOH, 83 °C No reaction  
Table 5. 1:  Phenolate cyclization conditions 
HO
OMs
254
HO
OH
255
E2
255
ortho
253
para
cond.
Table 1
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5.3.3. The Advancement of Tetrahydronaphthol 253 to a Dienone 
With the utility of the phenolate cyclization established, albeit with its issues, our 
attention now turned to the synthesis of dienone 220 (Scheme 5. 1).  The first attempt was 
based on the supposition that the phenolate might be used to open an epoxide, giving the 
dienone 220 directly.  The use of phenolates to open epoxides had been demonstrated,15 
though only for the synthesis of larger rings, but its application to this synthesis was 
loosely relevant.   
The ability to access larger amounts of pure ortho-product 256 governed the 
decision to carry it forward rather than the para 253, which maps the natural product.  
Nonetheless, both the ortho and para phenols were epoxidized, using m-CPBA to give 
epoxides 257 (60%) and 258 (48%), respectively (Scheme 5. 14).  With the epoxides in 
hand, their opening to form dienones was thus investigated. 
 
Scheme 5. 14:  Epoxidation of phenols 256 and 253 
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5.3.4. The epoxide approach to dienone formation 
The intramolecular opening of epoxides by phenoxide for the synthesis of 
spirocyclodienones was first reported by Whiting and co-workers.15 However, the 
application of this to the formation of bicyclo-[3.2.1] systems is unknown.  The reaction 
of epoxide 259 led to opening and spirocycle formation yielding tricycle 260 (Scheme 5. 
15).  The product resulted from opening at the less-substituted carbon.  Interestingly, 
epoxides 261 (n = 0) and 262 (n = 2), differing slightly in the length of their carbon 
linkages only, were unreactive under the conditions.  Therefore, the epoxide 257, which 
differs in the placement of the epoxy side chain on the tetrahydronaphthol ring, was 
investigated. 
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 Scheme 5. 15: Whiting’s epoxide opening investigations 
Treatment of epoxide 257 with t-BuOK in t-BuOH at reflux only returned 
unreacted starting material.  Further heating of the epoxide in a sealed tube and the use of 
different bases or solvents, returned the starting epoxide unchanged.  It seems the phenol 
is not able to adopt a conformation wherein the aromatic ring HOMO could attack the 
epoxide’s antibonding σ* orbital.  Therefore, as the phenol could not directly open the 
epoxide, alternative conditions were explored.  The thought was that opening of the 
epoxide 257 with a halide nucleophile would furnish an intermediate halohydrin 265.  
This halohydrin might then be displaced forming the dienone 264.  Even though under 
the basic conditions, the equilibrium would favor reclosure to the epoxide 257 strongly, 
the intermediacy of the halide 265 might allow for the irreversible formation of dienone 
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264.  The consumption of the halohydrin, would drive the equilibrium, producing the 
dieneone 264.  Thus, the second attempt at direct dienone formation was attempted. 
To test this hypothesis, the epoxide XXX was heated with t-BuOK in t-BuOH in 
the presence of a metal halide in a sealed tube.  Again, no product dienone was observed.  
A variety of bases, metal salts, and solvents were tried, but to no avail (Scheme 5. 16).  In 
most cases the epoxide was recovered, as when preformed in t-BuOH at reflux.  Further 
heating destroyed the starting material in undetermined ways.  In one instance, the use of 
Bu4N+Br– gave what appeared, but could not be isolated, to be bromohydrin formation as 
the epoxide was clearly gone, but no dienone was ever observed.  As the presence of 
enone peaks in a 1H NMR spectrum as paired doublets at ~6.8 and 6.0 ppm are 
diagnostic, their absence was conspicuous.   
 
Scheme 5. 16:  The attempted direct opening of epoxide 257 
Some instances using lithium salts gave crude mixtures of products where, no 
dienone was present, but an aldehyde proton (>9.0 ppm, similarly diagnostic) was 
observed in the 1H NMR spectrum.  Though attempts at isolation of the aldehyde failed, 
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its presence indicated that the epoxide, at least in the presence of lithium, preferred to 
open to the cation, which led to rearrangement via 1,2-hydride shift to the aldehyde.  All 
in all, the possibility of opening the epoxide directly to the dienone 264 seemed less and 
less viable. 
 
5.3.5.  Dienone Formation via the Displacement of a Halide 
The displacement of aliphatic halides intramolecularly to form dienones has been 
previously used in the synthesis of natural products by Masamune16,17 in his work towards 
the kaurene18 class of compounds.  This strategy was also used by Corey19 in his formal 
synthesis of platensimycin.  In this case, an allylic halide would be desired as its 
displacement would furnish a dienone with an exo-methylene.  Under the proposed route, 
this could intersect with Nicolaou’s intermediate 183. 
The direct allylic oxidation of alkene 256 was the first strategy explored.  The use 
of SeO2, a standard allylic oxidant, produced the product of allylic oxidation at the 
undesirable allylic carbon C-12 (266) (Scheme 5. 17).  The desired methyl group 
oxidation product 267 was determined to be present only in trace amounts.  The major 
product, alcohol 266 was obtained in 69% yield.  While the oxidative rearrangement of 
alcohol 266 to an aldehyde with an oxygen now on the appropriate carbon seemed a 
possibility, a more direct alternative was pursued. 
The epoxide 257, already in hand, contained the oxygen attached at the desired 
appropriate carbon.  Considering the variety of methods developed for the conversion of 
epoxides to allyl alcohols20 this seemed a more feasible approach.  At this point, the 
epoxidation of alkene 256, a reaction which did not translate well to scales >30 mg, was 
optimized.  Other epoxidation protocols (i.e. DMDO) gave similarly poor yields and the 
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hypothesis was that the presence of the phenol was producing undesired side reactions.  
To prevent this, the phenol was protected as its acetate, which could be epoxidized and 
deprotected in one-pot to give a quantitative yield of the same epoxide over the three 
steps (Scheme 5. 17).  Additionally, while the m-CPBA procedure required column 
purification, the improved three-step procedure produced pure epoxide as a white powder 
without the need for further purification. 
 
Scheme 5. 17: Allyic oxidation of phenol 256 
The rearrangement of epoxide 257 to allyic alcohol 267 was explored next.  
Exposure of epoxide 257 to amide bases such as LDA, LDE, and MgN(i-Pr)2 gave the 
recovered epoxide at room temperature, and warming led to decomposition.  Presumably, 
the phenolate, formed from deprotonation of the phenol, precludes rearrangement at 
ambient temperature.  Yet heating of the reactions only returned complex mixtures.  
Using TMSI, generated in situ, produced an undetermined product containing silyl 
groups, but no alkene peaks.  This could arise from isomerization of the allylic alcohol 
double bond to the tetrasubstituted alkene, upon the action of the generated HI.  
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Nonetheless, this could not be mitigated, and the desired allylic alcohol could not be 
obtained.   
Fortunately, treatment of the epoxide 257 with aluminum triisopropoxide 
furnished the desired allylic alcohol 267.   However, the aliphatic alcohol 268 was 
present as well, in an inseparable 1 : 1 mixture and 79% isolated yield (Scheme 5. 18).  
The unexpected side product, aliphatic alcohol 268, is understood to arise from the 
mechanism shown.  The epoxide first coordinates to the aluminum giving intermediate 
269.   It now has two paths for reaction.  The elimination of the epoxide, the desired 
pathway (red arrows), produces the desired allylic alcohol 267 via protonation of the 
resultant alkoxide 270.  The second path (blue arrows) involves the heterolytic cleavage 
of the epoxide to the tertiary cation and alkoxide 272.  This alkoxide can then rearrange 
via a 1,2-hydride shift, forming the aldehyde 273.  This pathway was also invoked to 
explain the observance of aldehyde peaks in earlier experiments with the epoxide 257 
(vide supra).  The aldehyde 273, still coordinated to the aluminum containing 
isopropoxide ligands, can then undergo a Meerwein-Pondorf-Verley reduction of the 
aldehyde to the alcohol 268 after protonation of aluminate 271.   
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Scheme 5. 18 :  Epoxide to allylic alcohol rearrangement and side reaction 
 
5.3.5.  Dienone formation 
With the alcohols 267 and 268 in hand, their conversion to the dienone was 
explored.  The alcohols, as a 1 : 1 mixture, were treated with I2, PPh3, and imidazole to 
furnish the iodides 274 and 275 (Scheme 5. 19).  However, only the aliphatic iodide 
could be isolated (48% yield, 96% conversion of the aliphatic iodide) in appreciable 
quantities.  The allylic iodide 275 may be extremely reactive, resulting in decomposition 
upon workup.  
Although the relevant allylic iodide could not be obtained in synthetically useful 
quantities, the less relevant aliphatic iodide 274 could.  Reaction of iodide 274 with 
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t-BuOK in t-BuOH at reflux produced the dienone 276 as an inseparable mixture of 
diastereomers in 92% yield (Scheme 5. 19).  Though dienone 276 was not thought to be 
directly convertible into enone acid 171 and thus platensimycin 160, the synthesis of a 
dienone as a model system had been completed.   
 
Scheme 5. 19: Dienone 276 synthesis 
While access to the dienone 276 was strategically important, it was not obvious 
that it could be directly converted to platensimcyin.  For that, the utility of the halide 
derived from the para-phenol 253 would need to be demonstrated. 
The acetate epoxide 277, derived from para-phenol 253 as per Scheme 5. 17, was 
treated to the allylic rearrangement conditions.  It was found that the acetate performed as 
well as the phenolic epoxides in these rearrangements, resulting in simulateneous 
deprotection.  The allylic alcohol 278 was again obtained as a 1 : 1 mixture with the 
aliphatic alcohol 279 in 69% total yield (Scheme 5. 20).  The iodination of alcohol 279 
was performed next.  The aliphatic iodide was still the only halide isolated from the 
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iodination reaction.  Treatment of iodide 280 with t-BuOK in t-BuOH at reflux, as before, 
produced the cross-conjugated dienone 281.  These compounds were not pursued further, 
nevertheless, accessing the dienones 276 and 281 was a success.  
 
Scheme 5. 20: Advancement of epoxide 277 to a dienone 
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5.4. SECOND GENERATION APPROACH: A BLOCKING GROUP SOLUTION 
The observation that phenol 254 cyclizes to give primarily the ortho cyclized 
product presented an issue that could not be solved through the desmethyl series phenol 
285.  However, installation of a non-H group in the ortho position of phenol 254 might 
direct the cyclization para.  The use of a similar strategy, using a methyl in the para 
position to direct an ortho cyclization was known, so the converse was reasonable.21  The 
synthesis of a substrate such as 282 would be targeted (Scheme 5. 21).  As the natural 
product contains a methyl group in this position it seemed the logical choice of R-group.   
 
Scheme 5. 21: Proposed blocking group strategy 
 
5.4.1.  A Directed ortho-Lithiation Strategy 
The phenethylalcohol 285, used an early intermediate in the desmethyl series 
above, was available in large quantities from commercially available chemicals and thus 
was a logical starting point for installing the 2-methyl group directly.  Unfortunately, the 
conversion of aryl 285 to its counterpart 2-methyl aryl 286 proved unfruitful (Scheme 5. 
22).  Therefore, an alternative course had to be devised.  The phenethyl alcohol would be 
constructed from a suitable 2-substituted phenol. 
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Scheme 5. 22:  Attempted conversion of desmethyl phenol 285 to 2-methyl phenol 286 
The ortho-directed lithiation and alkylation of aryls is a well established protocol 
for the synthesis of polysubstituted arenes.22  Consequently, it was pursued as an strategy 
for the synthesis of phenol 286.  The known triisopropylsilyl protected benzamide 287 
has been used in directed lithiation chemistry and for the purpose of maintaining 
consistency of the protecting groups, was used first.   
Clayden and co-workers used the lithiated triisopropyl benzamide 287 to open 
epoxides in the presence of BF3•OEt2.23  The extension of this procedure to the opening 
of ethylene oxide would produce the desired phenethyl alcohol. The lithiation of 
benzamide 287 was carried out using s-BuLi and upon quenching of the aryl lithium with 
ethylene oxide in the presence of BF3•OEt2 returned a complex mixture which appeared 
to be largely polymeric (Scheme 5. 23).  Elimination of the BF3•OEt2, the likely 
instigator of polymerization, gave a 20% yield of the desired phenethylalcohol 288, 
however this yield could not be improved at this time. 
Alkylating benzamide 287 with allyl bromide, followed by conversion of the allyl 
289 to ethanol 288 seemed attractive.  However, quenching of the lithiated benzamide 
with allyl bromide led cleanly to an aryl bromide, the product of lithium halogen 
exchange and not nucleophilic attack.24  Interestingly, many examples of lithiated 
benzamides similar to 287 were transmetalated to an aryl copper or cuprate species for 
successful alkylation.25  It proved to be an excellent solution in this case.  
Transmetalation of the lithiated benzamide with CuBr•SMe2, followed by quenching with 
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allyl bromide provided a quantitative yield of the allylated benzamide 289 (Scheme 5. 
23).  
 
Scheme 5. 23: The directed alkylation of benzamide 287 
The task of converting the allyl 289 to the ethanol 288 was subsequently achieved 
through ozonolysis and reduction.26  The allyl was ozonolyzed and then quenched with 
NaBH4.  Reduction of the intermediate secondary ozonide by NaBH4 provided the 
phenethylalcohol 288 in 98% yield, far better than via the initial oxirane opening 
reactions. 
Still, the benzamide carbonyl would need to be reduced to a methyl.  The thought 
of doing this in a two-step process where the amide is converted to the lactone, and the 
lactone reduced to the methyl was first considered.   The first step was to form the 
lactone27  290 (Scheme 5. 24).   While there are a few examples of the one-pot aryl 
epoxide opening and lactone formation,28 none of those procedures (namely workup of 
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the alkylation reaction with strong acid) worked in this case.  The pure amide 288 could 
be converted to the lactone under a variety of conditions with varying success, but all of 
these conditions resulted in quantitative desilylation of the phenol.  The best results for 
lactonization were managed with organic acids such as CSA and TsOH, however these 
reactions behaved erratically, often returning mostly the deprotected benzamide.  Basic 
conditions using alkaline hydroxides usually returned the seco-acid which was difficult to 
isolate and resulted in low mass recoveries.  Nonetheless, the lactone 290 was reduced to 
the benzylmethyl 292 using Red-Al in refluxing xylenes for a 60% yield.  In the end, 
another two-step process was found to be superior. 
 
Scheme 5. 24: The reduction of the diethylamide 288 to 2-methylphenol 292 
An alternative two-step process for the reduction of the 2-amide to the 2-methyl is 
outlined in Scheme 5. 24.  Reduction of the benzamide to the diethylbenzyl amine 291 
using LAH could be accomplished in refluxing THF (Scheme 5. 24).  Once again, 
deprotection of the silyl ether was facile.  Still, the deprotected amine could be obtained 
in quantitative yield.  Hydrogenation of benzyl amine 291 to 2-methylphenol 292 
proceeded in 89% yield, but only with Pd(OH)2 as the hydrogenation catalyst.29  Other Pd 
OH
O
O
TIPSO
O N
OH
CSA, PhMe
110 °C
0-92%
HO
OH
Red-Al, Xylenes
140 °C
60%
288
290
292
HO
N
OH
LAH, THF
65 °C
99%
H2, Pd(OH)2
MeOH
89%
291
 173 
catalysts were completely unreactive.  In fact, the only other conditions which returned 
the desired product involved the heating of amine 291 with a large excess (1000% wt.) of 
Raney Ni in refluxing EtOH for yields consistently in the 40-50% range.    Conversely, 
hydrogenation with Raney Ni (cat.) and H2 (g) gave no discernible product.   
In any case, the 2-methyl-3-phenethanol phenol 292 had been prepared and its 
conversion to an electrophile had been executed.  The diol 292 could be converted to its 
bromide 293, for direct comparison to the desmethyl series by refluxing the starting 
material in 48% HBr (aq.) (Scheme 5. 25).  The crude phenol was re-protected as its 
triisopropylsilyl ether 294 in preparation for the alkylation.  The two-step procedure gave 
bromide 294 in 84% overall. 
 
Scheme 5. 25:  Synthesis of bromide 294 
The alkylation of bromide 294 with 3,3-dimethylacrylic acid 247 was then 
performed.  Earlier examples of this reaction on the desmethyl bromide 239 gave 
substantial styrene formation and thus bromide 294 behaved similarly.  The enolate of 
acid 247 was formed with LDA and quenched with bromide 294.  The deconjugated acid 
295 was isolated in a mediocre 40% yield (Scheme 5. 26).  However, the bromide 294, 
accessible in gram quantities, behaved consistently in the alkylation, proceeding in a 
dependable 40% yield on multigram scales.  The issue of a substrate with a better leaving 
group, i.e. mesylate, was less pressing than whether the 2-methyl “blocking group” had 
the desired directing effect on the phenolate cyclization. 
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Scheme 5. 26:  The alkylation of bromide 294 
The acid 295 was converted to cyclization precursor mesylate 296 in a three-step 
procedure.  The acid was reduced with LAH and the crude alcohol was sulfonylated with 
MsCl.  After removal of the silyl group, phenol 296 was obtained in a 48% yield over the 
three steps, without any column chromatography (Scheme 5. 27).  The phenol mesylate 
296 was purified for the subsequent investigations.   
 
Scheme 5. 27:  Synthesis of a 2-methyl phenolate cyclization substrate 
The hypothesis that a 2-methyl “blocking group” could direct the phenolate 
cyclization to give the para-phenol exclusively was now tested.  Gratifyingly, treatment 
of mesylate 296 with with t-BuOK in t-BuOH at reflux gave the para-phenol 298 with 
the competing E2 product, diene 299 in a 4 : 1 ratio and 80% yield (Scheme 5. 28).   No 
ortho cyclization product, which would be a dienone 300, was identified.  This confirmed 
that the existence of a 2-substituent would direct the cyclization para.  The presence of 
the elimination product would clearly need to be addressed, but the issue of an improved 
synthesis of a 2-methyl alkylating agent was more pressing.   
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Scheme 5. 28:  The para-directed phenolate cyclization 
The synthesis of bromide 294 was acceptable for the investigative studies 
described above.   However, the difficulty in synthesizing the known silyl ether 
benzamide 287 (the synthesis from salicylic acid is low-yielding), the loss of the silyl 
protecting group during amide reduction, and the inefficient performance of the bromide 
294 in the alkylation led to the conclusion that a better route could be devised. 
 
5.4.2.  An Improved Directed ortho-Lithiation Strategy 
The choice to use a triisopropylsilyl protected phenol 294 was made for the 
purposes of direct comparison to the desmethyl series chemistry described above.  The 
desire to change only one variable (the 2-methyl substitution) in the established chemistry 
overrode the consequences of the silyl ether’s lability.  With the 2-methyl strategy 
established, the improved route was devised.  The anisic acid derived benzamide30 301 
was readily synthesized on hundred gram scales and was amenable to distillation, clear 
advantages for large-scale preparation and purification.   
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The anisamide 301 was allylated in a similar manner as before.31   Surprisingly, 
the use of s-BuLi gave ketone products arising from the addition of s-BuLi into the 
diethyl amide.  This product had not been observed in the triisopropylsilyl 287.  
Switching to t-BuLi eliminated this issue and allyl 302 could be obtained in 98% yield 
(Scheme 5. 29).  The allyl 302 behaved in the ozonolysis/reduction protocol as before, 
providing alcohol 303 in 73% yield.  
 
Scheme 5. 29:  The anisamide directed alkylation 
At this point, the utility of a direct ethylene oxide opening was re-examined.  The 
use of the aryl copper intermediate as a nucleophile (from transmetalation with 
CuBr•SMe2) had clearly improved the allylation chemistry, so its effect on oxirane 
openings was tested.  By using the aryl copper and raising the temperature at which 
ethylene oxide addition occurred to 23 °C, the alcohol 303 was optimally acquired in 
95% yield (Scheme 5. 29).  Another advantage to this benzamide route over the silylated 
benzamides was found during the isolation of alcohol 303.  Simple trituration of the 
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crude orange oil (spectroscopically of acceptable purity) with cold ether furnished the 
pure desired alcohol as a white powder, eliminating the chromatography necessary for the 
silyl benzamide alcohol 288. 
The effect of changing the phenolic protecting group from a silyl to methyl first 
manifested itself in the amide reduction.  Initial attempts at reducing the amide with LAH 
in refluxing THF were much slower, giving large amounts of unreacted starting material. 
Increasing the temperature by switching to LAH in refluxing toluene (65 °C – 110 °C) 
gave complete consumption of the starting amide, however substantial (as much as 50%) 
phenolic demethylation occurred.  In the end, LAH in refluxing THF for several days 
allowed the isolation of amine 304 in 99% yield (Scheme 5. 30).  The hydrogenation of 
benzyl amine to the 2-methyl phenethyl alcohol32 305 was similarly slowed by the 
presence of the phenolic methyl but after several days, the desired methyl alcohol could 
be obtained in quantitative yield (Strem® Pd(OH)2 was found to be essential for 
reproducability in this reaction).29  In those instances when time was short, the remaining 
unreacted amine (obtained through acidic extraction of the organic mixture with H3PO4)33 
could be recycled.   
 
Scheme 5. 30:  The synthesis of phenethyl alcohol 305 
The phenolic alcohol 292 had previously been converted to its bromide because of 
the presence of the diols.   In the case of alcohol 305, the phenol was blocked from 
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mesylation.  Since the removal of the methyl at a later stage had not yet been established, 
the desire for consistency in later steps led to the conversion of methyl 305 to bromide 
294 in the same conditions as before (73% over the two steps) (Scheme 5. 31).  The 
action of HBr was found to cleanly demethylate the anisole 305 to the phenol providing 
bromide 293.  Should a later substrate prove incompatible with demethylation strategies, 
the bromide 294 could be used, but now with improved access to it.  Additionally, the 
mesylate 306 (MsCl, NEt3, 99%) and the iodide 307 (I2, PPh3, imid., 63%) were prepared.   
Of the three electrophiles, the mesylate proved the most effective alkylating 
agent.  This was consistent with the observations of earlier alkylations (vide supra, 
Scheme 5. 9) and the mesylate was used from this point on. 
 
Scheme 5. 31 :  Conversion of alcohol 305 to electrophiles 294, 306, and 307 
In the alkylation, the dianion of acid 247 was quenched with mesylate 306 to give 
alkylation product 307 in 78% yield (Scheme 5. 32).  The removal of the phenolic methyl 
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was now examined.  Small amounts of the demethylated acid 308 could be obtained in 
small scale (~10 mg) reactions through the action of BBr3.  Larger scale experiments 
gave complex mixtures which exhibited the disappearance of the alkenyl protons.  This 
may have occurred through either reconjugation of the olefin to the acid or bromination 
of the olefin by advantageous Br2 or a combination of both.  The nucleophilic 
displacement of the methyl from the phenol with thiolates proved equally unsuccessful, 
giving no evidence of the desired demethylation.   
 
Scheme 5. 32:  The alkylation of mesylate 306 
Ultimately, the acid 307 was deemed a poor substrate for demethylation. With 
that in mind, the reduced acid 309 was converted to its mesylate 310 in an attempt to 
cleave the phenolic methyl on this substrate (Scheme 5. 33).  This would provide the 
phenolic mesylate 296, identical to that used in the earlier cyclization example (vide 
supra, Scheme 5. 28).  Unfortunately, no conditions for the desired demethylation could 
be found.  The nucleophilic thiolate conditions were clearly incompatible with the 
presence of an electrophilic mesylate and the use of BBr3 destroyed the olefin again. 
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Scheme 5. 33:  The attempted demethylation of mesylate 310 
Instead, the acid was reduced to the alcohol using LAH as before in 87% yield 
(Scheme 5. 34).  The phenolic methyl could then be removed under the action of sodium 
ethanethiolate.  Ethanethiol, NaH in DMF at 150 °C provided phenol 312 in 82% yield 
(or 71% over the two steps).  The usage of BBr3 gave similarly negative results as in the 
acid, where reaction of the olefin seemed to predominate.   
While alcohol 312 could be converted to its iodide 313 or bromide 314 in decent 
yields (83% and 87% respectively) their utility as phenolate cyclization substrates was 
questionable.  Experiments during the desmethyl series with a bromide instead of the 
mesylate 296 produced primarily the product of E2 elimination. Nevertheless, the use of 
the bromide 314 or iodide 313 in phenolate cyclizations was mandated by the inability to 
demethylate mesylate 310.  At this point,  the problem of competing elimination in the 
phenolate cyclization to tetrahydronaphthols would need to be solved. 
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Scheme 5. 34: The demethylation of phenolic 307 
The initial experiments in Ar2–6 cyclizations were prepared at room temperature, 
where the starting material was dissolved in solvent, the base was then added and the 
reaction heated to the designated temperature and maintained there until the reaction was 
complete.  However, careful examination of the phenolate cyclization revealed this was 
not optimal.  Bromide 314 was chosen for optimization as iodide 313 had a greater 
propensity for elimination than did the bromide.  As no product of intermolecular 
nucleophilic addition had ever been observed, the concentration of the reaction was not 
initially considered as a contributing factor when screening the conditions.  Nonetheless, 
it was clear from simple comparisons of side by side reactions that Cs2CO3 was an 
optimal base for the cyclization and that stronger bases such as tert-butoxide gave more 
elimination while weaker bases gave little or no product.  The use of aprotic solvents 
such as THF or DMF also gave greater amounts of E2.  So it was that Cs2CO3 in t-BuOH 
was chosen as the optimal base and solvent.   
With the base and solvent chosen upon, the temperature at which the reaction was 
run was called into question.  Essentially, which pathway occurrs at lower temperature, 
SN2 or E2 needed to be determined.  Nothing happens when the reaction is maintained at 
room temperature.  Slowly warming the suspension in 10 degree increments showed 
consumption of the bromide.  In fact, it was determined that the elimination occurs at 
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lower temperature.  Performing the reaction at 55 °C gave only the diene 299.  In an 
experiment designed at bypassing the threshold for activation energy for both pathways, 
the base would not be added until the appropriate temperature had been reached 
throughout the system.  When the base was not added until a solution of the bromide was 
refluxing rapidly, the elimination product was all but eradicated, appearing in ~10% 
based on the comparison of the 1H NMR integration.  Additionally, when the reaction 
was performed at  dilute concentrations for intramolecular cyclization (~0.005mM) with 
a great excess of base added after the solution had reached rapid reflux in t-BuOH, the 
desired cyclization product 298 was obtained with virtually no elimination product 299 
observable in the 1H NMR spectrum (Scheme 5. 35) (>95% cyclization).  These results 
combine to suggest a mechanism wherein conjugate base of the phenol is responsible for 
the elimination and not the Cs2CO3. 
 
Scheme 5. 35:  The optimized phenolate cyclization 
The phenol 314 could be protected as its acetate by dissolution in pyridine and 
acetic anhydride.  The reaction was immediately complete and evaporation of the 
volatiles gave the acetate 315 in quantitative yield, and of acceptable purity.  It was 
determined that this two-step process could be performed in a one-pot process from the 
bromide 314.  The cyclization was performed and the solvent removed by distillation.  
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The crude residue was then taken up in acetic anhydride and the excess Cs2CO3 served as 
the base.  After workup, the acetate 315 was again obtained in near-quantitative yield for 
the two steps.  With the acetate 315 in hand its conversion to the targeted intermediate 
dienones could be explored. 
 
5.4.3. Dienone formation 
Due to the earlier observations that the allyl halide route was unsuccessful, a 
bromohydrin intermediate, inspired by the Masamune work,16 was sought.  Treatment of 
acetate 315 with NBS in DCM with MeOH gave the bromohydrin.  The acetate was 
essential for this reaction’s success as the unprotected phenol gave aryl bromination 
products before bromohydrin formation.  The crude reaction mixture was then treated 
with K2CO3 and the acetate was cleaved to phenol 316.  Thus, the phenol bromohydrin 
316 was isolated in quantitative yield (Scheme 5. 36).  In short, the bromide 314 could be 
converted to bromohydrins 316 in 3 steps and 99% yield with no column 
chromatography. 
 
Scheme 5. 36:  Bromohydrin formation 
The bromohydrin diastereomers were inseparable and at the time this was seen as 
inconsequential.  The ring closure would arise via the ionization to the cation, losing any 
relevance as to the MeOH stereochemistry.  The mixture was subjected to the classical 
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dienone cyclization conditions (t-BuOK in t-BuOH) and heated for two days until 
completion.  The dienones 317 and 318 were formed in a 1 : 1 ratio and a combined yield 
of 32% (Scheme 5. 37).  This dienone formation proved to be less clean or efficient than 
earlier examples.  This difference in reactivity was understood by the assumption that the 
SN2 displacement at the neo-pentyl bromide carbons was more difficult and that 
competing decomposition may occur.  Incidentally, the isolation of both cyclized isomers 
is contrary to the observation made by Masamune (Scheme 5. 2) that only one isomer of 
bromohydrin, in his work, was cyclized.  The combined yield could be improved to 66% 
for both isomers by switching to Cs2CO3 as the base.  The methyl ether epimers were 
separable at this point.   
 
Scheme 5. 37:  Cyclization of bromohydrin 316 
The first attempt to convert the dienones 317 and 318 into platensimycin involved 
the deconjugative alkylations to install the propionate side chain.  The resultant 
trisubstituted olefin would then be hydroborated and oxidized to install the requisite ether 
oxygen.  Classically, dienones of this type have been alkylated using the cyclization 
conditions of t-BuOK in t-BuOH.  The conjugate addition of the dienone’s enolate to an 
acrylate was envisioned to directly put in the propionate side chain.  While Nicolaou’s 
work used an allyl group and functionalized it to the propionate in three steps, a more 
direct approach was preferable.  Unfortunately, no such reaction could be completed.  
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Under all conditions applied, the starting material was returned unchanged (Scheme 5. 
38).   
The use of LDA as a base in the alkylation was also explored and was met with 
similar frustrations when the reaction was performed at ambient temperatures and below.  
The use of excess methylacrylate as an electrophile to quench the LDA generated enolate 
produced an initially encouraging result.  The starting material was consumed, and a new 
product was evident.  However, the crude reaction mixture could only be described as a 
polymeric mess and purification of what appeared by 1H NMR to be a deconjugtated 
enone was not possible.  The use of one equivalent of acrylate to quench the same 
reaction returned the starting dienone unchanged.  Its assumed that when a huge excess of 
acrylate is present, the polymerization pathways did not consume the acrylate so quickly 
so that some conjugate addition could occur.  With only one equivalent in solution, 
polymerization precludes addition, by consuming all the acrylate before conjugate 
addition could take place.  The use of other electrophiles under these conditions such as 
the γ-bromopropionate, allyl bromide (as per Nicolaou) and NCS all gave no evidence of 
product formation. 
 
Scheme 5. 38:  Attempted use of dienone 317 and 318 
Although alkylation proved fruitless, an α-chlorine could be installed. To 
accomplish this, a solution of the dienone 317  with LDA in THF, was heated at reflux 
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for 2 hours, then cooled and quenched with NCS (Scheme 5. 39).  This gave chloride 320 
in 58% yield as a single isomer, assumed to be product of chlorine’s approach from the 
less sterically encumbered.  This is the stereochemical outcome Nicolaou observed in 
their allylation work, although the stereochemistry of chlorine 320 was not 
unambiguously determined.  The dienone 317 (believed to be the isomer where the MeO 
is on the convex face of the bicycle) was the only isomer found to be successful, in α-
chlorination.  With an α-substituent installed, the hydroboration/oxidation could be 
explored, and the Cl reductively removed, providing Nicolaou’s enone 183.   
 
Scheme 5. 39:  The chlorination of dienone 318 
The utility of isomerized olefin 320 was then tested.  With an eye towards ether 
formation, treatment of olefin 320 to hydroboration (BH3•THF) was performed.  The use 
of sub-stoichiometric equivalents gave the recovered olefin cleanly, with no evident 
reduction.  Contrast that with the result that an excess of BH3•THF gave products where 
the olefin proton and enone proton’s were no longer in the 1H NMR spectrum, indicating 
over reduction.  This is consistent with an observation Nicolaou made that borane led to  
overreduction of a similar enone in their work.5   Ultimately, chloride 320 could not be 
converted to the natural product.   
At this point an adjustment to our synthetic approach for the advancement of 
dienone 317 to platensimycin 160 was in order.  A possible solution was found through 
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the use of autoxidation, nature’s way of installing oxygens.  Our original goal of a 
stereoselective synthesis of the platensimycin core might still be achieved, however 
maintaining the appropriate oxidation state throughout, would not. 
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5.5. AUTOXIDATION AS AN ENDGAME STRATEGY 
 The use of autoxidation in organic synthesis has a rich history rooted in steroid 
chemistry.34,35  But it was an example of a mild, efficient, and stereoselective autoxidation 
of a structurally similar dienone that was compelling us to pursue this work.  In their 
synthesis of the sesquiterpene lactone decipienin A, Massanet and co-workers reported a 
mild autoxidation of an enone very similar in structure to 317 and 318.36  The oxidation 
of 7-epi-cyperone 322 with O2 and methanolic KOH was used as a starting point.  The 
reaction installed an axial oxygen stereoselectively, giving alcohol 323 in 100% yield 
(Scheme 5. 40).  The authors noted that thorough study of that reaction on different 
substrates revealed a strong substrate dependence.  It was observed that the enone 
α-methyl to the ketone was essential “to prevent decomposition of the molecule,” in an 
unspecified way. 
The utility of this reaction to the synthesis of platensimycin from autoxidized 
dienone 324 warranted further exploration as the dienone 317 contains an α-methyl.  
However, the subjection of dienones 317 and 318 to the conditions reported by Massanet 
gave no reaction.  The recovery of starting material precluded the decomposition 
Massanet alluded to in substrates not matched for this procedure.  The conclusion was 
that these conditions were thought to be too mild. 
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Scheme 5. 40:  Massanet’s autoxidation of 7-epi-cyperone 322 and its possible 
application to dienone 324 
Classically, the autoxidation of enolates was developed using the ubiquitous 
t-BuOK in t-BuOH.  However, treatment of dienone 317 to those conditions did not 
produce the desired alcohol either (Scheme 5. 41).  Initially, the mixture of isomers 317 
and 318 was used in these reactions.  Starting at room temperature and open to air or with 
a balloon of O2 attached, the reactions turned yellow immediately upon the addition of 
t-butoxide, but consumption of starting material was observed based on the crude 
reaction residue.  Heating the reaction to reflux open to air, the solution quickly turned 
brown and upon workup, only the dienone 317, believed to be the endo-OMe epimer, was 
recovered, quantitatively.  The exo-OMe 318 however was apparently destroyed.  This 
result was repeated separately with both pure 317 (revcovered quantitatively) and pure 
317 (destroyed) and was consistent.  The endo-OMe was always returned while the 
exo-OMe was not.  Additionally frustrating was the inability to recover any new 
compounds from the reaction; no dienone, enone, alkene or aromatic protons could be 
resolved in the 1H NMR spectra and thus the fate of 318 could not be deduced.  This 
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disparate reactivity must have a reasonable explanation, but that unfortunately could not 
be deduced through experimentation.   
 
Scheme 5. 41: Attempted autoxidation of dienones 
Both of the epimeric dienone ethers were stable to the reaction conditions when 
they were performed in a degassed sealed tube, absent O2, as in the attempted 
deconjugative alkylations (vide supra, Scheme 5. 38).  So it stands to reason that the 
decomposition of 318 is likely due to a successful oxidation by the now present O2 and 
subsequent decomposition of the product 325 or an intermediate.  The lack of reactivity 
observed in 317 could be simply due to the increased steric compression of having the 
O
317 & 318
O
324
O2, 10% KOH, MeOH
no reaction
O
OMe
318
O
OMe
325
O2, t-BuOK, t-BuOH, !
decomposition
O
317
OMe
O
OMe
O2, t-BuOK, t-BuOH, !
no reaction
OH
OH
OMe OMe
A
B
C
317
recovered S.M.
 191 
OMe inside the bicycle, preventing enolate formation and autoxidation.  In any case, it 
was apparent that these methoxyl dienones were not synthetically useful for autoxidation. 
The incongruent reactivities of the epimeric ethers can be understood by 
examination of their 3-D structures (Figure 5. 1).  The unreactive endo isomer has the 
OMe pointing towards the proton to be lost during enolate formation.  The axial H is 
hindered by the CH3, which is exacerbated by the propellar-like rotation of the OMe.  The 
approach of an incoming base, or subsequent electrophile, is blocked by the OMe.   The 
reactive exo-OMe does not contain this steric compression.  Enolate formation is likely 
facile as is the subsequent oxidation and an undetermined decomposition then ensues.  
This disappointing revelation forced an abandonment of the bromohydrin route. 
Autoxidation was still believed to be a route worth exploring.  
 
Figure 5. 1:  3-D structures of dienones 317 & 318 
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5.5.1. Second Generation Autoxidation Approach 
As the methoxyl dienones were unsuccessful in the autoxidation chemistry, the 
sterically simpler alkene dienones derived from the allyl halide might succeed.  To test 
this, the epoxide to allylic alcohol rearrangement route was instigated on the 2-methyl 
series. 
The acetate 315, available from the acetylation of the crude phenolate cyclization 
product (vide supra, Scheme 5. 35) was epoxidized using in situ generated DMDO, to 
provide the epoxide 326 as a mixture of diastereomers, cleanly and quantitatively 
(Scheme 5. 42).  This method of epoxide preparation was found to be far superior to m-
CPBA in its ease of preparation, ease of workup, and its scalable, reliable and efficient 
results.   
The epoxide 326 was available, and it was subjected to the rearrangement 
conditions found to work best through the desmethyl work.  The epoxides 326 were 
stirred with aluminum triisopropxide in refluxing toluene to provide a 1 : 1 mixture of 
alcohols in 89% combined yield.  Both the allylic alcohol 327 and aliphatic alcohol 328 
were obtained as deacetylation occurred in situ.  The inseparable alcohols were then 
converted to their bromides, and again, the aliphatic bromide 329 could be isolated in 
decent yield, while the allylic bromide (as with the iodide) was largely lost.  However, 
trace amounts of the allyic bromide were found to be present with the aliphatic bromides 
indicative of its viability of formation.  Optimization of this bromination, it was thought, 
would be best accomplished on the pure allylic alcohol 327, which would have to arise 
from a different rearrangement procdure. 
The aliphatic bromide 329 was cyclized to the dienones 330 as a mixture of 
methyl epimers.  The use of the milder base Cs2CO3 in the reaction, though slower, 
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provided a higher yielding reaction than with the t-butoxide cases.  Also, this reaction 
seemed concentration dependent as one might expect.  Masamune reported the use of 
0.001M reaction solutions, which we found to be suitable as well. 
 
Scheme 5. 42:  Synthesis of dienone 330 
With the less sterically congested bicyclic dienone, the autoxidation was found to 
be successful.  The 1 : 1 epimer mixture was heated with t-BuOK in t-BuOH at reflux, 
furnishing the axial alcohol 331 (Scheme 5. 43) in small amounts.  The major product 
was of oxidation of the exo-methyl epimer shown. This is consistent with the rationale for 
the disparate reactivities in the methoxyl series (317 and 318).  While trace amounts of 
the other oxidized product were isolated, that reaction was much slower.  The use of 
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Cs2CO3 in DMF at 90 °C open to air produced a 42% yield of the epimer shown.   This 
represents a satisfactory 84% conversion of the epimer. 
 
Scheme 5. 43: The autoxidation of dienone 330 
The success of the autoxidation notwithstanding, the formal synthesis of 
platensimycin requires an ether formation and selective enone reduction to Nicolaou’s 
intermediate.  The second problem, selective enone reduction, was thus explored. 
 
5.5.2. Strategies for the Completion of a Synthesis of (–)-Platensimycin 
The oxygen in 331 appeared to be of a single isomer, presumed to be axial based 
on the examples present in the literature.  This was fortuitous and allowed for the 
possibility of fulfillment of our plan.  The stereoselectivity of the approach was at the 
forefront of our goal.  As such, the reduction of the more-substituted enone in 331 was 
necessary.  In all other formal syntheses where a dienone such as these were used, 
overreduction to the saturated cyclohexanone followed by re-oxidation to the enone was 
the protocol followed.   The use of a hydroxyl directed reduction of the dienone to the 
less-substituted enone would consititute a straightforward solution to this problem.  This 
proposed solution is one that no other synthetic approach thus far disclosed could boast. 
Many methods have been developed for the directed reduction of β-hydroxy 
ketones but the hydroxyl directed reduction of enones has been less explored.  The use of 
H
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a coordinated reducing agent, able to deliver a hydride from the same face as the oxygen, 
yielding the cis-decalin ring juncture was desired.  It was with this in mind that several 
conditions using hydride reductants were evaluated. 
We began by testing reductants of the enone 331 with NaBH4.  In aprotic 
solvents, the experiment returned a complex mixture that appeared to be allylic alcohols, 
resulting from reduction of the carbonyl.  When the alcohol was exposed to LAH at –78 
°C, no reaction occurred, and the starting material was recovered.  When the same 
reaction was performed at 0 °C, workup with MeOH provided a mixture of what was 
clearly an enone, no longer cross-conjugated, and what appeared to be the over reduced 
allyic alcohol (Scheme 5. 44).  When the reaction was performed again at 0 °C, with the 
dropwise addition of LAH solution in toluene,37 the workup produced the desired enone, 
with trace amounts of the over reduction products.  Only one cyclohexanone isomer was 
obtained from the reaction and it is believed to be that shown, where the hydride was 
delivered intramolecularly via an aluminate intermediate 332.  The reduced alcohol 333 
was isolated in 50% yield. 
Scheme 5. 44: The stereoselective reduction of dienone 331 
The realization of a stereoselective reduction to an enone 333 opened the door to a 
completely stereoselective synthesis of platensimycin, if the ether ring can be formed.  
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The method used by Nicolaou involved the hydration of an alkene with an axial alcohol.  
It was thought that this strategy might also be viable in this case.   
It was at this point that a re-examination of the epoxide to allylic alcohol 
rearrangement was performed.  The acetate 326 had been utilized in the rearrangements 
using aluminum triisopropoxide with success.  The failures of the amide base mediated 
rearrangements on the desmethyl series was attributed to the presence of the phenol OH, 
and the acetate had never been explored.  This was accessible, easily attempted, and now 
relevant, so the acetate was investigated further. 
The acetate 326 was treated to an excess of LDA in THF at 23 °C and the starting 
material was quickly consumed.  However, workup of the reaction provided the desired 
allylic alcohol 327 in only 26% yield (Scheme 5. 45.  The major product was the 
deacetylated epoxide 334 which accounted for the mass balance.  Attempts to convert the 
phenolic epoxide 334 to the allylic alcohol by resubjection to the reaction conditions 
failed, and no product was observed.  Heating the reaction destroyed the starting material 
with no discernible product.   
 
Scheme 5. 45:  The conversion of epoxide 326 to allylic alcohol 327 
The use of LDE as the amide base has been traditionally more successful than 
LDA in these rearrangements.  Fortunately, switching to LDE led to complete conversion 
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of the acetate epoxide 326 to the allylic alcohol 327 in a 94% isolated yield (Scheme 5. 
46).  The allylic alcohol 327 could now be accessed cleanly and in the absence of the 
aliphatic alcohol 328.  Its conversion to an allylic halide still presented a problem.  The 
conditions used before (Br2, PPh3) were equally unsuccessful on the pure allylic alcohol.  
The use of CBr4 as the bromine source improved upon this, allowing for the isolation of 
the allylic bromide 336 in 39% yield.  The problem of isolation still remained, as the 
reactive allylic bromide is likely decomposing during the column chromatography.   
 
Scheme 5. 46: Synthesis of olefinic dienone 337 
With the allylic bromide available, the cyclization to the olefinic dienone 337 
could be performed.   Bicycle 337 was obtained in 76% from the allylic bromide.  
Currently, the autoxidation of 337 is under investigation. 
 
5.5.3.  Possible Routes to completion 
There are two possible paths to the completion of the formal synthesis of 
platensimycin from the project’s current state.  The first, and more direct, is the 
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autoxidation of 337, providing the axial oxygen (Scheme 5. 47).  The stereoselective 
hydroxyl directed LAH reduction would provide the enone 338.  Exposure of enone 338 
to TFA in DCM (as per Nicolaou) would close the ether ring, and complete a formal 
synthesis with 339.  The addition of the propionate side chain in a more direct fashion 
would be explored and the coupling to the synthesized aniline 175 would complete the 
total synthesis of platensimycin.   
Alternatively, the already autoxidized enone 333 might be converted to the natural 
product via oxidation of the methine proton.  The hydroxyl radical formed from the axial 
alcohol, is adjacent to the methine, which could abstract a hydrogen to produce the 
tertiary radical.  Oxidation of that radical to a halide (340) and displacement by the 
oxygen would alternatively complete the formal synthesis (339).   
 
Scheme 5. 47:  Possible routes to the completion of the synthesis of platensimycin 
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5.6. CONCLUSIONS 
The synthesis of the recently discovered potent antibiotic platensimycin was 
undertaken.  The plan for a stereoselective synthesis, what would be the first in this area, 
was laid out and the efforts toward achieving it described.  
The synthesis of the aniline portion of platensimycin has been completed in a 
short and efficient three step route. 
The synthesis of the tetracyclic enone acid core of platensimycin was 
investigated.  The stereoselective synthesis of an alcohol 333, lacking only the ether 
linkage to complete a formal synthesis, was presented.  The use of autoxidation to install 
the oxygen and its utility in the directed enone reduction were described.  Efforts to 
convert 333 to the ether 339 are underway. 
An alternative to alcohol 331, the alkene 337 was also synthesized and expressed.  
The successful autoxidation of 337 would essentially complete the formal synthesis, as 
closure of the ether ring, using the known procedure, would yield a methylated 
compound matching Mulzer’s and Corey’s intermediates.  Its transformation to the 
natural product is also currently being explored.   
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Chapter 6: Experimental Section  
 
6.1.  GENERAL METHODS  
Melting points were taken on a Thomas-Hoover capillary tube apparatus and are 
uncorrected. Infrared spectra were recorded on a Nicolet FT-IR spectrophotometer neat 
unless otherwise indicated.  1H and 13C NMR spectra were recorded on a General Electric 
QE-300 spectrometer at 300 MHz and 75 MHz, respectively and are reported in ppm 
relative to tetramethylsilane.  All NMR spectra were taken with CDCl3 as solvent unless 
otherwise noted.   Mass spectra were obtained on a VG ZAB2E or a Finnigan TSQ70.  
TLC was performed on glass sheets precoated with silica gel (Silica Gel 60, F254, 
0.25mm Layer Thickness).  Column chromatographic separations were performed on 
silica gel (Silica gel 60, 230-400 mesh) under pressure.  Solvents and commercial 
reagents were purified in accordance with Perrin and Armarego or used without further 
purification. 
All moisture sensitive reactions were performed under an atmosphere of Ar, and 
glassware was pre-dried at 125 °C prior to use.  THF and ether were dried by distillation 
over Na/benzophenone, CH2Cl2, Et3N, CH3CN, and i-Pr2NH were dried by distillation 
from CaH2.  All other reagents or solvents were used as received without further 
purification unless otherwise stated. 
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6.2.  EXPERIMENTAL CONDITIONS AND CHARACTERIZATIONS 
 
Methyl 5-Bromo- 2,4-Dihydroxybenzoate: 
To a stirred solution of the methyl 2,4-dihydroxybenzoate1 216 (8g, 48.4 mmol) in 
dry CH2Cl2 (250 mL) at 25 °C was added a solution of Br2 in dry CH2Cl2 (50 mL, 1M 
solution, 50 mmol) dropwise.  The reaction was monitored by TLC (CH2Cl2).  The 
addition was stopped when the solution obtained a persistant orange color indicative of 
excess Br2.  The reaction mixture was quenched with sat. aq. Na2S2O3 (250 mL) and 
extracted with CH2Cl2 (3 x 250 mL).  The combined organics were dried (Na2SO4), and 
concentrated in vacuo.  The resulting solid was taken up in CH2Cl2, filtered over a silica 
plug, and eluted with CH2Cl2 to give the monobromoaniline with trace amounts of the 
dibromo product.  The dibromo ester could be selectively crystallized and removed out of 
solution by allowing slow evaporation of the CH2Cl2 overnight.  The resulting filtrate was 
concentrated to give pure product (11.53 g, 96%) as a white crystalline solid: mp = 133 -
135 °C; Rf = 0.37 (DCM); IR (neat) 3309, 3080, 2955, 1669, 1444, 1348, 1256 cm-1; 1H 
NMR δ 7.97 (s, 1H), 6.63 (s, 1H), 3.94 (s, 3H); 13C NMR δ 52.3, 100.5, 103.9, 107.3, 
133.2, 157.9, 162.9, 169.3; HRMS for C8H8O4Br [MH+] m/z calc. 246.9606, found 
246.9606. 
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Methyl 5-bromo- 2, 4-dihydroxy-3-nitrobenzoate (232): 
 
To a stirred solution of the 5-bromo ester (6.0 g, 24.3 mmol) in acetonitrile (300 
mL) at 25 °C was added a solution of concentrated nitric acid (15.8N, 7.7 mL, 5.0 eq) in 
acetonitrile (100 mL) dropwise over 30 min.  The solution was stirred at 25 °C for 5 
hours and the consumption of starting material was monitored by TLC (40% 
EtOAc/hexanes).  Upon completion, the reaction mixture was poured into ice water.  The 
precipitate was collected, washed with H2O (2 x 100 mL), ether (1x 50 mL), and 
recrystallized in methanol to give nitro 232 as a pale yellow powder (4.48 g, 63% yield 
after recrystallization):  mp = 208-209 °C; Rf = 0.47 (40% EtOAc/hexanes); IR (neat) 
3192, 3091, 3002, 2951, 1684, 1435, 1321, 1292 cm-1; 1H NMR δ 8.79 (s, 1H), 4.04 (s, 
3H); 13C NMR δ 53.4, 100.3, 106.3, 127.4, 127.5, 157.4, 164.8, 168.9; HRMS for 
C8H7NO6Br [MH+] m/z calc. 291.9457, found 291.9460. 
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Methyl 3-amino-2, 4-dihydroxybenzoate hydrobromide (233): 
 
 
To a solution of nitroaryl 232 (40 mg, 0.14 mmol) in THF (3 mL) was bubbled H2 
(g).  To the solution was added Pd black (10 mg cat.) and a balloon of H2 (g) was 
attached.  The solution was stirred under hydrogen atmosphere for 2 days.  The reaction 
mixture was then filtered over celite, eluted with THF, and the crude filtrate was 
resubjected to H2(g) and Pd black for an additional 2 days. The reaction mixture was then 
filtered over celite, eluted with THF and concentrated in vacuo.  The resulting dark 
brown oil was triturated with CH2Cl2 to give the HBr salt of aniline hydrobromide 233 as 
a brown solid (33 mg, 94%):  mp = 216 °C (decomposition.); Rf = 0.30 (50% 
EtOAc/hexanes); IR (salt, diamond press) 3128, 2963, 2883, 1670, 1639, 1476, 1439, 
1331, 1204, 1145, 790 cm-1; 1H NMR (CD3OD) δ 7.78 (s, 1H), 6.50 (s, 1H) 3.92 (s, 3H); 
13C NMR (CD3OD) δ 52.9, 104.3, 105.5, 112.7, 126.4, 158.6, 164.6, 170.7; HRMS for 
C8H10NO4 [MH+] m/z calc. 184.0610, found 184.0611. 
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Methyl 2,4-dihydroxy-3-[3-(4-methoxyphenyl)propanamido]benzoate (235): 
 
 
To a stirred solution of 3-(4-methoxyphenyl)propanoic acid 234 (28 mg, 0.157 
mmol) in DCM (5 mL) with NEt3 (1 mL) was added dicyclohexylcarbodiimide (81 mg, 
0.393 mmol), aniline hydrobromide 233 (46 mg, 0.173 mmol) and the reaction was 
stirred at 23 °C for 18h.  The mixture was diluted in DCM (10 mL), washed with sat. aq. 
NH4Cl, (2 x 5 mL), brine and concentrated in vacuo.  The residue was purified by column 
chromatography (SiO2, 30% EtOAc in hexanes) to yield the amide 235 as a yellow oil 
(25 mg, 46%): Rf = 0.38 (30% EtOAc/hexanes); IR (neat) 3336, 2929, 2852, 1669, 1617, 
1540, 1251 cm-1; 1H NMR δ 7.40 (s, 1H), 7.14 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 Hz, 
2H), 6.53 (s, 1H), 3.89 (s, 3H), 3.80 (s, 3H), 3.00 (t, J = 7.4 Hz, 2H), 2.69 (t, J = 7.4 Hz, 
2H); 13C NMR δ 172.7, 169.7, 161.2, 158.4, 156.0, 131.8, 129.4, 129.3, 123.2, 118.8, 
114.2, 114.1, 106.5, 104.6, 55.2, 52.1, 39.0, 30.9, 24.9; HRMS for C18H20NO6 [MH+] m/z 
calc. 346.1291, found 346.1289. 
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Methyl 2-(3-{[tris(propan-2-yl)silyl]oxy}phenyl)acetate (237):   
 
 
To a stirred solution of methyl 2-(3-hydroxyphenyl)acetate2 236 (14.46g, 87.00 
mmol) in CH2Cl2 (100 mL) at room temperature was added triisopropylsilyl chloride 
(20.13g, 104.40 mmol) and imidazole (7.07g, 110.5 mmol) and the solution was stirred 
for 16h.  The reaction was poured into sat. aq. NH4Cl (100 mL), the organic layer 
separated and the aqueous layer extracted with CH2Cl2 (2 x 50 mL).  Thye combined 
organics were washed with sat. aq. NH4Cl (100 mL), brine (100mL) and concentrated.  
The crude residue was purified by column chromatography (SiO2, 10% EtOAc in 
hexanes) to provide silyl ether 237 as an orangish oil (27.8 g, 99%): Rf = 0.65 (10% 
EtOAc in hexanes); IR (neat) 2946, 2867, 1743, 1489, 1278, 1157 cm-1; 1H NMR δ 7.16 
(dd, J = 8.1, 7.3 Hz, 1H), 6.78 – 6.86 (m, 3H), 3.68 (s, 3H), 3.57 (s, 2H), 1.20 – 1.32 (m, 
3H), 1.10 (d, J = 6.8 Hz, 18H); 13C NMR δ 172.8, 156.2, 135.2, 129.4, 121.8, 120.9, 
118.6, 51.9, 41.2, 17.9, 12.6; HRMS for C18H31O3Si [MH+] m/z calc. 323.2042 Da, found 
323.2043 Da. 
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2-(3-{[tris(propan-2-yl)silyl]oxy}phenyl)ethan-1-ol (238):   
 
To a stirred suspension of lithium aluminum hydride (16.0 g, 420 mmol) in ether 
(250 mL) at 0 °C was added ester 237 (22.58 g, 70.0 mmol) in ether (100 mL) dropwise 
over 30 min.  The resulting suspension was stirred 16 h at 23 °C and then quenched by 
inverse addition via cannula to EtOAc (100 mL) at 0 °C and the suspension was stirred 
10 min.  To this solution was added sat. aq. Na2SO4 (20 mL) to quench any remaining 
lithium salts and the suspension was stirred 30 min, then filtered over Celite and 
concentrated in vacuo to give alcohol 238 as a pale brown oil (20.01 g, 97%) which was 
used without further  purification: Rf = 0.26 (30% EtOAc in hexanes); IR (neat) 2975, 
2935, 1629, 1597, 1582, 1468, 1427, 1072, 762 cm-1; 1H NMR δ 7.16 (t, J = 8.1 Hz, 1H), 
6.75 – 6.82 (m, 3H), 3.84 (t, J = 6.6 Hz, 2H), 2.82 (t, J = 6.6 Hz, 2H), 1.20 – 1.32 (m, 
3H), 1.10 (d, J = 6.8 Hz, 18H); 13C NMR δ 156.2, 135.2, 128.4, 121.8, 120.8, 118.6, 51.9, 
41.1, 17.8, 12.5; HRMS for C17H31O2Si [MH+] m/z calc. 295.2093 Da, found 295.2094 
Da. 
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2-(3-{[tris(propan-2-yl)silyl]oxy}phenyl)ethyl methanesulfonate (241):   
 
To a stirred solution of alcohol 238 (3.68 g, 12.5 mmol) in CH2Cl2 (25 mL) at 0°C 
with triethylamine (3.0 mL) was added methanesulfonyl chloride (1.16 mL, 15.0 mmol) 
dropwise over 15 min.  The reaction was allowed to stir overnight, after which, the 
solution was poured into sat. aq. NH4Cl (50mL), extracted with CH2Cl2 (2 x 50 mL), 
dried (Na2SO4) and concentrated in vacuo.  Column chromatographic purification of the 
the crude oil (SiO2, 20% ethyl acetate in hexanes) gave the mesylate 241 as a yellow oil 
(4.57 g, 98%): Rf = 0.60 (20% EtOAc in Hexanes); IR (neat) 3447, 2944, 2866, 1603, 
1585, 1485, 1355, 1276, 1175, 1004, 970, 882, 689 cm-1; 1H NMR δ 7.16 (t, J = 8.1 Hz, 
1H), 6.75 – 6.82 (m, 3H), 4.40 (t, J = 7.0 Hz, 2H), 3.00 (t, J = 6.8 Hz, 2H), 2.88 (s, 3H), 
1.20 – 1.32 (m, 3H), 1.10 (d, J = 6.8 Hz, 18H); 13C NMR δ 156.1, 137.6, 129.4, 121.5, 
120.4, 118.2, 60.1, 37.0, 35.3, 17.8, 12.5; HRMS for C18H33SiO4S [MH+] m/z calc. 
373.1876 Da, found 373.1863 Da. 
 
2-(3-{[tris(propan-2-yl)silyl]oxy}phenyl)ethyl 4-methylbenzene-1-sulfonate (240):   
 
  
To a stirred solution of alcohol 238 (2.00 g, 6.79 mmol) in CH2Cl2 (34 mL) with 
pyridine (2.0 mL) was added 4-methylbenzene-1-sulfonyl chloride (1.43 g, 7.47 mmol).  
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The reaction was stirred 16h, then dilute in CH2Cl2 (25 mL), washed with sat. aq. NH4Cl 
(50mL), aq. 20% CuSO4 (20 mL), brine and concentrated.  Column chromatographic 
purification of the the crude residue (SiO2, 10% ethyl acetate in hexanes) gave the 
tosylate 240 as a yellow oil (861 mg, 34%): Rf = 0.42 (10% EtOAc in Hexanes); IR (neat) 
2920, 2850, 1733, 1177, 667 cm-1; 1H NMR δ 7.71 (d, J = 8.1 Hz, 2H), 7.29 (d, J = 8.1 
Hz, 2H), 7.10 (dd, J = 8.1, 7.3 Hz, 1H), 6.73 (d, J = 8.1 Hz, 1H), 6.68 (d, J = 7.3 Hz, 1H), 
6.64 (s, 1H), 4.18 (t, J = 7.3 Hz), 2H), 2.89 (t, J = 7.3 Hz, 2H), 2.44 (s, 3H), 1.20 – 1.32 
(m, 3H), 1.08 (d, J = 6.8 Hz, 18H); 13C NMR (some resonances are overlapping) δ 156.2, 
137.6, 129.8, 129.4, 127.8, 121.5, 120.5, 118.3, 111.6, 70.5, 35.2, 29.7, 17.8, 12.6; 
HRMS for C24H37O4SiS [MH+] m/z calc. 449.2182 Da, found 449.2188 Da. 
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Ethyl 3-methyl-2-(3-{[tris(propan-2-yl)silyl]oxy}phenyl)but-3-enoate (243):   
 
 
A flame-dried, three-necked 250 mL flask under Ar (g) and equipped with stirbar 
was charged with diisopropylamine (6.85 mL, 48.9 mmol) and THF (50 mL).  The 
solution was cooled to –78 °C, n-BuLi (20.40 mL, 48.90 mmol, 2.4 M in hexanes) and 
hexamethylphosphoric triamide (HMPA) (8.50 mL, 48.70 mmol) were added via syringe.  
The cold bath was removed, the solution was stirred for 30 min.  To the solution, at –78 
°C, was added ethyl 3,3-dimethylacrylate 242 (6.7 mL, 47.90 mmol) in a minimal 
amount of THF (10 mL), via cannula and the reaction mixture was stirred at –78 °C for 
15 min and at 23 °C for an additional 1 h.  The suspension was then re-cooled to –78 °C 
and tosylate 240 (3.57 g, 9.58 mmol) in a minimal amount of THF (10 mL) was added 
via cannula.  The alkylation reaction was allowed to warm to 23 °C and stirred 1.5 h.  
The reaction was quenched by the addition of sat. aq. NH4Cl (100 mL), diluted with ether 
(100 mL) and transferred to a separatory funnel.  The organic layer was removed and the 
aqueous layer extracted with ether (100 mL).  The combined organic extracts were 
washed with brine (100 mL), dried (Na2SO4) and concentrated to give a crude oil which 
was purified by flash column chromatography (SiO2, 5% ethyl acetate in hexanes) 
provided ester 243 as a pure, colorless oil (1.05 g, 27%): IR (neat) 2944, 2867, 1733, 
1485, 1278 cm-1; 1H NMR δ 7.12 (t, J = 8.6 Hz 1H), 6.73 (m, 2H), 6.70 (s, 1H), 4.93 (s, 
1H), 4.89 (s, 1H), 4.15 (q, J = 7.1 hz, 2H), 3.03 (t, J = 7.5 Hz, 1H), 2.52 (t, J = 7.7 Hz, 
2H), 2.14 (quintet, J = 6.1, 7.8 Hz, 1H), 1.87 (quintet, J = 6.1, 7.8 Hz, 1H), 1.76 (s, 3H), 
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1.26 (t, J = 7.1 Hz, 3H), 1.20 – 1.32 (m, 3H), 1.10 (d, J = 6.8 Hz, 18H); 13C NMR δ 
173.5, 156.0, 142.9, 142.2, 129.1, 121.2, 120.1, 117.4, 114.0, 60.5, 52.2, 33.3, 31.6, 20.1, 
17.9, 14.2, 12.6; HRMS for C24H41O3Si [MH+] m/z calc. 405.2825 Da, found 405.2822 
Da. 
 
3-methyl-2-(3-{[tris(propan-2-yl)silyl]oxy}phenyl)but-3-enoic acid (248):   
 
A flame-dried, three-necked 500 mL flask under Ar (g) and equipped with stirbar 
was charged with diisopropylamine (9.75 mL, 69.50 mmol) and THF (100 mL).  The 
solution was cooled to –78 °C and n-BuLi (29.0 mL, 69.50 mmol, 2.4 M in hexanes) was 
added via syringe.  The cold bath was removed, the solution was stirred for 30 min, and 
then re-cooled to –78 °C.  A solution of 3,3-dimethylacrylic acid 247 (3.16 g, 31.60 
mmol) in a minimal amount of THF (20 mL) was added to the reaction flask via cannula 
and the reaction mixture was stirred at –78 °C for 15 min and at 23 °C for an additional 1 
h, during which, a white precipitate formed throughout the reaction vessel.  The 
suspension was then cooled to 0 °C and mesylate 241 (11.76 g, 31.60 mmol) in a minimal 
amount of THF (30 mL) was added via cannula.  The alkylation reaction was allowed to 
stir at 0 °C for 3.5 h.  The reaction was quenched by the addition of water (100 mL), 
diluted with ether (100 mL) and transferred to a separatory funnel.  The organic layer was 
removed and the aqueous layer extracted with ether (100 mL).  The aqueous layer was 
acidified with aq. H3PO4 (conc.) and extracted with ether (3 x 100 mL).  The combined 
organic extracts were washed with brine (100 mL), dried (Na2SO4) and concentrated to 
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give acid 248 as a yellow oil of sufficient purity (9.59 g, 81%): IR (neat) 2944, 2866, 
1705, 1484, 1277, 1157, 882 cm-1; 1H NMR δ 7.13 (t, J = 8.1 Hz 1H), 6.77 (m, 3H), 4.99 
(s, 1H), 4.95 (s, 1H), 3.08 (t, J = 7.5 Hz, 1H), 2.56 (t, J = 7.7 Hz, 2H), 2.06 – 2.24 (m, 
1H), 1.80 (s, 3H), 1.85 – 1.96 (m, 1H), 1.20 – 1.32 (m, 3H), 1.10 (d, J = 6.8 Hz, 18H); 
13C NMR δ 179.6, 156.0, 142.7, 141.6, 129.1, 121.2, 120.1. 117.4, 114.8, 51.9, 33.2, 
31.3, 20.1, 17.8, 12.6; HRMS for C22H37O3Si [MH+] m/z calc. 377.2512 Da, found 
377.2510 Da. 
 
3-methyl-2-[2-(3-{[tris(propan-2-yl)silyl]oxy}phenyl)ethyl]but-3-en-1-ol (244): 
 
 
To a stirred solution of ester 243 (1.15 g, 2.84 mmol) in dry ether (25 mL) at 0 °C 
was added LAH (s) (190 mg, 5.15 mmol).  After stirring for four hours, the reaction was 
quenched with the dropwise addition of sat. aq. Na2SO4 until bubbling ceased.  The 
suspension was filtered over celite, the filtrate dried (Na2SO4) and concentrated to give 
the alcohol 244 as a pure, colorless oil (1.02 g, 99%): IR (neat) 3371, 2931, 1585, 1465 
cm-1; 1H NMR δ 7.11 (t, J = 8.6 Hz 1H), 6.73 (m, 2H), 6.69 (s, 1H), 5.01 (s, 1H), 4.87 (s, 
1H), 3.52 (t, J = 4.5 Hz, 2H), 2.46 – 2.57 (m, 2H), 2.31 (quintet, J = 6.1, 7.8 Hz, 1H), 
1.72 (s, 3H), 1.61 – 1.69 (quintet, J = 6.8 Hz, 3H), 1.20 – 1.32 (m, 3H), 1.10 (d, J = 6.8 
Hz, 18H); 13C NMR δ 156.0, 144.6, 143.6, 129.0, 121.0, 120.0, 117.2, 114.4, 63.9, 49.3, 
33.2, 30.8, 18.6, 17.9, 12.7; HRMS for C22H39O2Si [MH+] m/z calc. 363.2719 Da, found 
363.2717 Da. 
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3-methyl-2-[2-(3-{[tris(propan-2-yl)silyl]oxy}phenyl)ethyl]but-3-en-1-yl 
methanesulfonate (250): 
 
 
To a stirred solution of alcohol 244 (1.02 g, 2.81 mmol) in DCM (15 mL) with 
NEt3 (1.60 mL) was added methansulfonyl chloride (250 µL, 3.09 mmol).  After stirring 
for 3 h, the reaction was poured into sat. aq. NH4Cl (20 mL) and extracted with DCM (3 
x 20 mL).  The combined organic extracts were washed with sat. aq. NH4Cl, brine, dried 
(Na2SO4) and concentrated to give a crude oil, which was chromatographed (SiO2, 20% 
EtOAc in hexanes) to give mesylate 250 as a pure, pale-yellow oil (1.07 g, 86%): Rf = 
0.40 (20% EtOAc in Hexanes); IR (neat) 2944, 2867, 1602, 1584, 1485, 1357, 1278, 
1176, 956, 883, 827, 689 cm-1; 1H NMR δ 7.12 (t, J = 8.1 Hz, 1H), 6.74 (m, 2H), 6.71 (s, 
2H), 4.99 (s, 1H), 4.87 (s, 1H), 4.16 (septet, J = 7.4, 9.5 Hz, 2H), 2.96 (s, 3H), 2.43 – 
2.60 (m, 3H), 1.75 (s, 3H), 1.60 – 1.80 (m, 2H), 1.20 – 1.32 (m, 3H), 1.10 (d, J = 6.8 Hz, 
18H); 13C NMR δ 154.3, 144.8, 141.9, 126.2, 121.4, 119.9, 115.7, 114.2, 63.9, 37.2, 31.6, 
29.9, 22.6, 19.3, 18.0, 13.0; HRMS for C23H41O4SiS [MH+] m/z calc. 441.3562 Da, found 
441.3560 Da. 
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2-[2-(3-hydroxyphenyl)ethyl]-3-methylbut-3-en-1-yl methanesulfonate (254):   
 
 
To a stirred solution of triisopropylsilyl ether 250 (2.49 g, 5.65 mmol) in N,N-
dimethylformamide (10 mL) was added CsF (950 mg, 6.25 mmol) and the reaction 
stirred overnight.  The solution was diluted in methyl tert-butyl ether (MTBE) (20 mL) 
and poured into water (20 mL).   The organic layer was dried (Na2SO4) and concentrated 
in vacuo.  Column chromatographic purification (SiO2, 30% EtOAc in hexanes) gave the 
phenol 254 as a brownish oil (1.56 g, 97%): Rf = 0.25 (30% EtOAc in Hexanes); IR 
(neat) 3466, 2938, 1588, 1456, 1350, 1173, 950 cm-1; 1H NMR δ 7.15 (t, J = 8.1 Hz, 1H), 
6.66 – 6.75 (m, 2H), 6.66 (s, 2H), 4.99 (s, 1H), 4.87 (s, 1H), 4.16 (septet, J = 7.5, 6.6 Hz, 
2H), 2.98 (s, 3H), 2.43 – 2.64 (m, 3H), 1.74 (s, 3H), 1.66 – 1.84 (m, 2H); 13C NMR δ 
155.6, 143.5, 142.5, 129.6, 120.8, 115.2, 114.5, 112.9, 71.3, 45.7, 37.5, 32.7, 30.6, 19.4; 
HRMS for C14H21O4S [MH+] m/z calc. 285.1161 Da, found 285.1162 Da. 
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7-(prop-1-en-2-yl)-5,6,7,8-tetrahydro-naphthalen-1-ol (256), 6-(prop-1-en-2-yl)-
5,6,7,8-tetrahydro-naphthalen-2-ol (253), and 3-(4-methyl-3-methylidenepent-4-en-1-
yl)phenol (255): 
 
 
To a stirred solution of mesylate 254 (0.104 g, 0.366 mmol) in tert-butanol (2 
mL) at rapid reflux was added t-BuOK (1 mL, 1.0M in t-BuOH) and the reaction was 
stirred at reflux for 16h.  The mixture was diluted in ether (10 mL) and washed with H2O 
(5 mL), brine (5 mL), and concentrated in vacuo to give a yellow oil which was purified 
by column chromatography (SiO2, 10% EtOAc in hexanes) to provide ortho 256 (38 mg, 
55%) and para 253 (28 mg with 255) (96% combined yield) both as yellow oils: 256: Rf 
= 0.25 (20% EtOAc in hexanes); IR (neat) 3398, 2928, 1585, 1464, 1259, 887, 766 cm-1; 
1H NMR δ 7.02 (t, J = 7.7 Hz, 1H), 6.72 (d, J = 7.6 Hz, 1H), 6.61 (d, J = 7.9 Hz, 1H), 
4.82 (s, 2H), 2.84 – 2.94 (m, 3H), 2.36 – 2.50 (m, 2H), 1.96 – 2.02 (m, 1H), 1.85 (s, 3H), 
1.59 – 1.73 (m, 1H); 13C NMR δ 153.3, 149.4, 138.3, 126.1, 123.0, 121.2, 111.8, 109.2, 
41.4, 29.7, 28.3, 27.6, 20.7; HRMS for C13H17O [MH+] m/z calc. 189.1282 Da, found 
189.1279 Da.  253: Rf = 0.20 (20% EtOAc in hexanes); IR (neat) 3398, 2928, 1585, 1464, 
1259, 887, 766 cm-1; 1H NMR δ 6.94 (d, J = 8.1 Hz, 1H), 6.60 (d, J = 8.1 Hz, 1H), 6.58 
(s, 1H), 4.79 (s, 1H), 4.77 (s, 1H), 2.77 – 2.83 (m, 2H), 2.61 (d of t, J = 11.0, 15.0 Hz, 
2H), 2.32 (m, 1H), 1.95 (m, 1H), 1.80 (s, 1H), 1.6 (m, 1H); 13C NMR δ 149.6, 138.7, 
130.0, 128.9, 120.9, 114.9, 112.9, 108.9, 41.9, 29.6, 28.0, 20.7, 17.9; HRMS for C13H17O 
[MH–] m/z calc 187.1123 Da, found 187.1126 Da. 255: Rf = 0.20 (20% EtOAc in 
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hexanes); IR (neat) 3392, 2927, 1595, 1464, 1274, 1063, 890 cm-1; 1H NMR δ 7.12 (t, J = 
7.4 Hz, 1H), 6.72 (m, 3H), 5.12 (d, J = 8.6 Hz, 2H), 4.98 (d, J = 11.5 Hz, 2H), 2.72 (t, J = 
9.1 Hz, 2H), 2.55 (t, J = 9.0 Hz, 2H), 1.92 (s, 3H); 13C NMR δ 156.0, 147.1, 144.0, 129.3, 
120.2, 115.2, 113.8, 112.7, 112.5, 112.3, 35.4, 35.1, 21.1; HRMS for C13H17O [MH+] m/z 
calc. 189.1279 Da, found 189.1283 Da. 
 
7-(2-methyloxiran-2-yl)-5,6,7,8-tetrahydronapthalen-1-ol (257): 
 
 
To a stirred solution of acetate OAc-256 (235 mg, 1.02 mmol) in DCM (10 mL) 
with NaHCO3 (s) (250 mg) was added m-chloroperbenzoic acid (mCPBA) (212 mg, 1.22 
mmol).  The suspension was stirred for 16 h, after which it was quenched with sat. aq. 
NaSO3 (10 mL), diluted in DCM (20 mL), washed with sat. aq. NaHCO3 (20 mL), brine 
(20 mL), and concentrated in vacuo.  The crude residue was taken up in MeOH (15 mL), 
K2CO3 (s) (300 mg) was added and the suspension stirred for 8 h.  The reaction was 
diluted in DCM (20 mL), poured into sat. aq. NH4Cl (20 mL), and extracted with DCM 
(2 x 20 mL).  The combined organics were washed with brine, dried (Na2SO4) and 
concentrated to give an inconsequential mixture of diastereomeric epoxides 257 as an off-
white powder (210 mg, 100%): mp = 116 – 120 °C; IR (neat) 3390, 2928, 1651, 1587, 
1465, 1275 cm-1; 1H NMR δ 6.99 (t, J = 7.8 Hz, 2H), 6.70 (d, J = 7.8 Hz, 2H), 6.60 (d, J 
= 7.8 Hz, 2H), 2.60 – 3.0 (m, 8H), 2.40 (d of t, J = 10.3, 7.4 Hz, 2H), 1.92 – 2.09 (m, 
4H), 1.42 – 1.75 (m, 4H), 1.40 (s, 3H), 1.37 (s, 3H); 13C NMR δ 153.6, 153.4, 138.3, 
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138.2, 136.3, 136.2, 126.2, 122.5, 121.2, 121.1, 111.9, 111.8, 59.5, 53.6, 52.9, 40.8, 40.2, 
29.6, 29.3, 25.2, 24.9, 24.7, 23.0, 22.8, 18.6, 17.7; HRMS for C13H17O2 [MH+] m/z calc. 
205.1229 Da, found 205.1231 Da. 
 
6-(2-methyloxiran-2-yl)-5,6,7,8-tetrahydronapthalen-1-ol (258): 
 
 
To a stirred solution of acetate OAc-253 (235 mg, 0.77 mmol) in DCM (10 mL) 
with NaHCO3 (s) (250 mg) was added m-chloroperbenzoic acid (mCPBA) (159 mg, 0.92 
mmol).  The suspension was stirred for 16 h, after which it was quenched with sat. aq. 
NaSO3 (10 mL), diluted in DCM (20 mL), washed with sat. aq. NaHCO3 (20 mL), brine 
(20 mL), and concentrated in vacuo.  The crude residue was taken up in MeOH (15 mL), 
K2CO3 (s) (300 mg) was added and the suspension stirred for 8 h.  The reaction was 
diluted in DCM (20 mL), poured into sat. aq. NH4Cl (20 mL), and extracted with DCM 
(2 x 20 mL).  The combined organics were washed with brine, dried (Na2SO4) and 
concentrated to give an inconsequential mixture of diastereomeric epoxides 258 as a 
purplish waxy solid (117 mg, 74%): mp = 72 – 74  °C; IR (neat) 3390, 2928, 1651, 1587, 
1465, 1275 cm-1; 1H NMR δ 6.94 (d, J = 8.1 Hz, 1H), 6.92 (d, J = 8.1 Hz, 1H), 6.61 (d, J 
= 8.1 Hz, 1H), 6.60 (d, J = 8.1 Hz, 1H), 6.57 (s, 2H), 2.54 – 2.85 (m, 8H), 2.02 (m, 2H), 
1.92 – 1.98 (m, 4H), 1.42 – 1.72 (m, 2H), 1.36 (s, 3H), 1.35 (s, 3H), 1.20 – 1.48 (m, 2H); 
13C NMR δ 153.6, 137.6, 137.5, 130.1, 129.9, 127.6, 127.5, 115.0, 114.9, 113.1, 59.9, 
HO
O
 222 
59.7, 53.6, 53.0, 41.1, 40.7, 40.6, 30.7, 30.7, 29.4, 29.2, 25.2, 25.1, 18.5, 17.9; HRMS for 
C13H17O2 [MH+] m/z calc. 205.1229 Da, found 205.1232 Da. 
 
7-(prop-1-en-2-yl)-5,6,7,8-tetrahydro-naphthalen-1, 7-diol (266): 
 
 
To a stirred solution of SeO2 (25 mg) in CH2Cl2 (2 mL) with water (0.1 mL) was 
added olefin 256 (12 mg, 0.064 mmol) ain CH2Cl2 (1 mL).  After stirring overnight, the 
suspension was concentrated and the crude residue chromatographed to provide diol 266 
(9 mg, 69%) as a yellowish oil: Rf = 0.34 (30% EtOAc in Hexanes); IR (neat) 3367, 3349, 
2924, 2853, 1464, 1271, 667 cm-1; 1H NMR δ 7.01 (t, J = 8.1 Hz, 1H), 6.76 (d, J = 7.6 
Hz, 1H), 6.60 (d, J = 8.1 Hz, 1H), 5.08 (s, 1H), 4.92 (s, 1H), 2.76 – 3.17 (m, 4H), 2.04 
(m, 2H), 1.94 (s, 3H); HRMS for C13H16O2 [MH+] m/z calc. 204.1150 Da, found 
204.1152 Da. 
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7-(3-hydoxyprop-1-en-2-yl)-5,6,7,8-tetrahydro-naphthalen-1-ol (267) and 7-(1-
hydroxypropan-2-yl)-5,6,7,8-tetrahydronaphthalen-1-ol (268): 
 
A solution of epoxide 257 (9.0 mg, 0.044 mmol) in toluene (1 mL) with 
alumnium triisopropoxide (25 mg) was stirred at reflux 110 °C for 16 h.  The mixture 
was diluted in EtOAc (10 mL) and washed repeatedly with sat. aq. sodium potassium 
tartrate (10 mL washings until clear), then washed with brine (10mL) and concentrated in 
vacuo to give an inseperable mixture of allylic alcohol 267 and aliphatic alcohol 268 as 
an off-white powder (4.0 mg, 44%): 267: Rf = 0.32 (20% EtOAc in Hexanes);  IR (neat) 
3420, 2926, 1652, 1635, 667 cm-1; 1H NMR δ 7.00 (t, J = 7.8 Hz, 1H), 6.71 (d, J = 7.5 
Hz, 1H), 6.60 (d, J = 7.8 Hz, 1H), 5.16 (s, 1H), 5.02 (s, 1H), 4.25 (s, 2H), 2.96 (d of d, J 
= 10.4, 11.8 Hz, 1H), 2.86 (m, 2H), 2.46 (d, J = 11.8 Hz, 1H), 2.04 – 1.99 (m, 1H), 1.30 – 
1.69 (m, 2H), 1.26 (s, 3H); 13C NMR δ 153.3, 152.9, 138.1, 126.1, 122.9, 121.2, 111.8, 
108.9, 65.2, 37.2, 29.7, 27.9, 14.2; HRMS for C13H16O2 [MH+] m/z calc. 204.1150 Da, 
found 204.1152 Da. 268: Rf = 0.32 (20% EtOAc in Hexanes);  IR (neat) 3420, 2926, 
1652, 1635, 667 cm-1; 1H NMR δ 6.99 (t, J = 7.8 Hz, 1H), 6.69 (d, J = 7.6 Hz, 1H), 6.60 
(d, J = 7.9 Hz, 1H), 3.76 (m, 1H), 3.64 (m, 1H), 2.79 (m, 3H), 2.36 (m, 1H), 1.69 – 1.93 
(m, 3H), 1.39 (m, 1H), 1.02 (d, J = 6.6 Hz, 3H); HRMS for C13H18O2 [MH+] m/z calc. 
206.1160 Da, found 206.1162 Da. 
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7-(3-iodoprop-1-en-2-yl)-5,6,7,8-tetrahydro-naphthalen-1-ol (275) and  
7-(1-iodopropan-2-yl)-5,6,7,8-tetrahydronaphthalen-1-ol (274): 
 
 
To a stirred solution of a mixture of aliphatic alcohol 268 and allylic alcohol 267 
(159 mg, 0.778 mmol) in benzene (10 mL) was added triphenylphosphine (224 mg, 0.856 
mmol), imidazole (119 mg, 1.75 mmol), and I2 (217 mg, 0.856 mmol).  The suspension 
was heated to reflux and stirred for 16 h, after which it was diluted in ether (20 mL), 
washed with sat. aq. NH4Cl (20 mL), H2O (20 mL), and brine (20 mL) and concentrated 
in vacuo.  The crude residue was chromatographed (SiO2, 10% EtOAc in hexanes) to 
give aliphatic iodide 274 as a brownish oil (120 mg, 48%) and the allylic iodide 275 as a 
brown oil (6 mg, 3%): 274: Rf = 0.36 (10% EtOAc in Hexanes);  IR (neat) 3420, 2922, 
1558, 1260, 1155, 667 cm-1; 1H NMR δ 7.01 (t, J = 7.8 Hz, 1H), 6.72 (d, J = 7.6 Hz, 1H), 
6.61 (d, J = 7.8 Hz, 1H), 3.36 (m, 2H), 2.84 (m, 3H), 2.28 (dt, J = 11.8, 4.5 Hz, 1H), 1.93 
(m, 3H), 1.29 – 1.52 (m, 2H), 1.11 (d, J = 6.7 Hz, 3H); HRMS for C13H17OI [MH+] m/z 
calc. 317.0322 Da, found 317.0318 Da. 275: Rf = 0.30 (10% EtOAc in Hexanes);  IR 
(neat) 3420, 2922, 1558, 1260, 1155, 667 cm-1; 1H NMR δ 7.01 (t, J = 7.7 Hz, 1H), 6.72 
(d, J = 7.7 Hz, 1H), 6.61 (d, J = 7.7 Hz, 1H), 5.35 (s, 1H), 5.05 (s, 1H), 4.09 (d, J = 1.2 
Hz, 2H), 3.07 (d of d, J = 5.2, 1.2 Hz, 1H), 2.88 (d of d, J = 4.4, 8.0 Hz, 2H), 2.70 (m, 
1H), 2.45 (d of d, J = 12.1, 5.1 Hz, 1H), 2.04 – 1.99 (m, 1H), 1.30 – 1.69 (m, 2H), 1.26 
(s, 3H); 13C NMR δ 153.2, 150.5, 138.0, 126.3, 122.7, 121.3, 112.9, 111.9, 37.7, 29.7, 
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29.6, 28.9, 28.0, 10.1; HRMS for C13H15OI [MH+] m/z calc. 315.0222 Da, found 
315.0218 Da. 
 
10-methyltricyco[7.2.1.01,6]dodeca-3,5-dien-2-one (276): 
 
 
To a solution of aliphatic iodide 274 (80 mg, 0.778 mmol) in t-BuOH (12 mL) 
was added t-BuOK (2 mL of 1.0 M solution in t-BuOH, prepared from K in t-BuOH) and 
the reaction was stirred at reflux for 16 h.  After allowing the reaction to cool to room 
temperature, it was diluted in H2O (20 mL) and extracted with EtOAc (3 x 20 mL).  The 
combined organics were washed with brine (20 mL) and concentrated in vacuo to provide 
an inseparable mixture (1:1) of diastereomeric dienones 276 as a brownish oil (44 mg, 
92%): IR (neat) 2934, 1660, 1627, 1558 cm-1; 1H NMR δ 7.03 (d of d, J = 7.0, 6.1 Hz, 
1H), 7.01 (d of d, J = 7.0, 6.1 Hz, 1H), 6.07 (d, J = 7.3 Hz, 1H), 6.04 (d, J = 6.7 Hz, 1H), 
5.92 (d of d, J = 7.7, 6.1 Hz, 1H), 5.91 (d of d, J = 7.7, 6.1 Hz, 1H), 1.20 – 2.80 (m, 20H), 
1.17 (d, J = 7.2 Hz, 3H), 1.12 (d, J = 6.7 Hz, 3H); 13C NMR (some resonances are 
overlapping) δ 204.2, 202.2, 162.1, 160.9, 142.9, 142.7, 124.7, 124.2, 112.8, 112.5, 60.8, 
51.1, 46.6, 44.5, 44.4, 42.8, 42.6, 36.9, 34.9, 30.1, 29.9, 29.7, 23.0, 15.5; HRMS for 
C13H17O [MH+] m/z calc. 189.1279 Da, found 189.1283 Da. 
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N,N-diethyl-2-prop-2-en-1-yl)-6-{[tris(propan-2-yl)silyl]oxy}benzamide (289):   
 
 
A stirred solution of diethyl 2-silyloxybenzamide3 287 (7.68 g, 21.97 mmol) in 
THF (100.0 mL) at –78 °C was treated with s-BuLi (37 mL, 47.5 mmol, 1.3 M in 
hexanes) dropwise via syringe pump over 20 min and then stirred for 1 h.  CuBr•SMe2 
(8.88 g, 43.2 mmol) was then added to this solution in one portion and the suspension 
was warmed to 23 °C and stirred 30 min.  After recooling the suspension to –78 °C, allyl 
bromide (3.7 mL, 43.2 mmol) was added, the cold bath removed and the reaction stirred 
at 23 °C for 16 h.  The reaction was quenched with sat. aq. NH4Cl (100 mL), and 
extracted with ether (2 x 100 mL).  The combined organics were washed with brine, 
concentrated, and the residue was chromatographed (SiO2, 10 % EtOAc in hexanes) to 
give allylated benzamide 289 as an orangish oil (8.56 g, 100%): Rf = 0.45 (10% EtOAc in 
hexanes); IR (neat) 2943, 2867, 1639, 1581, 1462, 1280, 1024 cm-1; 1H NMR δ 7.09 (dd, 
J = 8.1, 7.7 Hz, 1H), 6.77 (d, J = 7.7 Hz, 1H), 6.65 (d, J = 7.7 Hz, 1H), 5.89 (dt, J = 7.2, 
9.5 Hz, 1H), 5.02 (m, 2H), 3.80 (quartet, J = 6.6 Hz, 4H), 3.27 (m, 2H), 3.00 – 3.1 (dq, J 
= 7.2, 2.2 Hz, 2H), 1.10 (t, J = 5.6 Hz, 6H), 1.20 – 1.32 (m, 3H), 1.10 (d, J = 6.8 Hz, 
18H); 13C NMR δ 167.9, 151.6, 138.0, 136.5, 128.6, 121.4, 116.2, 112.1, 91.8, 43.0, 38.8, 
37.0, 17.6, 13.9, 12.9, 12.8; HRMS for C23H40NO2Si [MH+] m/z calc. 390.2828 Da, found 
390.2831 Da. 
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N,N-diethyl-2-(2-hydroxyethyl)-6-{[tris(propan-2-yl)silyl]oxy}benzamide (288):   
 
 
A solution of allyl 289 (4.04 g, 10.37 mmol) in DCM (50 mL) at –78 °C was  
treated with O3, continuously bubbling it through the solution until the solution became a 
persistent pale blue (3 hours).  The solution was warmed to 0 °C, and then to this was 
added dropwise a stirred solution of NaBH4 (3.14 g, 82.96 mmol) in EtOH/H2O (1 : 1, 50 
mL).  The reaction was stirred 18 h at 23 °C, then poured into aq. 4M HCl (25 mL) and 
acidified to pH ~ 1.  The solution was extracted with DCM (3 x 50 mL) and the 
combined organics were washed with H2O (50 mL), brine (50 mL), and concentrated in 
vacuo.  The crude residue was dissolved in ether (40 mL) and filtered over Celite and the 
solvent evaporated to yield phenethyl alcohol 288 (3.88 g, 95%) as a yellow oil: Rf = 0.68 
(EtOAc); IR (neat) 3392, 2942, 1639, 1586, 1469, 1436, 1260 cm-1; 1H NMR δ 7.15 (t, J 
= 8.1, 7.6 Hz, 1H), 6.83 (d, J = 7.6 Hz, 1H), 6.68 (d, J = 8.1 Hz, 1H), 3.90 (quintet, J = 
5.2 Hz, 1H), 3.68 (m, 2H), 3.37 (quintet, J = 6.9 Hz, 1H), 3.25 (q, J = 7.3 Hz, 1H), 3.07 
(q, J = 7.3 Hz, 1H), 2.75 (dt, J = 13.8, 6.6 Hz, 1H), 2.62 (dd, J = 9.1, 4.4 Hz, 1H),  1.24 
(t, J = 7.1 Hz, 3H), 1.20 – 1.32 (m, 3H), 1.00 (t, J = 7.4 Hz, 3H), 1.10 (d, J = 6.8 Hz, 
18H); 13C NMR δ 169.4, 151.2, 138.2, 129.4, 128.9, 122.0, 116.3, 36.3, 43.3, 39.7, 36.1, 
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17.9, 14.2, 13.1, 12.8; HRMS for C22H40NO3Si [MH+] m/z calc. 394.2777 Da, found 
394.2778 Da. 
 
8-hydroxy-3,4-dihydro-1H-2-benzopyran-1-one (290): 
 
 
A solution of amide 288 (124 mg, 0.315 mmol) in toluene (6 mL) with 
camphorsulfonic acid (88 mg, 0.378 mmol) was stirred at reflux for 16h.  The reaction 
was diluted in EtOAc (20 mL) and washed with sat. aq. NH4Cl (10 mL), H2O (10 mL), 
brine (10 mL) and concentrated to give a crude oil which was chromatographed (SiO2, 
20% EtOAc in hexanes) to yield known lactone4 290 as a colorless oil (48 mg, 92%): Rf = 
0.27 (20% EtOAc in Hexanes); IR (neat) 2925, 2865, 1683, 1464, 1237, 668 cm-1; 1H 
NMR δ 7.40 (dd, J = 7.6, 8.2 Hz, 1H), 6.89 (d, J = 7.6 Hz 1H), 6.70 (d, J = 8.2 Hz, 1H), 
4.56 (t, J = 6.2 Hz, 2H), 3.03 (t, J = 6.1 Hz, 2H); 13C NMR δ 162.2, 139.8, 136.2, 117.8, 
116.3, 108.4, 68.1, 17.7, 12.2;  HRMS for C9H9O3 [MH+] m/z calc. 165.0552 Da, found 
165.0549 Da. 
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2-[(diethylamino)methyl]-3-(2-hydroxyethyl)phenol (291):   
 
To a stirred suspension of lithium aluminum hydride (s) (0.50 g) in THF (20 mL) 
at 23 °C was added the amide 288 (850 mg, 2.16 mmol) as a solution in THF (10 mL) via 
addition funnel over 5 min.  The mixture was heated to reflux and stirred 2 days.  After 
cooling to 0 °C, the reaction mixture was quenched by dropwise addition to sat. aq. 
Na2SO4 (10 mL) via cannula.   Upon complete addition, the mixture was diluted in ethyl 
acetate (50 mL) and stirred for 1 h, warming to room temperature.  The solids were 
filtered under reduced pressure and washed with ethyl acetate until the washings ran was 
clear.  The filtrate was concentrated in vacuo to provide the amine 291 as a pure orange 
oil (476 mg, 99%) which was taken on without further purification: Rf = 0.10 (EtOAc); 
IR (neat) 3286, 2968, 2935, 2835, 1583, 1469, 1250, 1083 cm-1; 1H NMR δ 7.01 (t, J = 
8.1 Hz, 1H), 6.69 (d, J = 7.4 Hz, 1H), 6.67 (d, J = 8.1 Hz, 1H), 3.83 (s, 2H), 3.78 (t, J = 
6.7 Hz, 2H), 2.86 (t, J = 6.8 Hz, 2H), 2.62 (q, J = 7.3 Hz, 4H), 1.13 (t, J = 7.3 Hz, 6H); 
13C NMR δ 158.0, 142.6, 128.5, 125.1, 121.9, 107.9, 62.9, 45.7, 44.9, 42.7, 35.6, 10.2; 
HRMS for C13H22NO2 [MH+] m/z calc. 224.1651 Da, found 224.1654 Da. 
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3-(2-hydroxyethyl)-2-methylphenol (292):   
 
 
To a stirred solution of amine 291 (338 mg, 1.51 mmol) in methanol (15 mL), 
saturated with H2 (g) by bubbling through for 30 min, was added 20% Pd(OH)2 on carbon 
(60 mg).  To the reaction mixture was attached a balloon of H2 (g) through a septum and 
the reaction was allowed to stir under a balloon of H2 (g).  After 2 days of stirring under 
an atmosphere of H2 (g), the balloon was removed, and the mixture filtered through a 
Celite plug under reduced pressure.  After repeated methanol washings, the filtrates were 
combined and concentrated to give a crude brown oil.  The residue was dissolved in ethyl 
acetate (20 mL) and the organic layer washed with 1M aq. H3PO4 (20 mL), H2O (20 mL), 
brine (20 mL), dried (Na2SO4) and concentrated in vacuo to provide alcohol 292 as a 
spectroscopically pure, pale brown oil (205 mg, 89%) which was taken on without further 
purification.  Chromatographic purification of the product for the purpose of 
characterization (SiO2, 20% ethyl acetate in hexanes) gave a brown powder: mp = 87 - 90 
°C, Rf = 0.26 (30% EtOAc in Hexanes); IR (neat) 3336, 3286, 2928, 1584, 1464, 1257, 
1104 cm-1; 1H NMR δ 7.02 (t, J = 7.8 Hz, 1H), 6.79 (d, J = 7.4 Hz 1H), 6.67 (d, J = 7.8 
Hz, 1H), 3.83 (q, J = 5.1 Hz, 2H), 2.92 (t, J = 6.7 Hz, 2H), 2.23 (s, 3H); 13C NMR δ 
154.5, 137.8, 125.9, 123.1, 121.6, 113.2, 62.5, 36.5, 11.2;  HRMS for C9H13O2 [MH+] m/z 
calc. 153.0916 Da, found 153.0914 Da. 
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3-(2-bromoethyl)-2-methylphenol (293):   
 
 
A solution of alcohol 292 (7.68 g, 55.6 mmol) in 48% aq. HBr (60 mL) was 
heated to 100 °C and stirred 16 h.  The solution was cooled to 23 °C, poured into H2O (60 
mL) and extracted with EtOAc (3 x 50 mL).  The combined organics were washed with 
brine (50 mL), dried (Na2SO4) and concentrated in vacuo to provide a spectroscopically 
pure black oil which was taken on without further purification.  Column chromatographic 
purification for the purpose of characterization (SiO2, 20% ethyl acetate in hexanes) gave 
the bromophenol 293 as a white powder: mp = 108 – 109 °C; Rf = 0.55 (20% EtOAc in 
Hexanes); IR (neat) 3286, 2962, 2932, 1456, 1252, 1212 cm-1; 1H NMR δ 7.13 (t, J = 7.8 
Hz, 1H), 6.80 (d, J = 8.0 Hz, 1H), 6.74 (d, J = 7.8 Hz, 1H), 3.54 (t, J = 8.5 Hz, 2H), 3.21 
(t, J = 8.4 Hz, 2H), 2.22 (s, 3H); 13C NMR δ 153.9, 138.7, 126.3, 122.5, 121.8, 113.7, 
37.1, 31.6, 11.2; HRMS for C9H12OBr [MH+] m/z calc. 215.0072 Da, found 215.0072 Da. 
 
 
 
 
 
 
 
 
OH
Br
 232 
3-(2-bromoethyl)-2-methylphenoxytris(propan-2-yl)silane (294):   
 
 
To a solution of crude bromophenol 293 in CH2Cl2 (50 mL) was added imidazole 
(3.92 g, 61.16 mmol) and triisopropylsilyl choride (11.80 g, 61.16 mmol) and the reaction 
was stirred 16 h.  The solution was poured into sat. aq. NH4Cl (50 mL), extracted with 
CH2Cl2 (2 x 50 mL), dried (Na2SO4) and concentrated in vacuo.  Column 
chromatographic purification of the the crude oil (SiO2, 6% ethyl acetate in hexanes) 
gave the bromide 294 as a colorless oil (16.65 g, 84% from 292): Rf = 0.8 (2% EtOAc in 
Hexanes); IR (neat) 2944, 2866, 1583, 1463, 1273, 1066, 940, 882, 776 cm-1; 1H NMR δ 
7.00 (t, J = 7.8 Hz, 1H), 6.76 (t, J = 7.8 Hz, 2H), 3.51 (t, J = 8.5 Hz, 2H), 3.18 (t, J = 8.5 
Hz, 2H), 2.24 (s, 3H), 1.25 – 1.35 (m, 3H), 1.14 (d, J = 7.2 Hz, 18H); 13C NMR δ 154.5, 
138.7, 126.8, 125.9, 121.9, 116.7, 37.6, 31.7, 18.0, 13.0, 12.3; HRMS for C18H32OBrSi 
[MH+] m/z calc. 371.1406 Da, found 371.1404 Da. 
TIPSO
Br
 233 
 
3-methyl-2-[2-(2-methyl-3-{[tris(propan-2-yl)silyl]oxy}phenyl)ethyl]but-3-enoic acid 
(295):   
 
A flame-dried, three-necked 50 mL flask under Ar (g) and equipped with stirbar 
was charged with diisopropylamine (167 µL, 1.181 mmol) and THF (10 mL).  The 
solution was cooled to –78 °C and n-BuLi (0.513 mL, 1.181 mmol, 2.4 M in hexanes) 
was added via syringe.  The cold bath was removed and the solution was stirred for 15 
min and then re-cooled to –78 °C.  A solution of 3,3-dimethylacrylic acid 247 (54 mg, 
0.537 mmol) in a minimal amount of THF (5 mL) was added to the reaction flask via 
cannula and the reaction mixture was stirred at rt for 2 h, until a white precipitate formed 
throughout the reaction vessel.  The suspension was then re-cooled to –78 °C and 
bromide 294 (200 mg, 0.537 mmol) in a minimal amount of THF (5 mL) was added via 
cannula.  The reaction was allowed to stir at –78 °C for 2 h and overnight at room 
temperature.  The reaction was quenched by the addition of water (15 mL) and then 
diluted with ether and transferred to a separatory funnel.  The organic layer was removed 
and the aqueous layer extracted with ether (10 mL).  The aqueous layer was acidified 
with conc. aq. H3PO4 and extracted with ether (3 x 20 mL).  The combined organic 
extracts were washed with brine (20 mL), dried (Na2SO4) and concentrated to give acid 
295 as a gummy, yellow oil of sufficient purity (83 mg, 40%): Rf = 0.24 (30% EtOAc in 
Hexanes); IR (neat) 3077, 2945, 2867, 1706, 1464, 1272 cm-1; 1H NMR δ 6.97 (dd, J = 
7.8, 8.2 Hz, 1H), 6.74 (d, J = 7.4 Hz, 1H), 6.70 (d, J = 8.0 Hz, 1H), 5.0 (s, 1H), 4.99 (s, 
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1H), 3.13 (t, J = 7.4 Hz, 1H), 2.6 (t, J = 8.1 Hz, 2H), 2.21 (s, 3H), 1.82 (s, 3H), 1.84 – 
2.19 (m, 2H), 1.25 – 1.35 (m, 3H), 1.12 (d, J = 7.2 Hz, 18H); 13C NMR δ 179.4, 154.3, 
141.8, 141.1, 126.5, 125.6, 125.3, 121.6, 115.9, 114.6, 52.6, 31.6, 30.5, 18.0, 13.0, 12.1; 
HRMS for C23H39O3Si [MH+] m/z calc. 391.2688 Da, found 391.2654 Da. 
 
3-methyl-2-[2-(2-methyl-3-{[tris(propan-2-yl)silyl]oxy}phenyl)ethyl]but-3-en-1-ol: 
 
 
To a stirred solution of acid 295 (181 mg, 0.46 mmol) in dry ether (25 mL) at 0 
°C was added LAH (s) (190 mg, 5.15 mmol).  After stirring for four hours, the reaction 
was quenched with the dropwise addition of sat. aq. Na2SO4 until bubbling ceased.  The 
suspension was filtered over celite, the filtrate dried (Na2SO4) and concentrated to give 
the alcohol as a pure, colorless oil (173 mg, 99%): IR (neat) 3344, 2943, 2866, 1463, 
1272, 1051 cm-1; 1H NMR δ 6.95 (dd, J = 7.8, 7.5 Hz, 1H), 6.72 (d, J = 7.5 Hz, 1H), 6.64 
(d, J = 7.9 Hz, 1H), 5.01 (s, 1H), 4.90 (s, 1H), 3.54 (dd, J = 8.2, 5.7 Hz, 2H), 2.45 – 2.61 
(m, 2H), 2.36 (t, J = 6.3 Hz, 1H), 2.19 (s, 3H), 1.74 (s, 3H), 1.64 – 1.78 (m, 2H), 1.24 – 
1.35 (m, 3H), 1.08 (d, J = 7.1 Hz, 18H); 13C NMR δ 154.2, 126.4, 125.6, 125.5, 121.4, 
115.7, 115.6, 114.1, 49.9, 31.5, 29.6, 28.9, 18.04, 17.6, 12.9, 12.1;  HRMS for C23H41O2Si 
[MH+] m/z calc. 377.2876 Da, found 377.2881 Da. 
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3-methyl-2-[2-(2-methyl-3-{[tris(propan-2-yl)silyl]oxy}phenyl)ethyl]but-3-en-1-yl 
methanesulfonate (296): 
 
 
To a stirred solution of alcohol (216 mg, 0.573 mmol) in DCM (6 mL) with NEt3 
(1 mL) was added methansulfonyl chloride (0.10 mL, 12.36 mmol).  After stirring for 3 
h, the reaction was poured into sat. aq. NH4Cl (10 mL) and extracted with DCM (3 x 20 
mL).  The combined organic extracts were washed with sat. aq. NH4Cl, brine, dried 
(Na2SO4) and concentrated to give mesylate as a crude oil, which was taken on without 
further purification (254 mg, 97%): Rf = 0.40 (20% EtOAc in Hexanes); IR (neat) 3363, 
2943, 2866, 1463, 1273 cm-1; 1H NMR δ 6.94 (dd, J = 7.8, 7.7 Hz, 1H), 6.69 (d, J = 7.5 
Hz, 1H), 6.65 (d, J = 8.0 Hz, 1H), 4.98 (s, 1H), 4.88 (s, 1H), 4.14 (septet, J = 7.5, 6.2 Hz, 
2H), 2.97 (s, 3H), 2.48 – 2.62 (m, 3H), 2.16(s, 3H), 1.74 (s, 3H), 1.59 – 1.72 (m, 2H), 
1.24 – 1.35 (m, 3H), 1.08 (d, J = 7.1 Hz, 18H); 13C NMR δ 154.2, 144.7, 141.9, 125.6, 
121.5, 115.7, 114.3, 112.7, 63.9, 49.9, 31.6, 31.1, 29.9, 18.0, 13.0, 12.1, 11.0; HRMS for 
C24H42O4SSi [MH+] m/z calc. 455.2676 Da, found 455.2681 Da. 
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2-[2-(3-hydroxy-2-methylphenyl)ethyl]-3-methylbut-3-en-1-yl methanesulfonate 
(296):   
 
To a stirred solution of triisopropylsilyl ether (209 mg, 0.460 mmol) in THF (4 
mL) was added TBAF (2 mL, 1.0M in THF) and the reaction stirred 3h.  The solution 
was poured into sat. aq. NH4Cl (10 mL) and extracted with EtOAc (2 x 20 mL).   The 
combined organics were washed with water (20 mL), and the organic layer was dried 
(Na2SO4) and concentrated in vacuo.  Column chromatographic purification (SiO2, 30% 
EtOAc in hexanes) gave the phenol 296 as a brownish oil (62 mg, 45%): Rf = 0.25 (30% 
EtOAc in Hexanes); IR (neat) 3481, 2938, 1465, 1351, 1174, 950 cm-1; 1H NMR δ 6.99 
(dd, J = 8.1, 7.7 Hz, 1H), 6.72 (d, J = 7.5 Hz, 1H), 6.64 (d, J = 8.1 Hz, 1H), 5.01 (s, 1H), 
4.91 (s, 1H), 4.20 (septet, J = 7.5, 6.2 Hz, 2H), 2.99 (s, 3H), 2.50 – 2.64 (m, 3H), 2.17(s, 
3H), 1.77 (s, 3H), 1.64 – 1.78 (m, 2H); 13C NMR δ 142.7, 141.6, 126.2, 121.9, 121.4, 
114.5, 112.8, 106.2, 71.2, 46.2, 37.4, 30.8, 29.8, 19.5, 11.1; HRMS for C15H22O4S [MH+] 
m/z calc. 298.1239 Da, found 298.1235 Da. 
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N,N-Diethyl-2-methoxy-6-(prop-2-en-1-yl)benzamide (302):   
 
 
To a stirred solution of benzamide5, 6 301 (20.7 g, 0.100 mol) in THF (500 mL) at 
–78 °C was  added t-butyllithium (80.00 mL, 1.5 M solution in pentane) via cannula over 
30 min and the solution stirred an additional 1 h at –78 °C.  CuBr•SMe2 (24.60 g, 0.120 
mol) was added and the reaction was stirred for 30 min. at –78 °C, 1 h at 23 °C, and then 
recooled to –78 °C.  To this stirred suspension was added allyl bromide (9.0 mL, 10.4 
mmol) and the reaction was stirred 4 h at 23 °C. The reaction was quenched by the 
addition of sat. aq. NH4Cl (200 mL) and 1N HCl (aq.) (50 mL) and then diluted in ether 
(300 mL).   After washing of the organic layer with sat. aq. NH4Cl (2 x 500 mL) and 
brine (300 mL), concentration in vacuo provided the allyl product7 302 as a 
spectroscopically pure orange oil (24.3 g, 98%): Rf = 0.26 (30% EtOAc in hexanes); IR 
(neat) 2975, 2935, 1629, 1597, 1582, 1468, 1427, 1072, 762 cm-1; 1H NMR δ 7.20 (t, J = 
8.1 Hz, 1H), 6.81 (d, J = 8.1 Hz, 1H), 6.72 (d, J = 8.1 Hz, 1H), 5.89 (m, 1H), 5.02 (m, 
2H), 3.74 (s, 3H), 3.32 – 3.40 (quintet, J = 6.7 Hz, 2H), 3.27 (t, J = 6.8 Hz, 2H), 3.00 – 
3.1 (quintet, J = 6.7 Hz, 2H), 1.21 (t, J = 7.2 Hz, 3H), 0.99 (t, J = 7.2 Hz, 3H); 13C NMR 
δ 167.8, 155.1, 137.5, 136.3, 129.0, 125.9, 121.4, 116. 0, 108.3, 55.2, 42.5, 38.2, 36.8, 
13.7, 12.6; HRMS for C15H22NO2 [MH+] m/z calc. 248.1651 Da, found 248.1654 Da. 
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N,N-diethyl-2-(2-hydroxyethyl)-6-methoxybenzamide (303):   
 
 
To a stirred solution of benzamide 301 (15.55 g, 75.00 mmol) in THF (300 mL) at 
-78 °C was  added t-butyllithium (100 mL, 1.5 M solution in pentane) via cannula over 
30 min and the solution stirred an additional 1 h at -78 °C.  To the reaction was added 
CuBr•SMe2 (30.80 g, 150 mmol) and after stirring for 30 min., the reaction was allowed 
to warm to room temperature and stirred an additional 1 h.  Meanwhile, ethylene oxide 
(g) was passed through a cold finger and the liquid collected in a flame dried, double 
neck round bottom until approximately 50 mL had been collected.  To the room 
temperature, black reaction mixture was added the cold ethylene oxide (l) via cannula.  
After stirring for 30 min, the direct, dropwise addition of the cold-finger condensed 
ethylene oxide (l) was begun and maintained until the starting material was completely 
consumed (TLC monitoring).  The reaction was quenched by the addition of sat. aq. 
NH4Cl (100 mL) and diluted in ether (300 mL).   After washing of the organic layer with 
sat. aq. NH4Cl (2 x 500 mL) and brine (300 mL), concentration in vacuo provided a crude 
red oil which, upon trituration with cold ether, provided phenethylalcohol 302 as a pure, 
white powder (17.93 g, 95%): mp = 89 – 91 °C, Rf = 0.35 (EtOAc); IR (neat) 3392, 2972, 
2936, 1610, 1596, 1469, 1436, 1260, 1083 cm-1; 1H NMR δ 7.26 (t, J = 8.1 Hz, 1H), 6.86 
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(d, J = 7.4 Hz, 1H), 6.75 (d, J = 8.1 Hz, 1H), 3.86 – 3.91 (quintet, J = 5.2 Hz, 1H), 3.77 
(s, 3H), 3.68 – 3.75 (quintet, J = 5.2 Hz, 1H), 3.51 – 3.69 (m, 2H), 3.08 – 3.16 (d of 
quartets, J = 3.0, 7.4 Hz, 2H), 2.74 – 2.81 (m, 1H), 2.60 – 2.69 (m, 1H),  1.24 (t, J = 7.4 
Hz, 3H), 1.00 (t, J = 7.4 Hz, 3H); 13C NMR δ 168.8, 154.9, 137.7, 129.7, 126.3, 121.9, 
108.4, 63.0, 55.3, 42.7, 38.8, 36.0, 13.7, 12.6; HRMS for C14H21NO3 [MH+] m/z calc. 
252.1525 Da, found 252.1545 Da. 
 
N,N-diethyl-2-(2-hydroxyethyl)-6-methoxybenzamide (303):   
 
 
A solution of allyl 302 (2.63 g, 10.64 mmol) in DCM (50 mL) at –78 °C was  
treated with O3, continuously bubbling it through the solution until the solution became a 
persistent pale blue (2 hours).  The solution was warmed to 0 °C, and then to this was 
added dropwise a stirred solution of NaBH4 (3.00 g, 79.30 mmol) in EtOH/H2O (1 : 1, 50 
mL).  The reaction was stirred 3 h at 0 °C, then quenched by pouring it into aq. 3M HCl 
(25 mL) and further acidifying it to ph ~ 1.  The solution was extracted with DCM (3 x 
50 mL) and the combined organics were washed with brine (50 mL), and concentrated in 
vacuo to yield the alcohol 303 (3.88 g, 95%) as a colorless oil, which solidified on 
standing (1.96 g, 73%): characterized as above. 
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2-{2-[(diethylamino)methyl]-3-methoxyphenyl}ethanol (304):   
 
 
To a stirred suspension of lithium aluminum hydride (s) (LAH, 16.0 g) in THF 
(600 mL) at 0 °C was added the amide 303 (23.90 g, 95.10 mmol) as a solution in THF 
(100 mL) via addition funnel over 15 min.  The mixture was heated to reflux and stirred 2 
days.  After cooling to room temperature, the reaction mixture was quenched by dropwise 
addition to sat. aq. Na2SO4 (400 mL) at 0 °C via cannula.   Upon complete addition, the 
mixture was diluted in ethyl acetate (500 mL) and stirred for 1 h, warming to room 
temperature.  The solids were filtered under reduced pressure and washed with ethyl 
acetate until the washings ran was clear.  The filtrate was concentrated in vacuo to 
provide the amine 304 as a spectroscopically pure brown oil (22.24 g, 99%) which was 
taken on without further purification: Rf = 0.15 (EtOAc); IR (neat) 3392, 2969, 2937, 
2835, 1584, 1468, 1250, 1082 cm-1; 1H NMR δ 7.24 (t, J = 8.1 Hz, 1H), 6.89 (d, J = 7.4 
Hz, 1H), 6.75 (d, J = 8.1 Hz, 1H), 3.85 (t, J = 5.1 Hz, 2H), 3.81 (s, 3H), 3.63 (s, 2H), 2.89 
(t, J = 5.1 Hz, 2H), 2.56 (q, J = 6.6 Hz, 4H), 1.09 (t, J = 6.6 Hz, 6H); 13C NMR δ 158.0, 
142.6, 128.5, 125.1, 121.9, 107.9, 62.9, 55.3, 45.7, 44.9, 42.7, 35.6, 10.2; HRMS for 
C14H24NO2 [MH+] m/z calc. 238.1807 Da, found 238.1807 Da. 
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2-(3-methoxy-2-methylphenyl)ethanol (305):   
 
 
To a stirred solution of amine 304 (21.40 g, 0.0902 mol) in methanol (300 mL), 
saturated with H2 (g) by bubbling through for 30 min, was added 20% Pd(OH)2 on carbon 
(2.40 g).  To the reaction mixture was attached a balloon of H2 (g) through a septum and 
the reaction was allowed to stir overnight under a balloon of H2.  After 4 days of stirring 
under an atmosphere of H2 (g), the balloon was removed, and the mixture filtered through 
a Celite plug under reduced pressure.  After repeated methanol washings, the filtrates 
were combined and concentrated to give a crude brown oil.  The residue was dissolved in 
ethyl acetate (200 mL) and the organic layer washed with 1M aq. H3PO4 (100 mL), H2O 
(100 mL), brine (100 mL), dried (Na2SO4) and concentrated in vacuo to provide alcohol8,9 
305 as a spectroscopically pure, pale brown oil (14.86 g, 99%) which was taken on 
without further purification.  Chromatographic purification of the product for the purpose 
of characterization (SiO2, 20% ethyl acetate in hexanes) gave a white solid: mp = 54 - 56 
°C (lit.9 57 °C), Rf = 0.46 (30% EtOAc in Hexanes); IR (neat) 3336, 2928, 1584, 1464, 
1257, 1104 cm-1; 1H NMR δ 7.13 (t, J = 8.0 Hz, 1H), 6.81 (d, J = 7.8, Hz 1H), 6.76 (d, J 
= 8.1 Hz, 1H), 3.82 (s, 3H), 3.80 (t, J = 7.0 Hz, 2H), 2.92 (t, J = 7.0 Hz, 2H), 2.21 (s, 
3H); 13C NMR δ 157.7, 247.6, 126.0, 125.0, 122.0, 108.4, 62.5, 55.4, 36.6, 29.6; HRMS 
for C10H15O2 [MH+] m/z calc. 167.1072 Da, found 167.1069 Da. 
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3-methoxy-2-methylphenethyl methanesulfonate (306):   
 
To a stirred solution of alcohol 305 (5.74 g, 34.5 mmol) in CH2Cl2 (100 mL) at 
0°C with triethylamine (6.0 mL) was added methanesulfonyl chloride (3.00 mL, 38.0 
mmol) dropwise over 15 min.  The reaction was allowed to stir overnight, after which, 
the solution was poured into sat. aq. NH4Cl (100 mL), extracted with CH2Cl2 (2 x 100 
mL), dried (Na2SO4) and concentrated in vacuo.  Column chromatographic purification of 
the the crude oil (SiO2, 20% ethyl acetate in hexanes) gave the mesylate 306 as a yellow 
oil (8.35 g, 99%): Rf = 0.22 (20% EtOAc in Hexanes); IR (neat) 2955, 2918, 2849, 1575, 
1557, 1455 cm-1; 1H NMR δ 7.13 (t, J = 8.1 Hz, 1H), 6.80 (t, J = 8.1 Hz, 2H), 4.37 (t, J = 
7.4 Hz, 2H), 3.82 (s, 3H), 3.09 (t, J = 7.3 Hz, 2H), 2.87 (s, 3H), 2.21 (s, 3H); 13C NMR δ 
157.8, 135.4, 126.3, 125.1, 122.0, 108.9, 69.4, 55.4, 37.2, 33.2, 11.3; HRMS for 
C11H16O4S [MH+] m/z calc. 244.0769 Da, found 244.0771 Da. 
 
1-(2-iodoethyl)-3-methoxy-2-methylbenzene (307):   
 
 
To a stirred solution of triphenylphosphine (1.12 g, 4.93 mmol) in CH2Cl2 (40 
mL) was added imidazole (1.12 mg, 17.49 mmol), iodine (1.22 gg, 4.80 mmol) and 
alcohol 305 (600 mg, 3.60 mmol).  After stirring overnight, the suspension was 
O
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concentrated and the residue chromatographed (SiO2, 5% EtOAc in hexanes) to provide 
iodide9 307 as a yellow oil (626 mg, 63%): Rf = 0.82 (5% EtOAc in hexanes); IR (neat) 
2954, 1259, 1096, 668 cm-1; 1H NMR δ 7.13 (t, J = 8.1 Hz, 1H), 6.80 (d, J = 8.1 Hz, 2H), 
3.83 (s, 3H), 3.17 – 3.32 (m, 4H), 2.21 (s, 3H); 13C NMR δ 157.9, 140.3, 126.4, 1245, 
121.4, 108.8, 55.5, 38.5, 11.4, 3.9; HRMS for C10H14OI [MH+] m/z calc. 277.0089 Da, 
found 277.0091 Da. 
 244 
 
2-(3-methoxy-2-methylphenethyl)-3-methylbut-3-enoic acid (307):   
 
 
A flame-dried, three-necked 500 mL flask under Ar (g) and equipped with stirbar 
was charged with diisopropylamine (12.60 mL, 89.65 mmol) and THF (150 mL).  The 
solution was cooled to –78 °C and n-BuLi (37.4 mL, 89.65 mmol, 2.4 M in hexanes) was 
added via syringe.  The cold bath was removed and the solution was stirred for 30 min 
and then re-cooled to –78 °C.  A solution of 3,3-dimethylacrylic acid 247 (4.09 g, 40.82 
mmol) in a minimal amount of THF (50 mL) was added to the reaction flask via cannula 
and the reaction mixture was stirred at –78 °C for 1 h and at rt for an additional 1 h, until 
a white precipitate formed throughout the reaction vessel.  The suspension was then re-
cooled to –78 °C and mesylate 306 (8.31 g, 34.02 mmol) in a minimal amount of THF 
(50 mL) was added via cannula.  The alkylation reaction was allowed to stir at –78 °C for 
2 h and overnight at room temperature.  The reaction was quenched by the addition of 
water (150 mL) and then diluted with ether and transferred to a separatory funnel.  The 
organic layer was removed and the aqueous layer extracted with ether (100 mL).  The 
aqueous layer was acidified with H3PO4 (conc.) and extracted with ether (3 x 200 mL).  
The combined organic extracts were washed with brine (200 mL), dried (Na2SO4) and 
concentrated to give acid 307 as a gummy, orange oil of sufficient purity (6.63 g, 78%): 
Rf = 0.24 (30% EtOAc in Hexanes); IR (neat) 2952, 2835, 1705, 1585, 1464, 1258, 1104 
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cm-1; 1H NMR δ 7.10 (t, J = 8.1 Hz, 1H), 6.77 (d, J = 7.4 Hz, 1H), 6.72 (d, J = 8.8 Hz, 
1H), 5.0 (s, 1H), 4.98 (s, 1H), 3.82 (s, 3H), 3.13 (t, J = 7.4 Hz, 1H), 2.61 (t, J = 8.1 Hz, 
2H), 2.17 (s, 3H), 1.82 (s, 3H), 1.79 – 2.10 (m, 2H); 13C NMR δ 179.6, 157.7, 141.8, 
140.9, 126.0, 124.6, 121.5, 114.7, 108.1, 55.5, 52.7, 31.3, 30.5, 20.2, 11.1; HRMS for 
C15H21O3 [MH+] m/z calc. 249.1491 Da, found 249.1487 Da. 
 
2-(3-methoxy-2-methylphenethyl)-3-methylbut-3-en-1-ol (309):   
 
 
To a stirred suspension of LAH (3.0 g, 79.1 mmol) in ether (100 mL) at 0 °C was 
slowly added acid 307 (5.49 g, 22.1 mmol) as a solution in ether (50 mL) and the 
suspension was stirred at 23 °C for 16 h.  The reaction was quenched at 0 °C, by the 
dropwise addition of sat. aq. Na2SO4 until bubbling ceased.  The mixture was diluted in 
EtOAc, filtered, and concentrated in vacuo to yield alcohol 307 as a colorless oil (4.48 g, 
87%): Rf = 0.29 (20% EtOAc in Hexanes); IR (neat) 3371, 2931, 1585, 1465, 1258, 1105, 
1044 cm-1; 1H NMR δ 7.08 (t, J = 8.1 Hz 1H), 6.76 (d, J = 7.4 Hz, 1H), 6.71 (d, J = 8.1 
Hz, 1H), 5.0 (s, 1H), 4.89 (s, 1H), 3.80 (s, 3H), 3.53 (d, J = 5.9 Hz, 2H), 2.46 – 2.64 (m, 
2H), 2.2 – 2.4 (m, 1H), 2.16 (s, 3H), 1.74 (s, 3H), 1.56 – 1.70 (m, 2H); 13C NMR δ 144.7, 
141.8, 126.0, 124.4, 123.6, 121.4, 114.2, 107.9, 64.0, 55.5, 49.9, 31.3, 30.1, 18.8, 11.2; 
HRMS for C15H23O2 [MH+] m/z calc. 235.1698 Da, found 235.1703 Da. 
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2-(3-methoxy-2-methylphenethyl)-3-methylbut-3-en-1-yl methanesulfonate (310):   
 
 
To a stirred solution of alcohol 309 (520 mg, 2.22 mmol) in DCM (10 mL) with 
diisopropylethylamine (2.00 mL) at 0 °C was added methansulfonyl chloride (2.0 mL, 
25.8  mmol).  After stirring 16 h at 23 °C, the reaction was poured into sat. aq. NH4Cl (20 
mL) and extracted with DCM (3 x 20 mL).  The combined organic extracts were washed 
with brine, dried (Na2SO4) and concentrated to give a crude oil, which was 
chromatographed (SiO2, 20% EtOAc in hexanes) to give mesylate 310 as a pure, pale-
yellow oil (445 mg, 64%): Rf = 0.40 (20% EtOAc in Hexanes); IR (neat) 2940, 1584, 
1465, 1355, 1258, 1176, 1098, 954, 528 cm-1; 1H NMR δ 7.10 (d of d, J = 8.1, 7.4 Hz, 
1H), 6.75 (d, J = 7.4 Hz, 1H), 6.74 (d, J = 8.1 Hz, 1H), 5.01 (s, 1H), 4.91 (s, 1H), 4.16 
(septet, J = 6.6, 9.5 Hz, 2H), 3.82 (s, 3H), 2.99 (s, 3H), 2.43 – 2.71 (m, 3H), 2.16 (s, 3H), 
1.77 (s, 3H), 1.61 – 1.75 (m, 2H); 13C NMR δ 157.7, 142.8, 0126.1, 124.3, 121.3, 114.4, 
113.8, 107.9, 71.2, 55.5, 46.3, 37.4, 30.9, 29.9, 19.5, 11.1; HRMS for C16H24O4S [MH+] 
m/z calc. 312.1395 Da, found 312.1398 Da. 
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3-[4-hydroxy-3-(prop-1-en-2-yl)butyl]-2-methylphenol (312):   
 
NaH (60% dispersion in mineral oil) was added portionwise to a solution of 
anisole 309 (2.4 g, 10.2 mmol) and ethanethiol (10 mL) in DMF (100 mL) at 0 °C.  The 
suspension was stirred at reflux for 12 h, cooled, and poured into 1M H3PO4 (100 ml).  
The aqueous layer was extracted with MTBE (3 x 100 mL) and the combined organics 
were washed with brine (2 x 100 mL), dried (Na2SO4), and concentrated.  The crude 
residue was purified by column chromatography (SiO2, 20% EtOAc in hexanes) to 
provide phenol 312 as a brownish oil (1.84 g, 82%): Rf = 0.11 (20% EtOAc in Hexanes); 
IR (neat) 3350, 2936, 1585, 1465, 1275, 1036 cm-1; 1H NMR δ 6.98 (t, J = 8.1 Hz, 1H), 
6.72 (d, J = 7.4 Hz, 1H), 6.63 (d, J = 8.1 Hz, 1H), 5.03 (s, 2H), 3.54 – 3.63 (quintet, J = 
5.1, 8.1 Hz, 2H), 2.46 – 2.67 (m, 2H), 2.33 – 2.43 (m, 1H), 2.18 (s, 3H), 1.75 (s, 3H), 
1.56 – 1.70 (m, 2H); 13C NMR δ 163.6, 154.0, 144.5, 142.0, 126.0, 121.2, 63.9, 49.7, 
31.2, 29.9, 18.7, 11.0; HRMS for C14H21O2 [MH+] m/z calc. 221.1542 Da, found 
221.1544 Da. 
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3-(3-(bromomethyl)-4-methylpent-4-enyl)-2-methylphenol (314):   
 
 
To a stirred solution of triphenylphosphine (1.82 g, 8.00 mmol) in CH2Cl2 (35 
mL) in a 25 °C water bath was added bromine (1.20 g, 7.28 mmol) in CH2Cl2 (10 mL) 
dropwise over 10 min.  To this solution, imidazole (1.0 g, 14.68 mmol) and alcohol 312 
(400 mg, 1.82 mmol) were added and the reaction was stirred overnight.  After pouring 
the solution into sat. aq. NH4Cl (50 mL) and extracting with CH2Cl2 (2 x 50 mL), the 
combined organic extracts were concentrated and the residue chromatographed (SiO2, 5% 
ethyl acetate in hexanes) to provide bromide 314 as a yellow oil (450 mg, 87%): Rf = 0.6 
(20% EtOAc in Hexanes); IR (neat) 3446, 2937, 1584, 1464, 1457, 1273, 1063, 667 cm-1; 
1H NMR δ 7.00 (t, J = 8.1 Hz, 1H), 6.74 (d, J = 7.4 Hz, 1H), 6.64 (d, J = 8.1 Hz, 1H), 5.0 
(s, 1H), 4.89 (s, 1H),  3.42 (d, J = 7.4 Hz, 2H), 2.46 – 2.66 (m, 3H), 2.19 (s, 3H), 1.78 – 
1.88 (m, 1H), 1.75 (s, 3H), 1.61 – 1.71 (m, 1H); 13C NMR δ 153.8, 144.2, 141.9, 126.2, 
121.7, 121.5, 113.9, 112.7, 49.2, 36.3, 32.3, 31.3, 18.9, 11.1; HRMS for C14H20OBr 
[MH+] m/z calc. 283.0698 Da, found 283.0702 Da. 
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3-(3-(iodomethyl)-4-methylpent-4-enyl)-2-methylphenol (313):   
 
 
To a stirred solution of triphenylphosphine (420 mg, 1.60 mmol) in CH2Cl2 (10 
mL) was added imidazole (220 mg, 3.20 mmol), iodine (370 mg, 2.45 mmol) and alcohol 
313 (160 mg, 0.73 mmol). After stirring overnight, the suspension was concentrated and 
the residue chromatographed (SiO2, 10% ethyl acetate in hexanes) to provide iodide 314 
as a yellow oil (198 mg, 83%): Rf = 0.23 (10% EtOAc in Hexanes); IR (neat) 3446, 2934, 
2867, 1584, 1465, 1273, 1182, 1063, 897, 783, 718 cm-1; 1H NMR δ 7.00 (t, J = 8.1 Hz, 
1H), 6.74 (d, J = 7.4 Hz, 1H), 6.64 (d, J = 8.1 Hz, 1H), 5.0 (s, 1H), 4.86 (s, 1H),  3.24 
(dd, J = 6.6 Hz, 2H), 2.37 – 2.61 (m, 3H), 2.19 (s, 3H), 1.75 – 1.85 (m, 1H), 1.72 (s, 3H), 
1.61 – 1.71 (m, 1H); 13C NMR δ 153.8, 144.7, 141.9, 126.2, 121.5, 113.9, 113.8, 112.8, 
49.4, 36.6, 31.6, 18.6, 11.2, 11.1; HRMS for C14H20OI [MH+] m/z calc. 331.0559 Da, 
found 331.0562 Da. 
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1-methyl-6-(prop-1-en-2-yl)-5,6,7,8-tetrahydro-naphthalen-2-ol (298):   
 
 
To a stirred solution of bromide 314 (0.549 g, 1.94 mmol) in tert-butanol (550 
mL) at rapid reflux was added Cs2CO3 (1.50 g, 4.61 mmol).  The reaction was stirred at 
reflux for 48h after which, the tert-butanol was removed by distillation.  The remaining 
residue was taken up in sat. aq. NH4Cl (100 mL), neutralized with 0.5 N HCl (aq.), and 
extracted with ethyl acetate (3 x 50 mL).  The combined organic layers were washed with 
brine and concentrated in vacuo to give a yellow oil which was taken on without further 
purification.  Column chromatographic purification (SiO2, 40% CH2Cl2 in hexanes), 
carried out for the purposes of characterization, provided phenol 298 as an off-white 
powder: Rf = 0.25 (40% CH2Cl2 in hexanes); mp = 93 - 95 °C, IR (neat) 3319, 2917, 885, 
795 cm-1; 1H NMR δ 6.82 (d, J = 8.1 Hz, 1H), 6.61 (d, J = 8.1 Hz, 1H), 4.79 (s, 2H), 2.77 
– 2.89 (m, 2H), 2.61 – 2.70 (d of t, J = 5.2, 6.6 Hz, 2H), 2.22 – 2.32 (m, 1H), 2.14 (s, 
3H), 2.03 – 2.12 (m, 1H), 1.82 (s, 3H), 1.59 – 1.69 (d of q, J = 5.9, 6.1 Hz, 1H); 13C NMR 
δ 151.5, 149.7, 136.1, 128.7, 126.7, 121.9, 112.5, 108.7, 41.2, 35.0, 28.2, 27.5, 20.8, 
15.1; HRMS for C14H19O [MH+] m/z calc. 203.1436 Da, found 203.1438 Da. 
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2-methyl-3-(4-methyl-3-methylidenepent-4-en-1-yl)phenol) (299): 
 
Diene 299 was obtained from the elimination of bromide 314 as a side product in 
the phenolate cyclization as a yellow oil: Rf = 0.20 (40% CH2Cl2 in hexanes); IR (neat) 
3392, 2927, 1595, 1464, 1274, 1063, 890 cm-1; 1H NMR δ 7.01 (t, J = 8.1 Hz, 1H), 6.78 
(d, J = 7.4 Hz, 1H), 6.64 (d, J = 8.1 Hz 1H), 5.16 (d, J = 8.9 Hz, 2H), 5.02 (d, J = 11.0 
Hz, 2H), 2.80 (t, J = 8.2 Hz, 2H), 2.52 (t, J = 7.3 Hz, 2H), 2.22 (s, 3H), 1.96 (s, 3H); 13C 
NMR δ 153.7, 147.4, 142.5, 142.3, 126.2, 121.5, 112.6, 112.4, 110.6, 108.8, 34.5, 33.1, 
21.1, 11.1; HRMS for C14H19O [MH+] m/z calc. 203.1436 Da, found 203.1438 Da. 
 
1-methyl-6-(prop-1-en-2-yl)-5,6,7,8-tetrahydro-naphthalen-2-yl acetate (315):   
 
 
To a stirred solution of phenol 298 (0.549 g, 2.71 mmol) in pyridine (10 mL) at 
room temperature was added acetic anhyride (5 mL).  The reaction was stirred at room 
temperature for 30 min and was concentrated in vacuo.  The remaining residue was 
purified via column chromatography (SiO2, 40% CH2Cl2 in hexanes) to provide the 
phenolic acetate 315 as a pale yellow oil (0.663 g, 100%): Rf = 0.33 (40% CH2Cl2 in 
hexanes); IR (neat) 2924, 1761, 1222, 1196, 667 cm-1; 1H NMR δ 6.96 (d, J = 8.1 Hz, 
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1H), 6.79 (d, J = 8.1 Hz, 1H), 4.79 (s, 1H), 4.77 (s, 1H), 2.79 – 2.87 (m. 2H), 2.63 – 2.74 
(m, 2H), 2.33 (s, 3H), 2.26 – 2.31 (m, 1H), 2.06 – 2.13 (m, 1H), 2.03 (s, 3H), 1.81 (s, 
3H), 1.59 – 1.69 (d of q, J = 5.9, 6.1 Hz, 1H); 13C NMR δ 169.7, 149.3, 146.9, 136.4, 
134.6, 127.9, 127.2, 118.8, 109.0, 40.9, 35.2, 27.9, 27.5, 20.8, 11.9; HRMS for C16H21O2 
[MH+] m/z calc. 245.1542 Da, found 245.1545 Da. 
 
1-methyl-6-(prop-1-en-2-yl)-5,6,7,8-tetrahydro-naphthalen-2-yl acetate (315):   
 
To a stirred solution of bromide 314 (2.61, 9.22 mmol) in tert-butanol (1.8 L) at 
rapid reflux was added Cs2CO3 (12.00 g, 36.88 mmol).  The reaction was stirred at reflux 
for 36 h after which, the tert-butanol was removed by distillation.  The remaining residue 
was taken up in acetic anhydride (150 mL) and stirred for 6 h at room temperature, after 
which, the mixture was concentrated in vacuo.  The remaining residue was dissolved in 
sat. aq. NH4Cl (100 mL), and extracted with ethyl acetate (3 x 200 mL).  The combined 
organic layers were washed with brine and concentrated in vacuo to give phenol acetate 
315 as a pale yellow oil (2.18 g, 96%): characterized as above. 
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6-(1-bromo-2-methoxypropan-2-yl)-1-methyl-5,6,7,8-tetrahydro-naphthalen-2-yl 
(316):   
 
To a room temperature, stirred solution of olefin 315 (220 mg, 0.900 mmol) in 
CH2Cl2 (10 mL) was added freshly recrystallized N-bromosuccinimide (NBS) (176 mg, 
0.990 mmol).  After stirring for 15 min (or until complete dissolution of the NBS was 
achieved), distilled methanol (10 mL) was added and the reaction stirred overnight.  To 
the reaction mixture was added K2CO3 (s) (500 mg) and stirring was continued for 4h.  
The mixture was poured into H2O (30 mL) and extracted with ether (3 x 50 mL).  The 
combined organic extracts were washed with brine, dried (Na2SO4) and concentrated in 
vacuo to provide a yellow oil which was chromatographed (SiO2, 20% ethyl acetate in 
hexanes) to give bromohydrin 316 as a mixture of inseparable diastereomers (1:1) as a 
pale yellow oil which foamed in vacuo (278 mg, 99%): Rf = 0.45 (20% EtOAc in 
Hexanes); IR (neat) 3369, 2933, 1488, 1457, 1278, 1065, 731 cm-1; 1H NMR δ 6.84 (d, J 
= 8.1 Hz, 1H), 6.82 (d, J = 8.1 Hz, 1H), 6.62 (d, J = 8.1 Hz, 2H), 3.60 (d of d, J = 11.0, 
6.1 Hz, 4H), 3.28 (s, 6H), 2.78 – 2.91 (d of t, J = 13.2, 4.4 Hz, 4H), 2.59 (t, J = 6.0 Hz, 
4H), 2.06 – 2.21 (m, 4H), 2.13 (s, 6H), 1.91 – 1.97 (m, 2H), 1.35 – 1.47 (m, 2H), 1.28 (s, 
3H), 1.26 (s, 3H); 13C NMR (some resonances are overlapping) δ 151.4, 136.5, 136.1, 
128.9, 127.2, 121.7, 121.6, 112.6, 49.3, 49.2, 39.8, 39.6, 38.3, 37.8, 30.7, 30.2, 27.9, 27.8, 
24.7, 23.6, 18.3, 17.5, 11.0; HRMS for C15H22O2Br [MH+] m/z calc. 313.0803 Da, found 
313.0800 Da. 
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10-methoxy-5,10-dimethyltricyclo[7.2.1.01,6]dodeca-2,5-dien-4-one (317 & 318):   
 
 
 
To a stirred solution of bromides 316 (0.868 g, 2.77 mmol) in tert-butanol (600 
mL) was added Cs2CO3 (8.68 g).  The reaction was stirred at reflux for 48h after which, 
the tert-butanol was removed by distillation.  The remaining residue was taken up in 
brine (100 mL) and extracted with ethyl acetate (3 x 50 mL).  The combined organic 
layers were washed with brine, concentrated, and purified (SiO2, 30% EtOAc in hexanes) 
to provide dienones 317 and 318 as yellow oils (1:1, 0.423g, 66%): Rf = 0.20, 0.18 (20% 
ethyl acetate in hexanes); 317: IR (neat) 2935, 1653, 1066, 667 cm-1; 1H NMR δ 6.61 (d, 
J = 9.5 Hz, 1H), 6.23 (d, J = 10.3 Hz, 1H), 3.31 (s, 3H), 2.73 – 2.81 (dd, J = 9.9, 7.3 Hz, 
1H), 2.63 – 2.70 (m, 1H), 2.08 – 2.45 (m, 3H), 1.87 (s, 3H), 1.75 – 1.94 (m, 2H), 1.45 (s, 
3H), 1.40 – 1.59 (m, 2H); 13C NMR δ 186.5, 160.5, 153.9, 127.9, 126.7, 84.5, 55.5, 51.8, 
48.3, 45.0, 43.5, 27.4, 26.3, 25.9, 10.4; HRMS for C15H21O2 [MH+] m/z calc. 233.1536 
Da, found 233.15361 Da; 318: IR (neat) 2935, 1657, 1627, 1066 cm-1; 1H NMR δ 6.76 (d, 
J = 10.3 Hz, 1H), 6.24 (d, J = 9.6 Hz, 1H), 3.22 (s, 3H), 2.77 – 2.86 (dd, J = 16.9, 7.3 Hz, 
1H), 2.46 (dt, J = 16.3, 2.9 Hz, 1H), 2.06 – 2.37 (m, 3H), 1.86 (s, 3H), 1.54 – 1.70 (m, 
2H), 1.41 (s, 3H), 1.20 – 1.33 (m, 2H); 13C NMR δ 186.5, 159.5, 154.4, 128.6, 127.2, 
86.0, 52.5, 49.6, 48.9, 43.2, 40.6, 26.4, 24.8, 18.6, 10.4; HRMS for C15H21O2 [MH+] m/z 
calc. 233.1536 Da, found 233.15361 Da. 
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5-chloro-10-methoxy-5,10-dimethyltricyclo[7.2.1.01,6]dodeca-2,6-dien-4-one (320):   
 
 
To a stirred solution of dienone 317 (0.009 g, 0.039 mmol) in THF (6 mL) was 
added LDA (2 mL, 1.0M in THF).  The reaction was stirred at reflux for 2h, cooled to 
room temperature and stirred 1h.  To this reaction was added NCS (25 mg, 0.187 mmol) 
and stirred 2h.  The reaction was quenched by the addition of sat. aq. NH4Cl (5 mL) and 
poured into ether (10 mL).  The organic layer was separated and washed with sat. aq. 
NH4Cl (5 mL), brine (5 mL) and the solvent was evaporated.  The remaining residue was 
purified (SiO2, 30% EtOAc in hexanes) to provide α-Cl dienone 320 as a yellow oil 
(0.006g, 58%): Rf = 0.68 (30% EtOAc in hexanes); IR (neat) 2930, 1662, 1446, 1071 
cm-1; 1H NMR δ 6.48 (d, J = 10.3 Hz, 1H), 5.50 (d, J = 9.6 Hz, 1H), 5.40 (t, J = 7.3 Hz, 
1H), 3.28 (s, 3H), 2.70 (dd, J = 14.5, 6.6 Hz, 1H), 2.23 (m, 1H), 1.88 – 2.15 (m, 4H), 1.80 
(s, 3H), 1.58 (s, 3H), 1.40 – 1.50 (m, 1H); 13C NMR δ 155.9, 140.2, 135.8, 132.0, 123.7, 
121.4, 51.6, 50.7, 46.7, 45.7, 29.6, 28.2, 26.3, 23.3, 14.0. 
 
 
 
 
 
 
 
OMe
O
Cl
 256 
1-methyl-6-(2-methyloxiran-2-yl)-5,6,7,8-tetrahydronaphthalen-2-yl acetate (326):   
 
To a stirred solution of olefin 315 (445 mg, 1.82 mmol) in CH2Cl2/acetone (1:1, 
20 mL) with sat. aq. NaHCO3 (10 mL) was added sat. aq. Oxone dropwise until the olefin 
was consumed (TLC monitoring).  The resulting suspension was diluted in ether (20 mL) 
and washed with H2O (2 x 20 mL), brine (20 mL) and concentrated in vacuo to yield the 
epoxides 326 as an otherwise pure, inseparable mixture of diastereomers (1:1) as a pale 
yellow oil (469 mg, 99%): Rf = 0.24 (10% EtOAc in Hexanes); IR (neat) 2928, 1761, 
1480, 1368, 1223, 1196 cm-1; 1H NMR δ 6.96 (t, J = 7.3 Hz, 2H), 6.80 (d, J = 8.1 Hz, 
2H), 2.81 – 2.89 (m, 3H), 2.55 – 2.76 (m, 11H), 2.32 (s, 6H), 2.05 – 2.16 (m, 2H), 2.02 
(s, 6H), 1.55 – 1.71 (m, 2H), 1.36 (s, 3H), 1.34 (s, 3H); 13C NMR δ 169.7, 147.0, 136.4, 
136.4, 133.8, 133.7, 128.2, 127.4, 127.2, 119.1, 59.2, 59.1, 53.4, 52.7, 40.2, 39.7, 32.0, 
27.3, 27.1, 25.2, 25.0, 20.8, 18.6, 18.0, 12.0; HRMS for C16H21O3 [MH+] m/z calc. 
261.1491 Da, found 261.1494 Da. 
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1-methyl-6-(2-methyloxiran-2-yl)-5,6,7,8-tetrahydronaphthalen-2-ol: 
   
 
A solution of acetate epoxide 326 (34 mg, 0.13 mmol) in MeOH (5 mL) with 
K2CO3 (s) (100 mg) was stirred for 4 h.  The reaction was diluted in H2O (10 mL) and 
extracted with DCM (2 x 20 mL).  The combined organics were washed with brine, dried 
(Na2SO4) and concentrated to give an inconsequential mixture of phenolic diastereomeric 
epoxides as a purplish waxy solid (28 mg, 99%): IR (neat) 2928, 1650, 1588, 1465 cm-1; 
1H NMR δ 6.83 (dd, J = 7.4, 6.6 Hz, 2H), 6.61 (d, J = 8.1 Hz, 2H), 2.54 – 2.89 (m, 12H), 
2.06 – 2.19 (m, 2H), 2.12 (s, 6H), 2.05 – 2.16 (m, 2H), 1.26 – 1.63 (m, 4H), 1.36 (s, 3H), 
1.34 (s, 3H); 13C NMR δ 151.5, 136.1, 136.0, 128.1, 127.8, 127.0, 126.9, 126.8, 121.8, 
121.7, 112.7, 60.7, 60.5, 59.4, 59.3, 53.5, 52.8, 47.9, 41.6, 40.5, 39.9, 37.1, 31.7, 29.6, 
27.9, 27.3, 27.1, 25.4, 25.2, 23.5, 18.6, 17.8, 14.2, 14.1, 11.0; HRMS for C14H19O2 [MH+] 
m/z calc. 219.1385 Da, found 219.1385 Da. 
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6-(3-hydroxyprop-1-en-2-yl)-1-methyl-5,6,7,8-tetrahydro-naphthalen-2-ol (327): 
 
 
A solution of epoxides 326 (170 mg, 0.691 mmol) in THF (4 mL) at 23 °C under 
an atmosphere of Ar, was treated with lithium diethylamide (6 mL, 0.5 M solution in 
THF) and stirred for 2h.  The reaction mixture was poured into sat. aq. NH4Cl (10 mL) 
and extracted with EtOAc (2 x 20 mL).  The combined organics were washed with brine, 
concentrated and the crude residue purified by column chromatography (SiO2, 30% 
EtOAc in hexanes) to provide the allylic alcohol 327 as a white powder (132 mg, 94%): 
mp = 112.3 - 113.8 °C; Rf = 0.36 (30% EtOAc in Hexanes);  IR (neat) 3350, 2922, 2853, 
1455, 1279, 1074, 906, 802 cm-1; 1H NMR δ 6.79 (d, J = 8.1 Hz, 1H), 6.58 (d, J = 8.1 Hz, 
1H), 5.10 (s, 1H), 4.95 (s, 1H), 4.20 (s, 2H), 2.77 – 2.86 (m, 2H), 2.55 – 2.70 (m, 2H), 
2.29 – 2.37 (m, 1H), 2.10 (s, 3H), 1.58 – 1.70 (m, 2H), 1.23 (s, 3H); 13C NMR δ 51.3, 
139.8, 135.9, 128.7, 126.8, 121.8, 60.5, 39.9, 39.7, 35.5, 33.9, 31.9, 27.6, 27.4, 25.7, 21.0, 
14.1, 13.6, 13.3, 7.8; HRMS for C14H19O2 [MH+] m/z calc. 219.1385 Da, found 219.1385 
Da. 
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6-(1-hydroxypropan-2-yl)-1-methyl-5,6,7,8-tetrahydro-naphthalen-1-ol (328): 
 
 
A solution of epoxides 326 (420 mg, 1.61 mmol) in toluene (30 mL) was treated 
with Al(Oi-Pr)3 (1.20 g, 5.87 mmol) and the resulting suspension stirred at reflux for 16h.  
The solvent was evaporated and the crude residue was partitioned between EtOAc (20 
mL) and sat. aq. sodium potassium tartrate (20 mL).  The aqueous layer was extracted 
with EtOAc (2 x 20 mL) and the combined organics were washed with brine, dried 
(MgSO4) and concentrated in vacuo to yield an inseparable mixture (1:1) of the saturated 
alcohols 328 and the allylic alcohol 327 as an otherwise pure, pale yellow powder (326 
mg, 93%): Rf = 0.36 (30% EtOAc in hexanes);  IR (neat) 3383, 2962, 2918, 1260, 1089, 
1018, 802 cm-1; 1H NMR δ 6.79 (d, J = 8.1 Hz, 2H), 6.60 (d, J = 8.1 Hz, 2H), 3.73 (dd, J 
= 5.2, 4.4 Hz, 4H), 3.58 (dd, J = 5.2, 6.6 Hz, 4H), 2.36 – 2.88 (m, 8H), 1.69 – 2.21 (m, 
2H), 2.12 (s, 6H), 1.38 – 1.66 (m, 4H), 1.27 (d, J = 7.3 Hz, 3H), 1.25 (d, J = 6.6 Hz, 3H); 
13C NMR (some resonances are overlapping) δ 153.0, 151.4, 136.0, 129.5, 128.8, 126.9, 
112.6, 108.5, 65.2, 35.6, 29.7, 28.6, 27.5, 11.0; HRMS for C14H21O2 [MH+] m/z calc. 
221.2268 Da, found 221.2270 Da. 
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6-(1-bromopropan-2-yl)-1-methyl-5,6,7,8-tetrahydro-naphthalen-1-ol (329): 
 
 
To a stirred solution of alcohol 329 (78 mg, 0.35 mmol) in DCM (10 mL) was 
added triphenylphosphine (126 mg, 0.56 mmol) and carbon tetrabromide (186 mg, 0.56 
mmol).  After stirring for 2h, the solution was diluted in ether (20 mL), washed with sat. 
aq. NaHCO3 (20 mL), brine, and concentrated.  Column chromatographic purfication of 
the crude oil (SiO2, 20% EtOAc in hexanes) provided inseparable bromides 329 as a 
yellow oil: Rf = 0.27 (10% EtOAc in hexanes);  IR (neat) 3404, 2921, 1486, 1455, 1275, 
802 cm-1; 1H NMR δ 6.81 (d, J = 8.1 Hz, 2H), 6.60 (d, J = 8.1 Hz, 2H), 3.52 (m, 4H), 
2.47 – 2.88 (m, 8H), 2.12 (s, 6H), 1.95 – 2.06 (m, 2H), 1.73 – 1.85 (m, 4H), 1.29 – 1.48 
(m, 2H), 1.11 (d, J = 6.6 Hz, 3H), 1.09 (d, J = 5.2 Hz, 3H); 13C NMR (some resonances 
are overlapping) δ 151.4, 136.3, 128.5, 127.1, 121.7, 112.6, 40.1, 39.8, 39.3, 38.9, 36.9, 
36.8, 33.7, 31.9, 30.9, 27.3, 27.2, 25.8, 16.1, 15.6, 10.9; HRMS for C14H20OBr [MH+] m/z 
calc. 283.0698 Da, found 283.0699 Da. 
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6-(1-iodopropan-2-yl)-1-methyl-5,6,7,8-tetrahydro-naphthalen-1-ol: 
 
 
To a stirred solution of alcohol 328 (159 mg, 0.723 mmol) in benzene (10 mL) 
was added triphenylphosphine (224 mg, 0.987 mmol), imidazole (119 mg, 1.85 mmol), 
and I2 (217 mg, 0.856 mmol).  The suspension was heated to reflux and stirred for 16 h, 
after which it was diluted in ether (20 mL), washed with sat. aq. NH4Cl (20 mL), H2O (20 
mL), and brine (20 mL) and concentrated in vacuo.  The crude residue was 
chromatographed (SiO2, 10% EtOAc in hexanes) to give the title compound as a 
brownish oil (82 mg, 33%): Rf = 0.40 (10% EtOAc in Hexanes); IR (neat) 3420, 2926, 
1559, 1155, 667 cm-1; 1H NMR δ 6.82 (d, J = 8.1 Hz, 2H), 6.60 (d, J = 8.1 Hz, 2H), 3.35 
(dq, J = 9.6, 4.4 Hz, 4H), 2.45 – 2.8 (m, 10H), 1.69 – 2.21 (m, 6H), 2.12 (s, 6H), 1.38 – 
1.66 (m, 4H), 1.08 (d, J = 4.6 Hz, 3H), 1.07 (d, J = 5.2 Hz, 3H); 13C NMR δ 159.1, 151.1, 
136.0, 128.1, 127.1, 127.0, 126.9, 126.8, 121.8, 121.7, 112.7, 53.5, 52.8, 41.2, 41.6, 38.6, 
33.9, 31.7, 29.6, 27.2, 27.0, 25.6, 17.4, 15.9, 10.7; HRMS for C14H20OI [MH+] m/z calc. 
331.0559 Da, found 331.0563 Da. 
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5,10-dimethyltricyco[7.2.1.01,6]dodeca-2,5-dien-4-one (330): 
 
To a solution of bromide 329 (14 mg, 0.050 mmol) in t-BuOH (12 mL) was added 
Cs2CO3 (30 mg, 0.092 mmol) and the reaction was stirred at reflux for 16 h.  After 
allowing the reaction to cool to room temperature, it was diluted in brine (20 mL) and 
extracted with EtOAc (3 x 20 mL).  The combined organics were washed with brine (20 
mL) and concentrated in vacuo to provide a mixture (1:1) of diastereomeric dienones 330 
as a brownish oil (8 mg, 80%): Rf = 0.64, 0.57 (20% EtOAc in Hexanes); IR (neat) 2929, 
2865, 1656, 1652, 1626, 1622, 829 cm-1; 1H NMR δ 6.72 (d, J = 9.6 Hz, 1H), 6.67 (d, J = 
10.3 Hz, 1H), 6.24 (d, J = 10.3 Hz, 1H), 6.23 (d, J = 9.6 Hz, 1H), 2.80 (dd, J = 16.2, 10.3 
Hz, 4H), 1.20 – 2.27 (m, 16H), 1.87 (s, 6H), 1.15 (d, J = 7.4 Hz, 3H), 1.14 (d, J = 7.4 Hz, 
3H); 13C NMR δ 186.6, 160.6, 159.6, 154.8, 154.7, 127.7, 127.3, 126.9, 60.3, 49.4, 46.3, 
45.3, 43.2, 42.9, 42.6, 39.9, 37.0, 31.9, 31.1, 26.8, 25.5, 25.1, 23.3, 20.9, 15.9, 14.1, 14.0; 
HRMS for C14H19O [MH+] m/z calc. 203.1436 Da, found 203.1440 Da. 
 
 
 
 
 
 
 
O
H
 263 
7-hydroxy-5,10-dimethyltricyco[7.2.1.01,6]dodeca-2,5-dien-4-one (331): 
 
 
A solution of dienone 330 (16 mg, 0.0792 mmol) in DMF (10 mL) was treated 
with Cs2CO3 (150 mg, 0.448 mmol) and the resulting suspension stirred at 90 °C open to 
air, for 16h.  The solvent was removed in vacuo and the residue taken up in brine (20 mL) 
and extracted with ether (2 x 20 mL).  The combined organic extracts were dried 
(MgSO4) and concentrated to provide autoxidation product 331 as a colorless oil (8 mg, 
46%): Rf = 0.21 (20% EtOAc in Hexanes); IR (neat) 2921, 1653, 1558, 668 cm-1; 1H 
NMR δ 6.72 (d, J = 9.6 Hz, 1H), 6.27 (d, J = 10.3 Hz, 1H), 4.94 (d, J = 5.9 Hz, 1H), 2.65 
(m, 1H), 2.32 (ddd, J = 8.1, 5.2, 3.0 Hz, 1H), 2.04 – 2.19 (m, 2H), 1.97 (s, 3H), 1.85 –
1.91 (m, 1H), 1.18 – 1.46 (m, 2H), 1.08 (d, J = 7.4 Hz, 3H); 13C NMR δ 173.7, 158.7, 
152.4, 133.5, 131.2, 66.0, 45.4, 43.2, 42.3, 39.9, 29.7, 28.5, 23.8, 10.4; HRMS for 
C14H19O2 [MH+] m/z calc. 219.1385 Da, found 219.1389 Da. 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
OH
H
 264 
7-hydroxy-5,10-dimethyltricyclo[7.2.1.01,6]dodec-2-en-4-one (333): 
 
 
To a stirred solution of hydroxydienone 331 (2 mg, 0.0092 mmol) in THF (2 mL) 
at 0 °C was added LAH (0.1 mL, 1.0M in toluene) dropwise.  After 5 min., the reaction 
was quenched by the dropwise addition of MeOH (1 mL). The solvent was evaporated 
and the residue washed with DCM (10 mL).  The organic washings were dried (Na2SO4) 
and concentrated in vacuo.  Column chromatographic purification (SiO2, 30% EtOAc in 
hexanes) yielded enone 333 as a yellow oil (1 mg, 48%): Rf = 0.18 (30% EtOAc in 
Hexanes); IR (neat) 3446, 2922, 1668, 1260 cm-1; 1H NMR δ 6.69 (d, J = 10.4 Hz, 1H), 
5.91 (d, J = 9.6 Hz, 1H), 4.80 (d, J = 5.2 Hz, 1H), 1.82 (d, J = 9.6 Hz, 3H), 1.62 – 1.81 
(m, 4H), 1.02 (d, J = 6.6 Hz, 3H); 13C NMR δ 168.2, 127.5, 107.8, 47.6, 41.4, 41.3, 37.5, 
35.9, 34.8, 29.7, 23.9, 23.7, 13.1; HRMS for C14H21O2 [MH+] m/z calc. 221.1540 Da, 
found 221.1542 Da. 
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6-(3-bromoprop-1-en-2-yl)-1-methyl-5,6,7,8-tetrahydronaphthalen-2-ol (336): 
 
 
To a stirred solution of alcohol XXX (25 mg, 0.115 mmol) in DCM (6 mL) was 
added triphenylphosphine (75 mg, 0.330 mmol) and carbon tetrabromide (110 mg, 0.330 
mmol).  After stirring for 2h, the solution was diluted in ether (20 mL), washed with sat. 
aq. NaHCO3 (20 mL), brine, and concentrated.  Column chromatographic purfication of 
the crude oil (SiO2, 5% EtOAc in hexanes) provided bromide XXX (12 mg, 37%) as a 
yellow oil: Rf = 0.54 (10% EtOAc in hexanes); IR (neat) 2920, 2849, 1260 cm-1; 1H NMR 
δ 6.83 (d, J = 8.1 Hz, 1H), 6.61 (d, J = 8.1 Hz, 1H), 5.27 (s, 1H), 5.07 (s, 1H), 4.10 (s, 
2H), 2.80 – 2.95 (m, 2H), 2.60 – 2.74 (m, 3H), 2.13 (s, 3H), 1.52 – 1.70 (m, 2H), 1.26 (s, 
3H); HRMS for C14H18OBr [MH+] m/z calc. 281.0541 Da, found 281.0546 Da. 
 
 
 
 
 
 
 
 
 
 
Br
HO
 266 
5-methyl-10-methylidenetricyclo[7.2.1.01,6]dodeca-2,5-dien-4-one (330): 
 
To a solution of bromide 336 (40 mg, 0.143 mmol) in t-BuOH (40 mL) was added 
Cs2CO3 (600 mg, 1.84 mmol) and the reaction was stirred at reflux for 16 h.  After 
allowing the reaction to cool to room temperature, it was diluted in brine (20 mL) and 
extracted with EtOAc (3 x 20 mL).  The combined organics were washed with brine (20 
mL) and concentrated in vacuo.  Column chromatography of the crude residue (SiO2, 
20% EtOAc in hexanes) provided dienone 337 as a colorless oil (22 mg, 76%): Rf = 0.64 
(20% EtOAc in Hexanes); IR (neat) 2928, 1658, 1628 cm-1; 1H NMR δ 6.70 (d, J = 10.3 
Hz, 1H), 6.29 (d, J = 9.6 Hz, 1H), 5.05 (s, 1H), 4.96 (s, 1H), 2.93 (bs, 1H), 2.80 (dd, J = 
15.4, 5.8 Hz, 1H), 2.58 (ddd, J = 17.6, 2.9, 2.2 Hz, 1H), 2.32 (m, 1H), 2.18 (s, 3H), 2.08 
(m, 1H), 1.86 (m, 1H), 1.65 (m, 1H), 1.47 (dd, 11.1, 2.2 (H, 1H), 1.26 (m, 1H); 13C NMR 
δ 186.6, 153.5, 152.5, 128.3, 127.8, 106.3, 102.8, 44.9, 43.5, 42.8, 33.5, 29.7, 24.9, 10.5; 
HRMS for C14H17O [MH+] m/z calc. 201.1279 Da, found 201.1282 Da. 
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List of Abbreviations 
1,2-DCE   1,2-dichloroethane  
1,2-DME   1,2-dimethoxyethane  
Ac acetyl 
AIBN 2,2’-azobisisobutyronitrile 
Ar aryl 
atm atmosphere 
BHT butylated hydroxytoluene 
BINAP 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl 
Bn benzyl 
Boc tert-butyloxycarbonyl 
BOM benzyloxymethyl 
BOPCl bis(2-oxo-3-oxazolidinyl)phosphinic chloride 
br broad 
Bu butyl 
CAN ammonium cerium(IV) nitrate 
cat. catalytic 
Cbz benzyloxycarbonyl 
CI chemical ionization 
cod cyclooctodiene 
m-CPBA m-chloroperoxybenzoic acid 
CSA camphorsulfonic acid 
d doublet 
DABCO 1,3-diazabicyclo[2.2.2]octane 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCC 1,3-dicyclohexylcarbodiimide 
DCE 1,2-dichloroethane 
DCM dichloromethane 
dd double doublet 
DDQ 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DEAD diethyl azodicarboxylate 
DIOP (4R,5R)-(-)-O-isopropylidine-2,3-dihydroxy-1,4-bis
 (diphenylphosphino)butane 
DIAD diisopropyl azodicarboxylate 
DIBAL diisobutylaluminium hydride 
DIBALH diisobutylaluminium hydride 
DMAP 4-N,N-dimethylaminopyridine 
DMDO dimethyldioxirane 
DMF N,N-dimethylformamide 
DMP Dess-Martin periodinane 
DMSO dimethylsulfoxide 
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DMTS dimethylthexylsilyl 
equiv. equivalents 
Et ethyl 
Fmoc 9-fluorenylmethoxycarbonyl 
HRMS high resolution mass spectrometry 
HMDS 1,1,1,3,3,3-hexamethyldisilazane 
HMPA hexamethylphorphoramide  
imid. imidazole 
IR infrared 
KHMDS potassium bis(trimethylsilyl)amide 
LHMDS lithium bis(trimethylsilyl)amide 
LAH lithium aluminum hydride 
m multiplet 
m meta 
M molar 
Me methyl 
mol mole 
MEM methoxyethoxymethyl 
MOM methoxymethyl 
mp melting point 
Ms methanesulfonyl 
MS mass spectrometry 
NBA N-bromoacetamide 
NBS N-bromosuccinimide 
NCS N-chlorosuccinimide 
NIS N-iodosuccinimide 
NMR nuclear magnetic tesonance 
Ns p-nitrobenzenesulfonyl 
o ortho 
p para 
PCC pyridinium chlorochromate 
Ph phenyl 
Pht phthalimidyl 
PIFA [bis(trifluoroacetoxy)iodo]benzene 
PMB para-methoxybenzyl 
ppm parts per million 
Pr propyl 
pyr. pyridine 
PyBOP® benzotriazolyloxy-tris[pyrrolidino]-phosphonium 
 hexafluorophosphate 
ORTEP Oak Ridge thermal ellipsoid program 
oxid. oxidation 
R alkyl 
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q quartet 
qu quintet 
s singlet 
t triplet 
TBAF tetrabutylammonium fluoride 
TBDPS tert-butyldiphenylsilyl 
TBDMS or TBS tert-butyldimethylsilyl 
TEA triethylamine 
TES triethylsilyl 
tert tertiary 
TFA trifluoroacetic acid 
TFAA trifluoroacetic anhydride 
THF tetrahydrofuran 
TIPS triisopropylsilyl 
TLC thin layer chromatography 
TMEDA N,N,N',N'-tetramethylethylenediamine 
TMS trimethylsilyl 
TMSOTf trimethylsilyl trifluoromethanesulfonate 
Trt trityl 
Ts toluenesulfonyl 
TsOH or pTSA toluenesulfonic acid 
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